This
page
is
part
of
the
Continuous
Integration
Build
of
FHIR
Specification
(v4.0.1:
R4
-
Mixed
Normative
and
STU
)
in
it's
permanent
home
(it
will
always
(will
be
available
incorrect/inconsistent
at
this
URL).
The
current
version
which
supercedes
this
version
is
5.0.0
.
For
a
full
list
of
available
versions,
see
times).
See
the
Directory
of
published
versions
.
Page
versions:
R5
R4B
R4
R3
R2
Work
Group
|
|
Use
Context
:
|
Official
URL
:
http://hl7.org/fhir/ValueSet/observation-codes
|
|
|||
| active as of 2025-12-17 |
|
|||
|
|
|
|||
This value set is used in the following places:
This
value
set
includes
all
LOINC
codes
from
the
following
code
systems:
Generated Narrative: ValueSet observation-codes
Last updated: 2025-12-17T09:50:17.012Z
http://loinc.org
version
Not
Stated
(use
latest
from
terminology
server)
This
expansion
generated
01
Nov
2019
17
Dec
2025
ValueSet
Expansion from tx.fhir.org based on Loinc v2.81
This value set has >1000 codes in it. In order to keep the publication size manageable, only a selection (1000 codes) of the whole set of codes is shown
| System | Code | Display |
status
![]() |
http://loinc.org
|
100000-9
|
Health informatics pioneer and the father of LOINC | |
http://loinc.org
|
100001-7
|
|
|
http://loinc.org
|
100002-5
|
Specimen care is maintained | |
http://loinc.org
|
100003-3
|
|
|
http://loinc.org
|
100004-1
|
Demonstrates knowledge of the expected psychosocial responses to the procedure | |
http://loinc.org
|
100005-8
|
|
|
http://loinc.org
|
100006-6
|
Demonstrates knowledge of medication management | |
http://loinc.org
|
100007-4
|
|
|
http://loinc.org
|
10000-8
|
R wave duration in lead AVR | |
http://loinc.org
|
100008-2
|
Demonstrates knowledge of wound management | |
http://loinc.org
|
100009-0
|
|
|
http://loinc.org
|
100010-8
|
No injury related to procedure equipment, medical supplies, or instrumentation | |
http://loinc.org
|
100011-6
|
|
|
http://loinc.org
|
100012-4
|
Participates in decisions affecting the patient's plan of care | |
http://loinc.org
|
100013-2
|
| |
http://loinc.org
|
100014-0
|
Psychosocial health is maintained at or improved from baseline | |
http://loinc.org
|
100015-7
|
No injury related to positioning due to care or procedure | |
http://loinc.org
|
10001-6
|
R
wave
duration
in
lead
|
|
http://loinc.org
|
100016-5
|
No injury related to a laser source | |
http://loinc.org
|
100017-3
|
|
|
http://loinc.org
|
100018-1
|
Hospice care Note | |
http://loinc.org
|
100019-9
|
| |
http://loinc.org
|
100020-7
|
|
|
http://loinc.org
|
100021-5
|
GNAQ gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | |
http://loinc.org
|
100022-3
|
|
|
http://loinc.org
|
100023-1
|
IDH2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | |
http://loinc.org
|
10002-4
|
R
wave
duration
in
lead
|
|
http://loinc.org
|
100024-9
|
SETBP1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | |
http://loinc.org
|
100025-6
|
|
|
http://loinc.org
|
100026-4
|
MET gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | |
http://loinc.org
|
100027-2
|
| |
http://loinc.org
|
100028-0
|
FBXW7 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal | |
http://loinc.org
|
100029-8
|
| |
http://loinc.org
|
100030-6
![]() | Axis I: Temporal aspects score [Mainz Pain Staging System] | |
http://loinc.org
|
100031-4
|
Axis II: Spatial aspects score [Mainz Pain Staging System] | |
http://loinc.org
|
10003-2
|
|
|
http://loinc.org
|
100032-2
|
Axis III: Drug taking behavior score [Mainz Pain Staging System] | |
http://loinc.org
|
100033-0
|
|
|
http://loinc.org
|
100034-8
|
Provider of automated external defibrillator use | |
http://loinc.org
|
100035-5
|
|
|
http://loinc.org
|
100036-3
|
Exam finding location of Lung | |
http://loinc.org
|
100037-1
|
| |
http://loinc.org
|
100038-9
![]() | Patient evaluation disposition EMS unit | |
http://loinc.org
|
100039-7
|
Crew disposition for patient care EMS unit | |
http://loinc.org
|
10004-0
|
|
|
http://loinc.org
|
100040-5
|
Patient transport disposition EMS unit | |
http://loinc.org
|
100041-3
|
|
|
http://loinc.org
|
100042-1
|
Atovaquone [Susceptibility] | |
http://loinc.org
|
100043-9
|
| |
http://loinc.org
|
100044-7
|
Cefcapene [Susceptibility] | |
http://loinc.org
|
100045-4
|
|
|
http://loinc.org
|
100046-2
|
Cefquinome [Susceptibility] | |
http://loinc.org
|
100047-0
|
|
|
http://loinc.org
|
100048-8
|
Clarithromycin+Ethambutol [Susceptibility] | |
http://loinc.org
|
100049-6
|
|
|
http://loinc.org
|
100050-4
|
Erythromycin+Ethambutol [Susceptibility] | |
http://loinc.org
|
100051-2
|
|
|
http://loinc.org
|
100052-0
|
Flomoxef [Susceptibility] | |
http://loinc.org
|
100053-8
|
|
|
http://loinc.org
|
100054-6
|
Gamithromycin [Susceptibility] | |
http://loinc.org
|
100055-3
|
|
|
http://loinc.org
|
100056-1
|
Panipenem [Susceptibility] | |
http://loinc.org
|
10005-7
|
|
|
http://loinc.org
|
100057-9
|
Prothionamide [Susceptibility] | |
http://loinc.org
|
100058-7
|
|
|
http://loinc.org
|
100059-5
|
Rifapentine [Susceptibility] | |
http://loinc.org
|
100060-3
|
|
|
http://loinc.org
|
100061-1
|
Tosufloxacin [Susceptibility] | |
http://loinc.org
|
100062-9
|
| |
http://loinc.org
|
100063-7
![]() | Primary skin concern | |
http://loinc.org
|
100064-5
|
Itch severity Reporting Period - Reported | |
http://loinc.org
|
10006-5
|
|
|
http://loinc.org
|
100065-2
|
Satisfied with treatment | |
http://loinc.org
|
100066-0
|
| TRIAL |
http://loinc.org
|
100067-8
|
Eye Image magnification | TRIAL |
http://loinc.org
|
100068-6
|
| TRIAL |
http://loinc.org
|
100069-4
|
Left eye Fixation point [Angle] | TRIAL |
http://loinc.org
|
100070-2
|
| TRIAL |
http://loinc.org
|
100071-0
![]() | Left cornea Cell density | TRIAL |
http://loinc.org
|
100072-8
|
Right cornea Coefficient of variation | TRIAL |
http://loinc.org
|
10007-3
|
|
|
http://loinc.org
|
100073-6
|
Left cornea Coefficient of variation | TRIAL |
http://loinc.org
|
100074-4
|
| TRIAL |
http://loinc.org
|
100075-1
|
Left cornea Hexagonality | TRIAL |
http://loinc.org
|
100076-9
|
| TRIAL |
http://loinc.org
|
100077-7
|
Left cornea Endothelial cells counted | TRIAL |
http://loinc.org
|
100078-5
|
| TRIAL |
http://loinc.org
|
100079-3
![]() | Left cornea Endothelial cell area.min | TRIAL |
http://loinc.org
|
100080-1
|
Right cornea Endothelial cell area.max | TRIAL |
http://loinc.org
|
10008-1
|
|
|
http://loinc.org
|
100081-9
|
Left cornea Endothelial cell area.max | TRIAL |
http://loinc.org
|
100082-7
|
| TRIAL |
http://loinc.org
|
100083-5
|
Left cornea Endothelial cell area.mean | TRIAL |
http://loinc.org
|
100084-3
|
| TRIAL |
http://loinc.org
|
100085-0
![]() | Left cornea Cell area.standard deviation | TRIAL |
http://loinc.org
|
100086-8
|
Right cornea Type of Analysis method by Specular microscopy | TRIAL |
http://loinc.org
|
100087-6
|
|
|
http://loinc.org
|
100088-4
|
Taenia solium larva Ab bands panel - Serum by Immunoblot | |
http://loinc.org
|
100089-2
|
| |
http://loinc.org
|
1000-9
|
|
|
http://loinc.org
|
100090-0
|
|
|
http://loinc.org
|
100091-8
|
|
|
http://loinc.org
|
100092-6
|
Trypanosoma cruzi Ab bands panel - Serum by Immunoblot | |
http://loinc.org
|
100093-4
|
|
|
http://loinc.org
|
100094-2
|
|
|
http://loinc.org
|
100095-9
|
|
|
http://loinc.org
|
100096-7
|
Trypanosoma cruzi 42kD IgG Ab [Presence] in Serum by Immunoblot | |
http://loinc.org
|
100097-5
|
|
|
http://loinc.org
|
100098-3
|
Trypanosoma cruzi 120-200kD IgG Ab [Presence] in Serum by Immunoblot | |
http://loinc.org
|
10009-9
|
|
|
http://loinc.org
|
100099-1
|
Trypanosoma cruzi 160kD IgG Ab [Presence] in Serum by Immunoblot | |
http://loinc.org
|
100100-7
|
|
|
http://loinc.org
|
100101-5
|
Fasciola sp 8-9kD IgG Ab [Presence] in Serum by Immunoblot | |
http://loinc.org
|
100102-3
|
|
|
http://loinc.org
|
100103-1
|
Fasciola sp 60kD IgG Ab [Presence] in Serum by Immunoblot | |
http://loinc.org
|
100104-9
|
|
|
http://loinc.org
|
100105-6
|
Filaria IgG and IgM panel - Serum | |
http://loinc.org
|
100106-4
|
| |
http://loinc.org
|
10010-7
|
|
|
http://loinc.org
|
100107-2
|
Leishmania sp IgG Ab [Presence] in Serum by Immunoassay | |
http://loinc.org
|
100108-0
|
|
|
http://loinc.org
|
100109-8
|
Leishmania sp Ab bands panel - Serum by Immunoblot | |
http://loinc.org
|
100110-6
|
|
|
http://loinc.org
|
100111-4
|
Leishmania sp 16kD IgG Ab [Presence] in Serum by Immunoblot | |
http://loinc.org
|
100112-2
|
| |
http://loinc.org
|
100113-0
![]() | Helicobacter pylori Ab panel - Serum | |
http://loinc.org
|
100114-8
|
Toxoplasma gondii 30kD Ab [Presence] in Serum by Immunoblot | |
http://loinc.org
|
10011-5
|
|
|
http://loinc.org
|
100115-5
|
Toxoplasma gondii 31kD Ab [Presence] in Serum by Immunoblot | |
http://loinc.org
|
100116-3
|
|
|
http://loinc.org
|
100117-1
|
Toxoplasma gondii 40kD Ab [Presence] in Serum by Immunoblot | |
http://loinc.org
|
100118-9
|
| |
http://loinc.org
|
100119-7
|
Toxoplasma gondii 45kD Ab [Presence] in Serum by Immunoblot | |
http://loinc.org
|
100120-5
|
Chlamydia trachomatis Ab panel - Serum | |
http://loinc.org
|
100121-3
|
|
|
http://loinc.org
|
100122-1
|
Chlamydophila pneumoniae Ab panel - Serum | |
http://loinc.org
|
10012-3
|
|
|
http://loinc.org
|
100123-9
|
Chlamydophila pneumoniae IgA Ab [Presence] in Serum by Immunoassay | |
http://loinc.org
|
100124-7
|
|
|
http://loinc.org
|
100125-4
|
Chlamydophila psittaci Ab panel - Serum | |
http://loinc.org
|
100126-2
|
| |
http://loinc.org
|
100127-0
|
Campylobacter sp Ab panel - Serum | |
http://loinc.org
|
100128-8
|
Cryptococcus sp Ag panel - Serum | |
http://loinc.org
|
100129-6
|
| |
http://loinc.org
|
100130-4
|
Schistosoma mansoni Ab [Presence] in Serum by Immunoblot | |
http://loinc.org
|
10013-1
|
|
|
http://loinc.org
|
100131-2
|
|
|
http://loinc.org
|
100132-0
|
| |
http://loinc.org
|
100133-8
|
Schistosoma sp 10kD Ab [Presence] in Serum by Immunoblot | |
http://loinc.org
|
100134-6
|
|
|
http://loinc.org
|
100135-3
|
Schistosoma sp 12-13kD Ab [Presence] in Serum by Immunoblot | |
http://loinc.org
|
100136-1
|
| |
http://loinc.org
|
100137-9
|
Schistosoma sp 15-16kD Ab [Presence] in Serum by Immunoblot | |
http://loinc.org
|
100138-7
|
|
|
http://loinc.org
|
100139-5
|
Schistosoma sp 22-24kD Ab [Presence] in Serum by Immunoblot | |
http://loinc.org
|
100140-3
|
|
|
http://loinc.org
|
100141-1
|
Schistosoma sp 65kD Ab [Presence] in Serum by Immunoblot | |
http://loinc.org
|
100142-9
|
| |
http://loinc.org
|
100143-7
|
Schistosoma sp 80kD Ab [Presence] in Serum by Immunoblot | |
http://loinc.org
|
100144-5
|
|
|
http://loinc.org
|
100145-2
|
Schistosoma sp 110kD Ab [Presence] in Serum by Immunoblot | |
http://loinc.org
|
100146-0
|
| |
http://loinc.org
|
100147-8
![]() | Toxoplasma gondii Ab bands panel - Serum by Immunoblot | |
http://loinc.org
|
100148-6
|
Schistosoma sp Ab bands panel - Serum by Immunoblot | |
http://loinc.org
|
10014-9
|
|
|
http://loinc.org
|
100149-4
|
6-oxo-piperidine-2-carboxylate and 6(R+S)-oxo-propylpiperidine-2-carboxylate panel - Urine and Serum or Plasma | |
http://loinc.org
|
100150-2
|
|
|
http://loinc.org
|
100151-0
|
|
|
http://loinc.org
|
100152-8
|
6-oxo-piperidine-2-carboxylate/Creatinine [Molar ratio] in Urine | |
http://loinc.org
|
100153-6
|
| |
http://loinc.org
|
100154-4
![]() | Specimen collection supervision level | |
http://loinc.org
|
100155-1
|
Left cornea Type of Analysis method by Specular microscopy | TRIAL |
http://loinc.org
|
10015-6
|
| |
http://loinc.org
|
100156-9
![]() | SARS-CoV-2 (COVID-19) variant [Type] in Specimen by NAA with probe detection | |
http://loinc.org
|
100157-7
|
SARS-CoV-2 (COVID-19) lineage [Type] in Specimen by Sequencing | |
http://loinc.org
|
100158-5
|
| |
http://loinc.org
|
100159-3
![]() | Knee Society Score pre-op panel [Knee Society Score] | |
http://loinc.org
|
100160-1
|
Knee replacement | |
http://loinc.org
|
100161-9
|
| |
http://loinc.org
|
100162-7
![]() | Knee alignment W standing X-ray measured | |
http://loinc.org
|
100163-5
|
Knee medial AndOr lateral instability W full extension | |
http://loinc.org
|
10016-4
|
|
|
http://loinc.org
|
100164-3
|
Knee AP instability W 90 degree flexion | |
http://loinc.org
|
100165-0
|
|
|
http://loinc.org
|
100166-8
|
Flexion contracture range of Knee | |
http://loinc.org
|
100167-6
|
| |
http://loinc.org
|
100168-4
![]() | Knee pain severity with level walking | |
http://loinc.org
|
100169-2
|
Knee pain severity with stairs or inclines | |
http://loinc.org
|
1001-7
|
| |
http://loinc.org
|
100170-0
![]() | Knee feels normal | |
http://loinc.org
|
100171-8
|
Satisfaction with level of knee pain while sitting | |
http://loinc.org
|
10017-2
|
|
|
http://loinc.org
|
100172-6
|
|
|
http://loinc.org
|
100173-4
|
Satisfaction with knee function while getting out of bed | |
http://loinc.org
|
100174-2
|
|
|
http://loinc.org
|
100175-9
|
Satisfaction with knee function while performing recreational activities | |
http://loinc.org
|
100176-7
|
|
|
http://loinc.org
|
100177-5
|
Expect surgery will improve ability to perform activities of daily living | |
http://loinc.org
|
100178-3
|
|
|
http://loinc.org
|
100179-1
|
Walk without assistive mobility devices | |
http://loinc.org
|
10018-0
|
|
|
http://loinc.org
|
100180-9
|
Assistive mobility devices used | |
http://loinc.org
|
100181-7
|
|
|
http://loinc.org
|
100182-5
|
Duration of standing before sitting due to knee discomfort | |
http://loinc.org
|
100183-3
|
|
|
http://loinc.org
|
100184-1
|
How bothersome is knee when walking on an uneven surface | |
http://loinc.org
|
100185-8
|
|
|
http://loinc.org
|
100186-6
|
How bothersome is knee when climbing up or down a flight of stairs | |
http://loinc.org
|
100187-4
|
|
|
http://loinc.org
|
100188-2
|
How bothersome is knee when getting into or out of a car | |
http://loinc.org
|
100189-0
|
|
|
http://loinc.org
|
100190-8
|
How bothersome is knee when climbing a ladder or step stool | |
http://loinc.org
|
100191-6
|
|
|
http://loinc.org
|
100192-4
|
How bothersome is knee when squatting | |
http://loinc.org
|
100193-2
|
|
|
http://loinc.org
|
100194-0
|
How bothersome is knee when running | |
http://loinc.org
|
100195-7
|
| |
http://loinc.org
|
100196-5
|
Pre-op total score [Knee Society Score] | |
http://loinc.org
|
100197-3
|
Exercise activity and pain severity panel | |
http://loinc.org
|
10019-8
|
|
|
http://loinc.org
|
100198-1
|
| |
http://loinc.org
|
100199-9
|
Pre-op symptoms score [Knee Society Score] | |
http://loinc.org
|
100200-5
|
|
|
http://loinc.org
|
100201-3
|
Pre-op functional activities score [Knee Society Score] | |
http://loinc.org
|
100202-1
|
|
|
http://loinc.org
|
100203-9
|
Knee Society Score post-op panel [Knee Society Score] | |
http://loinc.org
|
100204-7
|
|
|
http://loinc.org
|
100205-4
|
Accuracy of pre-surgery expectations to perform activities of daily living | |
http://loinc.org
|
10020-6
|
|
|
http://loinc.org
|
100206-2
|
Accuracy of pre-surgery expectations to perform leisure, recreational, or sports activities | |
http://loinc.org
|
100207-0
|
| |
http://loinc.org
|
100208-8
|
Post-op objective knee indicators score [Knee Society Score] | |
http://loinc.org
|
100209-6
|
|
|
http://loinc.org
|
100210-4
|
Post-op patient expectations score [Knee Society Score] | |
http://loinc.org
|
100211-2
|
| |
http://loinc.org
|
100212-0
|
Post-op discretionary knee activities score [Knee Society Score] | |
http://loinc.org
|
100213-8
|
|
|
http://loinc.org
|
10021-4
|
|
|
http://loinc.org
|
100214-6
|
|
|
http://loinc.org
|
100215-3
|
Episode of care medical records Document Transplant surgery | |
http://loinc.org
|
100216-1
|
|
|
http://loinc.org
|
100217-9
|
Synoptic report Document Surgical oncology | |
http://loinc.org
|
100218-7
|
|
|
http://loinc.org
|
100219-5
|
Surgical oncology of melanoma cancer synoptic report | |
http://loinc.org
|
100220-3
|
|
|
http://loinc.org
|
100221-1
|
Surgical oncology of thyroid cancer synoptic report | |
http://loinc.org
|
10022-2
|
|
|
http://loinc.org
|
100222-9
|
|
|
http://loinc.org
|
100223-7
|
Physical findings of Retina Narrative | |
http://loinc.org
|
100224-5
|
|
|
http://loinc.org
|
100225-2
|
Bone density quantitative ultrasound study | |
http://loinc.org
|
100226-0
|
|
|
http://loinc.org
|
100227-8
|
Colon capsule endoscopy study Document | |
http://loinc.org
|
100228-6
|
|
|
http://loinc.org
|
100229-4
|
Endoscopic ultrasound study Document | |
http://loinc.org
|
10023-0
|
|
|
http://loinc.org
|
100230-2
|
Routine prenatal assessment panel | |
http://loinc.org
|
100231-0
|
|
|
http://loinc.org
|
100232-8
|
Impacts of Events Scale-Revised panel | |
http://loinc.org
|
100233-6
|
|
|
http://loinc.org
|
100234-4
|
Trouble staying asleep | |
http://loinc.org
|
100235-1
|
| |
http://loinc.org
|
100236-9
|
Felt irritable AndOr angry | |
http://loinc.org
|
100237-7
|
|
|
http://loinc.org
|
100238-5
|
Thought about adverse event unintentionally | |
http://loinc.org
|
100239-3
|
|
|
http://loinc.org
|
100240-1
|
Avoided reminders of adverse event | |
http://loinc.org
|
100241-9
|
|
|
http://loinc.org
|
100242-7
|
Easily startled | |
http://loinc.org
|
100243-5
|
| |
http://loinc.org
|
100244-3
|
Aware of feelings about adverse event, but did not address them | |
http://loinc.org
|
100245-0
|
| |
http://loinc.org
|
100246-8
![]() | Acted or felt the same as during adverse event | |
http://loinc.org
|
100247-6
|
Trouble falling asleep | |
http://loinc.org
|
10024-8
|
| |
http://loinc.org
|
100248-4
|
Waves of strong feelings about adverse event | |
http://loinc.org
|
100249-2
|
Tried to remove adverse event from memory | |
http://loinc.org
|
1002-5
|
|
|
http://loinc.org
|
100250-0
|
Trouble concentrating | |
http://loinc.org
|
100251-8
|
|
|
http://loinc.org
|
100252-6
|
Had dreams about adverse event | |
http://loinc.org
|
100253-4
|
|
|
http://loinc.org
|
100254-2
|
Tried not to talk about adverse event | |
http://loinc.org
|
10025-5
|
|
|
http://loinc.org
|
100255-9
|
Total score [Impact of Event Scale-Revised] | |
http://loinc.org
|
100256-7
|
|
|
http://loinc.org
|
100257-5
|
Feel unsteady when standing or walking | |
http://loinc.org
|
100258-3
|
| |
http://loinc.org
|
100259-1
|
Aware of tactile sensations | |
http://loinc.org
|
100260-9
|
| |
http://loinc.org
|
100261-7
![]() | Critical of own thoughts AndOr feelings | |
http://loinc.org
|
100262-5
|
Able to notice distressing thoughts AndOr feelings without having to react | |
http://loinc.org
|
10026-3
|
|
|
http://loinc.org
|
100263-3
|
Easily distracted | |
http://loinc.org
|
100264-1
|
|
|
http://loinc.org
|
100265-8
|
Aware of dietary intake impact on self | |
http://loinc.org
|
100266-6
|
|
|
http://loinc.org
|
100267-4
|
Aware of auditory stimuli | |
http://loinc.org
|
100268-2
|
| |
http://loinc.org
|
100269-0
|
Do things without paying attention | |
http://loinc.org
|
100270-8
|
|
|
http://loinc.org
|
10027-1
|
|
|
http://loinc.org
|
100271-6
|
|
|
http://loinc.org
|
100272-4
|
|
|
http://loinc.org
|
100273-2
|
|
|
http://loinc.org
|
100274-0
|
Observing score [FFMQ] | |
http://loinc.org
|
100275-7
|
|
|
http://loinc.org
|
100276-5
|
Acting with awareness score [FFMQ] | |
http://loinc.org
|
100277-3
|
|
|
http://loinc.org
|
100278-1
|
Nonreactivity score [FFMQ] | |
http://loinc.org
|
100279-9
|
|
|
http://loinc.org
|
100280-7
|
Five Facet Mindfulness Questionnaire panel [FFMQ] | |
http://loinc.org
|
100281-5
|
| |
http://loinc.org
|
100282-3
|
Vaccine exemption certificate | |
http://loinc.org
|
100283-1
|
|
|
http://loinc.org
|
100284-9
|
Walking - functional ability | |
http://loinc.org
|
100285-6
|
|
|
http://loinc.org
|
100286-4
|
Able to board public transportation | |
http://loinc.org
|
100287-2
|
|
|
http://loinc.org
|
100288-0
|
Absence of deformity score [Harris Hip Score] | |
http://loinc.org
|
10028-9
|
|
|
http://loinc.org
|
100289-8
|
|
|
http://loinc.org
|
100290-6
|
Range of motion score [Harris Hip Score] | |
http://loinc.org
|
100291-4
|
|
|
http://loinc.org
|
100292-2
|
Pre-op patient satisfaction score [Knee Society Score] | |
http://loinc.org
|
100293-0
|
|
|
http://loinc.org
|
100294-8
|
Hip Abduction range of motion | |
http://loinc.org
|
100295-5
|
|
|
http://loinc.org
|
100296-3
|
Hip External rotation range of motion | |
http://loinc.org
|
10029-7
|
|
|
http://loinc.org
|
100297-1
|
Hip Internal rotation range of motion | |
http://loinc.org
|
100298-9
|
|
|
http://loinc.org
|
100299-7
|
Post-op patient satisfaction score [Knee Society Score] | |
http://loinc.org
|
100300-3
|
| |
http://loinc.org
|
100301-1
|
Start time Unspecified body region | |
http://loinc.org
|
100302-9
|
| |
http://loinc.org
|
100303-7
|
Condition certainty of presence | |
http://loinc.org
|
100304-5
|
Flights climbed [#] Reporting Period | |
http://loinc.org
|
10030-5
|
|
|
http://loinc.org
|
100305-2
|
| |
http://loinc.org
|
100306-0
|
|
|
http://loinc.org
|
100307-8
|
Behavioral screening elder mistreatment | |
http://loinc.org
|
100308-6
|
| |
http://loinc.org
|
100309-4
![]() | Activity support person | |
http://loinc.org
|
100310-2
|
Reliability of support person | |
http://loinc.org
|
100311-0
|
| |
http://loinc.org
|
100312-8
|
Person or persons that makes sure there is enough food, medicines or any other things needed in house | |
http://loinc.org
|
10031-3
|
|
|
http://loinc.org
|
100313-6
|
Need help with household things such as cook meals, help feed, or provide correct medicines each day | |
http://loinc.org
|
100314-4
|
| |
http://loinc.org
|
100315-1
![]() | Need help getting out of bed, showered, or dressed | |
http://loinc.org
|
100316-9
|
Need help to make sure bills get paid | |
http://loinc.org
|
100317-7
|
| |
http://loinc.org
|
100318-5
|
Have help with finances AndOr financial decisions | |
http://loinc.org
|
100319-3
|
| |
http://loinc.org
|
100320-1
![]() | Financial support person usually asks for permission before making decisions | |
http://loinc.org
|
10032-1
|
R' wave duration in lead V5 | |
http://loinc.org
|
100321-9
|
| |
http://loinc.org
|
100322-7
![]() | Have access to paperwork for financial decisions made | |
http://loinc.org
|
100323-5
|
Financial support person forged signature | |
http://loinc.org
|
100324-3
|
| |
http://loinc.org
|
100325-0
![]() | Experienced theft by support person | |
http://loinc.org
|
100326-8
|
Money spent or property sold without permission | |
http://loinc.org
|
100327-6
|
| |
http://loinc.org
|
100328-4
|
Stranger forced document signature for financial gain | |
http://loinc.org
|
100329-2
|
Feared for safety due to verbal attack | |
http://loinc.org
|
1003-3
|
|
|
http://loinc.org
|
100330-0
|
Felt humiliated due to ridicule | |
http://loinc.org
|
100331-8
|
| |
http://loinc.org
|
100332-6
![]() | Ignored by close friend or relative for extended period | |
http://loinc.org
|
100333-4
|
Physically hit or threatened | |
http://loinc.org
|
100334-2
|
|
|
http://loinc.org
|
100335-9
|
Coerced sexual activity | |
http://loinc.org
|
100336-7
|
|
|
http://loinc.org
|
100337-5
|
Coerced to undress or expose private body area | |
http://loinc.org
|
100338-3
|
|
|
http://loinc.org
|
10033-9
|
R' wave duration in lead V6 | |
http://loinc.org
|
100339-1
|
|
|
http://loinc.org
|
100340-9
|
Range of motion panel Hip | |
http://loinc.org
|
100341-7
|
|
|
http://loinc.org
|
100342-5
|
Volatile Organic Compounds associated with SARS-CoV-2 infection [Presence] in Exhaled gas by Gas chromatography-mass spectrometry | |
http://loinc.org
|
100343-3
|
| |
http://loinc.org
|
100344-1
![]() | Influenza virus A RNA [Presence] in Saliva (oral fluid) by NAA with probe detection | |
http://loinc.org
|
100345-8
|
Influenza virus A and B and SARS-CoV-2 (COVID-19) RNA panel - Specimen by NAA with probe detection | |
http://loinc.org
|
100346-6
|
|
|
http://loinc.org
|
10034-7
|
S wave amplitude in lead AVF | |
http://loinc.org
|
100347-4
|
|
|
http://loinc.org
|
100348-2
|
Model for end-stage liver disease sodium score | |
http://loinc.org
|
100349-0
|
|
|
http://loinc.org
|
100350-8
|
Sesamum indicum 1 IgE Ab [Units/volume] in Serum | |
http://loinc.org
|
100351-6
|
|
|
http://loinc.org
|
100352-4
|
|
|
http://loinc.org
|
100353-2
|
|
|
http://loinc.org
|
10035-4
|
S wave amplitude in lead AVL | |
http://loinc.org
|
100354-0
|
|
|
http://loinc.org
|
100355-7
|
|
|
http://loinc.org
|
100356-5
|
Chlamydia trachomatis and Neisseria gonorrhoeae and Trichomonas vaginalis DNA [Identifier] in Specimen by NAA with probe detection | |
http://loinc.org
|
100357-3
|
|
|
http://loinc.org
|
100358-1
|
Phentermine [Presence] in Cord tissue by Screen method | |
http://loinc.org
|
100359-9
|
|
|
http://loinc.org
|
100360-7
|
Brief Resilience Scale panel [BRS] | |
http://loinc.org
|
100361-5
|
|
|
http://loinc.org
|
10036-2
|
S wave amplitude in lead AVR | |
http://loinc.org
|
100362-3
|
|
|
http://loinc.org
|
100363-1
|
Easily recover from a stressful event | |
http://loinc.org
|
100364-9
|
|
|
http://loinc.org
|
100365-6
|
Easily recover from difficulties | |
http://loinc.org
|
100366-4
|
|
|
http://loinc.org
|
100367-2
|
Total Score BRS | |
http://loinc.org
|
100368-0
|
|
|
http://loinc.org
|
100369-8
|
NM Thyroid gland Views W Tl-201 IV | |
http://loinc.org
|
10037-0
|
|
|
http://loinc.org
|
100370-6
|
Orthopoxvirus DNA [Identifier] in Specimen by NAA with probe detection | |
http://loinc.org
|
100371-4
|
| |
http://loinc.org
|
100372-2
|
Abiraterone [Mass/volume] in Serum or Plasma | |
http://loinc.org
|
100373-0
|
| |
http://loinc.org
|
100374-8
|
Aloe vera IgG Ab [Units/volume] in Serum | |
http://loinc.org
|
100375-5
|
|
|
http://loinc.org
|
100376-3
|
Bamboo sprouts IgG Ab [Units/volume] in Serum | |
http://loinc.org
|
100377-1
|
|
|
http://loinc.org
|
100378-9
|
Sheep cheese IgG Ab [Units/volume] in Serum | |
http://loinc.org
|
100379-7
|
| |
http://loinc.org
|
100380-5
|
Red cabbage IgG Ab [Units/volume] in Serum | |
http://loinc.org
|
100381-3
|
|
|
http://loinc.org
|
100382-1
|
FDA package insert REMS addressed risk | |
http://loinc.org
|
100383-9
|
|
|
http://loinc.org
|
100384-7
|
Turnip IgG Ab [Units/volume] in Serum | |
http://loinc.org
|
100385-4
|
|
|
http://loinc.org
|
100386-2
|
Rosemary IgG Ab [Units/volume] in Serum | |
http://loinc.org
|
100387-0
|
| |
http://loinc.org
|
10038-8
|
S wave amplitude in lead II | |
http://loinc.org
|
100388-8
|
|
|
http://loinc.org
|
100389-6
|
Pistachio IgG Ab [Units/volume] in Serum | |
http://loinc.org
|
100390-4
|
|
|
http://loinc.org
|
100391-2
|
Dates IgG Ab [Units/volume] in Serum | |
http://loinc.org
|
100392-0
|
|
|
http://loinc.org
|
100393-8
|
Allergen Mushroom mix 2 (Xerocomus, Boletus) IgG Ab [Units/volume] in Serum | |
http://loinc.org
|
100394-6
|
|
|
http://loinc.org
|
100395-3
|
Carob IgG Ab [Units/volume] in Serum | |
http://loinc.org
|
10039-6
|
|
|
http://loinc.org
|
100396-1
|
Rapeseed IgG Ab [Units/volume] in Serum | |
http://loinc.org
|
100397-9
|
|
|
http://loinc.org
|
100398-7
|
Goose meat IgG Ab [Units/volume] in Serum | |
http://loinc.org
|
100399-5
|
|
|
http://loinc.org
|
100400-1
|
Quail meat IgG Ab [Units/volume] in Serum | |
http://loinc.org
|
100401-9
|
|
|
http://loinc.org
|
100402-7
|
Venison meat IgG Ab [Units/volume] in Serum | |
http://loinc.org
|
100403-5
|
|
|
http://loinc.org
|
10040-4
|
S wave amplitude in lead V1 | |
http://loinc.org
|
100404-3
|
|
|
http://loinc.org
|
100405-0
|
Kefir IgG Ab [Units/volume] in Serum | |
http://loinc.org
|
100406-8
|
| |
http://loinc.org
|
100407-6
|
Camembert cheese IgG Ab [Units/volume] in Serum | |
http://loinc.org
|
100408-4
|
|
|
http://loinc.org
|
100409-2
|
Processed cheese IgG Ab [Units/volume] in Serum | |
http://loinc.org
|
1004-1
|
|
|
http://loinc.org
|
100410-0
|
Curd cheese IgG Ab [Units/volume] in Serum | |
http://loinc.org
|
100411-8
|
|
|
http://loinc.org
|
10041-2
|
S wave amplitude in lead V2 | |
http://loinc.org
|
100412-6
|
|
|
http://loinc.org
|
100413-4
|
Fennel Fresh IgG Ab [Units/volume] in Serum | |
http://loinc.org
|
100414-2
|
|
|
http://loinc.org
|
100415-9
|
Kale IgG Ab [Units/volume] in Serum | |
http://loinc.org
|
100416-7
|
|
|
http://loinc.org
|
100417-5
|
Vitis sp leaf IgG Ab [Units/volume] in Serum | |
http://loinc.org
|
100418-3
|
| |
http://loinc.org
|
100419-1
|
Snow pea IgG Ab [Units/volume] in Serum | |
http://loinc.org
|
10042-0
|
| |
http://loinc.org
|
100420-9
|
Fava bean IgG Ab [Units/volume] in Serum | |
http://loinc.org
|
100421-7
|
|
|
http://loinc.org
|
100422-5
|
Common Chicory IgG Ab [Units/volume] in Serum | |
http://loinc.org
|
100423-3
|
| |
http://loinc.org
|
100424-1
|
8(9)-Cholestenol [Mass/volume] in Serum or Plasma | |
http://loinc.org
|
100425-8
|
| |
http://loinc.org
|
100426-6
|
Squalene [Mass/volume] in Serum or Plasma | |
http://loinc.org
|
100427-4
|
|
|
http://loinc.org
|
100428-2
|
Carnitine free and total and acylcarnitine panel - Urine | |
http://loinc.org
|
100429-0
|
|
|
http://loinc.org
|
100430-8
|
Cells.LRBA+/Cells.CD3+CD14-CD45+ in Blood by Flow cytometry (FC) | |
http://loinc.org
|
100431-6
|
|
|
http://loinc.org
|
100432-4
|
Cells.LRBA+/Cells.CD3-CD14-CD19+CD45+ in Blood by Flow cytometry (FC) | |
http://loinc.org
|
100433-2
|
|
|
http://loinc.org
|
100434-0
|
Orthopoxvirus.non-variola DNA [Presence] in Specimen by NAA with probe detection | |
http://loinc.org
|
100435-7
|
|
|
http://loinc.org
|
100436-5
|
Ubiquitin carboxyl-terminal hydrolase-L1 [Mass/volume] in Serum by Immunoassay | |
http://loinc.org
|
100437-3
|
|
|
http://loinc.org
|
10043-8
|
S wave amplitude in lead V4 | |
http://loinc.org
|
100438-1
|
|
|
http://loinc.org
|
100439-9
|
|
|
http://loinc.org
|
100440-7
|
|
|
http://loinc.org
|
100441-5
|
|
|
http://loinc.org
|
100442-3
|
|
|
http://loinc.org
|
100443-1
|
|
|
http://loinc.org
|
100444-9
|
|
|
http://loinc.org
|
100445-6
|
|
|
http://loinc.org
|
10044-6
|
S wave amplitude in lead V5 | |
http://loinc.org
|
100446-4
|
|
|
http://loinc.org
|
100447-2
|
|
|
http://loinc.org
|
100448-0
|
|
|
http://loinc.org
|
100449-8
|
|
|
http://loinc.org
|
100450-6
|
Child and adolescent psychiatry Outpatient Progress note | |
http://loinc.org
|
100451-4
|
|
|
http://loinc.org
|
100452-2
|
Clinical cardiac electrophysiology Outpatient Progress note | |
http://loinc.org
|
10045-3
|
|
|
http://loinc.org
|
100453-0
|
Clinical genetics Outpatient Progress note | |
http://loinc.org
|
100454-8
|
|
|
http://loinc.org
|
100455-5
|
Clinical pathology Outpatient Progress note | |
http://loinc.org
|
100456-3
|
|
|
http://loinc.org
|
100457-1
|
Consultant Outpatient Progress note | |
http://loinc.org
|
100458-9
|
|
|
http://loinc.org
|
100459-7
|
Outpatient COVID-19 Progress note | |
http://loinc.org
|
100460-5
|
| |
http://loinc.org
|
10046-1
|
S wave duration in lead AVF | |
http://loinc.org
|
100461-3
|
| |
http://loinc.org
|
100462-1
|
Dialysis and Therapeutic apheresis Outpatient Progress note | |
http://loinc.org
|
100463-9
|
| |
http://loinc.org
|
100464-7
|
Endocrinology Outpatient Progress note | |
http://loinc.org
|
100465-4
|
|
|
http://loinc.org
|
100466-2
|
Gastroenterology Outpatient Progress note | |
http://loinc.org
|
100467-0
|
|
|
http://loinc.org
|
100468-8
|
Gynecologic oncology Outpatient Progress note | |
http://loinc.org
|
100469-6
|
|
|
http://loinc.org
|
100470-4
|
Healthcare navigator Outpatient Progress note | |
http://loinc.org
|
100471-2
|
|
|
http://loinc.org
|
100472-0
|
Heart failure+Transplant cardiology Outpatient Progress note | |
http://loinc.org
|
100473-8
|
|
|
http://loinc.org
|
100474-6
|
Hematology+Medical oncology Outpatient Progress note | |
http://loinc.org
|
100475-3
|
|
|
http://loinc.org
|
100476-1
|
Immunology Outpatient Progress note | |
http://loinc.org
|
100477-9
|
|
|
http://loinc.org
|
100478-7
|
Internal medicine Outpatient Progress note | |
http://loinc.org
|
10047-9
|
|
|
http://loinc.org
|
100479-5
|
Interventional cardiology Outpatient Progress note | |
http://loinc.org
|
100480-3
|
| |
http://loinc.org
|
100481-1
|
Outpatient Mechanical circulatory support Progress note | |
http://loinc.org
|
100482-9
|
| |
http://loinc.org
|
100483-7
|
|
|
http://loinc.org
|
100484-5
|
Multi-specialty program Outpatient Progress note | |
http://loinc.org
|
100485-2
|
|
|
http://loinc.org
|
100486-0
|
Nephrology Outpatient Progress note | |
http://loinc.org
|
10048-7
|
| |
http://loinc.org
|
100487-8
![]() | Neurological surgery Outpatient Progress note | |
http://loinc.org
|
100488-6
|
Neurology Outpatient Progress note | |
http://loinc.org
|
100489-4
|
|
|
http://loinc.org
|
100490-2
|
Nurse practitioner Outpatient Progress note | |
http://loinc.org
|
100491-0
|
|
|
http://loinc.org
|
100492-8
|
Nutrition and dietetics Outpatient Progress note | |
http://loinc.org
|
100493-6
|
|
|
http://loinc.org
|
100494-4
|
Obstetrics Outpatient Progress note | |
http://loinc.org
|
10049-5
|
|
|
http://loinc.org
|
100495-1
|
Occupational therapy Outpatient Progress note | |
http://loinc.org
|
100496-9
|
|
|
http://loinc.org
|
100497-7
|
Ophthalmology Outpatient Progress note | |
http://loinc.org
|
100498-5
|
|
|
http://loinc.org
|
100499-3
|
Oral and Maxillofacial Surgery Outpatient Progress note | |
http://loinc.org
|
100500-8
|
|
|
http://loinc.org
|
100501-6
|
Orthotics prosthetics Outpatient Progress note | |
http://loinc.org
|
100502-4
|
|
|
http://loinc.org
|
10050-3
|
S wave duration in lead II | |
http://loinc.org
|
100503-2
|
|
|
http://loinc.org
|
100504-0
|
Palliative care Outpatient Progress note | |
http://loinc.org
|
100505-7
|
|
|
http://loinc.org
|
100506-5
|
Pediatric dermatology Outpatient Progress note | |
http://loinc.org
|
100507-3
|
|
|
http://loinc.org
|
100508-1
|
Pediatric gastroenterology Outpatient Progress note | |
http://loinc.org
|
100509-9
|
| |
http://loinc.org
|
100510-7
|
Pediatric infectious diseases Outpatient Progress note | |
http://loinc.org
|
10051-1
|
|
|
http://loinc.org
|
100511-5
|
Pediatric otolaryngology Outpatient Progress note | |
http://loinc.org
|
100512-3
|
| |
http://loinc.org
|
100513-1
|
Pediatric rheumatology Outpatient Progress note | |
http://loinc.org
|
100514-9
|
|
|
http://loinc.org
|
100515-6
|
Pediatric transplant hepatology Outpatient Progress note | |
http://loinc.org
|
100516-4
|
|
|
http://loinc.org
|
100517-2
|
Pharmacogenomics Outpatient Progress note | |
http://loinc.org
|
100518-0
|
|
|
http://loinc.org
|
100519-8
|
Physical therapy Outpatient Progress note | |
http://loinc.org
|
100520-6
|
|
|
http://loinc.org
|
100521-4
|
Podiatry Outpatient Progress note | |
http://loinc.org
|
100522-2
|
|
|
http://loinc.org
|
100523-0
|
Psychology Outpatient Progress note | |
http://loinc.org
|
100524-8
|
|
|
http://loinc.org
|
100525-5
|
Radiation oncology Outpatient Progress note | |
http://loinc.org
|
100526-3
|
|
|
http://loinc.org
|
100527-1
|
Recreational therapy Outpatient Progress note | |
http://loinc.org
|
100528-9
|
|
|
http://loinc.org
|
10052-9
|
S wave duration in lead V1 | |
http://loinc.org
|
100529-7
|
|
|
http://loinc.org
|
100530-5
|
Rheumatology Outpatient Progress note | |
http://loinc.org
|
100531-3
|
| |
http://loinc.org
|
100532-1
|
Social worker Outpatient Progress note | |
http://loinc.org
|
100533-9
|
|
|
http://loinc.org
|
100534-7
|
Speech-language pathology Outpatient Progress note | |
http://loinc.org
|
100535-4
|
|
|
http://loinc.org
|
100536-2
|
Sports medicine Outpatient Progress note | |
http://loinc.org
|
10053-7
|
|
|
http://loinc.org
|
100537-0
|
Surgery of the hand Outpatient Progress note | |
http://loinc.org
|
100538-8
|
|
|
http://loinc.org
|
100539-6
|
Thromboembolism Outpatient Progress note | |
http://loinc.org
|
100540-4
|
|
|
http://loinc.org
|
100541-2
|
Trauma Outpatient Progress note | |
http://loinc.org
|
100542-0
|
|
|
http://loinc.org
|
100543-8
|
Vascular neurology Outpatient Progress note | |
http://loinc.org
|
100544-6
|
| |
http://loinc.org
|
10054-5
|
S wave duration in lead V3 | |
http://loinc.org
|
100545-3
|
|
|
http://loinc.org
|
100546-1
|
Wound, Ostomy, and Continence Care Outpatient Progress note | |
http://loinc.org
|
100547-9
|
|
|
http://loinc.org
|
100548-7
|
Allergy and Immunology Hospital Progress note | |
http://loinc.org
|
100549-5
|
|
|
http://loinc.org
|
100550-3
|
Attending Hospital Progress note | |
http://loinc.org
|
100551-1
|
| |
http://loinc.org
|
10055-2
|
S wave duration in lead V4 | |
http://loinc.org
|
100552-9
|
|
|
http://loinc.org
|
100553-7
|
Blood banking and transfusion medicine Hospital Progress note | |
http://loinc.org
|
100554-5
|
| |
http://loinc.org
|
100555-2
|
Breastfeeding Hospital Progress note | |
http://loinc.org
|
100556-0
|
|
|
http://loinc.org
|
100557-8
|
Cardiac surgery Hospital Progress note | |
http://loinc.org
|
100558-6
|
|
|
http://loinc.org
|
100559-4
|
Child and adolescent psychiatry Hospital Progress note | |
http://loinc.org
|
10056-0
|
|
|
http://loinc.org
|
100560-2
|
Clinical cardiac electrophysiology Hospital Progress note | |
http://loinc.org
|
100561-0
|
|
|
http://loinc.org
|
100562-8
|
Clinical neurophysiology Hospital Progress note | |
http://loinc.org
|
100563-6
|
|
|
http://loinc.org
|
100564-4
|
Colon and rectal surgery Hospital Progress note | |
http://loinc.org
|
100565-1
|
| |
http://loinc.org
|
100566-9
|
Dentistry Hospital Progress note | |
http://loinc.org
|
100567-7
|
|
|
http://loinc.org
|
100568-5
|
Developmental-behavioral pediatrics Hospital Progress note | |
http://loinc.org
|
100569-3
|
|
|
http://loinc.org
|
100570-1
|
Eating disorders Hospital Progress note | |
http://loinc.org
|
100571-9
|
|
|
http://loinc.org
|
100572-7
|
Family medicine Hospital Progress note | |
http://loinc.org
|
100573-5
|
|
|
http://loinc.org
|
100574-3
|
General medicine Hospital Progress note | |
http://loinc.org
|
100575-0
|
|
|
http://loinc.org
|
100576-8
|
Gynecologic oncology Hospital Progress note | |
http://loinc.org
|
100577-6
|
|
|
http://loinc.org
|
10057-8
|
S wave duration in lead V6 | |
http://loinc.org
|
100578-4
|
|
|
http://loinc.org
|
100579-2
|
Heart failure Hospital Progress note | |
http://loinc.org
|
1005-8
|
|
|
http://loinc.org
|
100580-0
|
|
|
http://loinc.org
|
100581-8
|
|
|
http://loinc.org
|
100582-6
|
|
|
http://loinc.org
|
100583-4
|
| |
http://loinc.org
|
100584-2
|
Immunology Hospital Progress note | |
http://loinc.org
|
100585-9
|
| |
http://loinc.org
|
10058-6
|
S' wave amplitude in lead AVF | |
http://loinc.org
|
100586-7
|
|
|
http://loinc.org
|
100587-5
|
Interventional cardiology Hospital Progress note | |
http://loinc.org
|
100588-3
|
|
|
http://loinc.org
|
100589-1
|
Hospital Mechanical circulatory support Progress note | |
http://loinc.org
|
100590-9
|
| |
http://loinc.org
|
100591-7
|
Mental health Hospital Progress note | |
http://loinc.org
|
100592-5
|
|
|
http://loinc.org
|
100593-3
|
Neonatal perinatal medicine Hospital Progress note | |
http://loinc.org
|
10059-4
|
| |
http://loinc.org
|
100594-1
|
Nephrology Hospital Progress note | |
http://loinc.org
|
100595-8
|
|
|
http://loinc.org
|
100596-6
|
Neurology Hospital Progress note | |
http://loinc.org
|
100597-4
|
|
|
http://loinc.org
|
100598-2
|
|
|
http://loinc.org
|
100599-0
|
Nurse Hospital Progress note | |
http://loinc.org
|
100600-6
|
|
|
http://loinc.org
|
100601-4
|
Obstetrics and Gynecology Hospital Progress note | |
http://loinc.org
|
10060-2
|
|
|
http://loinc.org
|
100602-2
|
Obstetrics Hospital Progress note | |
http://loinc.org
|
100603-0
|
|
|
http://loinc.org
|
100604-8
|
Oncology Hospital Progress note | |
http://loinc.org
|
100605-5
|
|
|
http://loinc.org
|
100606-3
|
Oral and Maxillofacial Surgery Hospital Progress note | |
http://loinc.org
|
100607-1
|
|
|
http://loinc.org
|
100608-9
|
Orthotics prosthetics Hospital Progress note | |
http://loinc.org
|
100609-7
|
|
|
http://loinc.org
|
10061-0
|
S' wave amplitude in lead I | |
http://loinc.org
|
100610-5
|
|
|
http://loinc.org
|
100611-3
|
Palliative care Hospital Progress note | |
http://loinc.org
|
100612-1
|
|
|
http://loinc.org
|
100613-9
|
Pediatric cardiology Hospital Progress note | |
http://loinc.org
|
100614-7
|
|
|
http://loinc.org
|
100615-4
|
Pediatric endocrinology Hospital Progress note | |
http://loinc.org
|
100616-2
|
|
|
http://loinc.org
|
100617-0
|
Pediatric hematology-oncology Hospital Progress note | |
http://loinc.org
|
100618-8
|
| |
http://loinc.org
|
100619-6
|
Pediatric otolaryngology Hospital Progress note | |
http://loinc.org
|
100620-4
|
|
|
http://loinc.org
|
100621-2
|
Pediatric rheumatology Hospital Progress note | |
http://loinc.org
|
100622-0
|
|
|
http://loinc.org
|
100623-8
|
Pediatric transplant hepatology Hospital Progress note | |
http://loinc.org
|
100624-6
|
|
|
http://loinc.org
|
100625-3
|
Pharmacology Hospital Progress note | |
http://loinc.org
|
100626-1
|
|
|
http://loinc.org
|
100627-9
|
Physical therapy Hospital Progress note | |
http://loinc.org
|
10062-8
|
|
|
http://loinc.org
|
100628-7
|
Plastic surgery Hospital Progress note | |
http://loinc.org
|
100629-5
|
|
|
http://loinc.org
|
100630-3
|
Psychology Hospital Progress note | |
http://loinc.org
|
100631-1
|
|
|
http://loinc.org
|
100632-9
|
Radiology Hospital Progress note | |
http://loinc.org
|
100633-7
|
|
|
http://loinc.org
|
100634-5
|
Recreational therapy Hospital Progress note | |
http://loinc.org
|
100635-2
|
|
|
http://loinc.org
|
10063-6
|
S' wave amplitude in lead III | |
http://loinc.org
|
100636-0
|
|
|
http://loinc.org
|
100637-8
|
Rheumatology Hospital Progress note | |
http://loinc.org
|
100638-6
|
|
|
http://loinc.org
|
100639-4
|
Social worker Hospital Progress note | |
http://loinc.org
|
100640-2
|
|
|
http://loinc.org
|
100641-0
|
Speech-language pathology Hospital Progress note | |
http://loinc.org
|
100642-8
|
|
|
http://loinc.org
|
100643-6
|
Surgery of the hand Hospital Progress note | |
http://loinc.org
|
10064-4
|
|
|
http://loinc.org
|
100644-4
|
Thromboembolism Hospital Progress note | |
http://loinc.org
|
100645-1
|
| |
http://loinc.org
|
100646-9
|
Urology Hospital Progress note | |
http://loinc.org
|
100647-7
|
| |
http://loinc.org
|
100648-5
|
Vascular surgery Hospital Progress note | |
http://loinc.org
|
100649-3
|
|
|
http://loinc.org
|
100650-1
|
Wound, Ostomy, and Continence Care Hospital Progress note | |
http://loinc.org
|
10065-1
|
|
|
http://loinc.org
|
100651-9
|
Hospital COVID-19 Intubation Progress note | |
http://loinc.org
|
100652-7
|
| |
http://loinc.org
|
100653-5
|
Pure tone air conduction threshold audiometry panel | |
http://loinc.org
|
100654-3
|
|
|
http://loinc.org
|
100655-0
|
XR Sella turcica Lateral | |
http://loinc.org
|
100656-8
|
|
|
http://loinc.org
|
100657-6
|
Maternal and fetal medicine Telephone encounter+Hospital Progress note | |
http://loinc.org
|
100658-4
|
|
|
http://loinc.org
|
100659-2
|
Maternal and fetal medicine Hospital Progress note | |
http://loinc.org
|
1006-6
|
|
|
http://loinc.org
|
100660-0
|
|
|
http://loinc.org
|
100661-8
|
|
|
http://loinc.org
|
100662-6
|
|
|
http://loinc.org
|
100663-4
|
|
|
http://loinc.org
|
100664-2
|
|
|
http://loinc.org
|
100665-9
|
|
|
http://loinc.org
|
100666-7
|
|
|
http://loinc.org
|
100667-5
|
|
|
http://loinc.org
|
100668-3
|
|
|
http://loinc.org
|
10066-9
|
|
|
http://loinc.org
|
100669-1
|
|
|
http://loinc.org
|
100670-9
|
|
|
http://loinc.org
|
100671-7
|
|
|
http://loinc.org
|
100672-5
|
|
|
http://loinc.org
|
100673-3
|
| |
http://loinc.org
|
100674-1
|
BK virus DNA [Log #/volume] (viral load) in Blood by NAA with probe detection | |
http://loinc.org
|
100675-8
|
|
|
http://loinc.org
|
100676-6
|
|
|
http://loinc.org
|
10067-7
|
|
|
http://loinc.org
|
100677-4
|
|
|
http://loinc.org
|
100678-2
|
|
|
http://loinc.org
|
100679-0
|
Herpes
|
|
http://loinc.org
|
100680-8
|
Herpes virus 6 DNA [Log #/volume] (viral load) in Blood by NAA with probe detection | |
http://loinc.org
|
100681-6
|
|
|
http://loinc.org
|
100682-4
|
|
|
http://loinc.org
|
100683-2
|
| |
http://loinc.org
|
100684-0
|
|
|
http://loinc.org
|
10068-5
|
|
|
http://loinc.org
|
100685-7
|
|
|
http://loinc.org
|
100686-5
|
|
|
http://loinc.org
|
100687-3
|
|
|
http://loinc.org
|
100688-1
|
|
|
http://loinc.org
|
100689-9
|
|
|
http://loinc.org
|
100690-7
|
Toxoplasma
gondii
DNA
|
|
http://loinc.org
|
100691-5
|
Varicella
zoster
virus
DNA
|
|
http://loinc.org
|
100692-3
|
|
|
http://loinc.org
|
10069-3
|
|
|
http://loinc.org
|
100693-1
|
|
|
http://loinc.org
|
100694-9
|
|
|
http://loinc.org
|
100695-6
|
|
|
http://loinc.org
|
100696-4
|
|
|
http://loinc.org
|
100697-2
|
|
|
http://loinc.org
|
100698-0
|
|
|
http://loinc.org
|
100699-8
|
Rifabutin+Ethambutol [Susceptibility] | |
http://loinc.org
|
100700-4
|
| |
http://loinc.org
|
10070-1
|
|
|
http://loinc.org
|
100701-2
|
|
|
http://loinc.org
|
100702-0
|
|
|
http://loinc.org
|
100703-8
|
|
|
http://loinc.org
|
100704-6
|
|
|
http://loinc.org
|
100705-3
|
|
|
http://loinc.org
|
100706-1
|
|
|
http://loinc.org
|
100707-9
|
|
|
http://loinc.org
|
100708-7
|
Plasma cells/Leukocytes in Synovial fluid | |
http://loinc.org
|
100709-5
|
|
|
http://loinc.org
|
100710-3
|
Chlamydia trachomatis and Neisseria gonorrhoeae rRNA panel - Throat by NAA with probe detection | |
http://loinc.org
|
100711-1
|
| |
http://loinc.org
|
100712-9
|
|
|
http://loinc.org
|
100713-7
|
|
|
http://loinc.org
|
100714-5
|
|
|
http://loinc.org
|
100715-2
|
|
|
http://loinc.org
|
100716-0
|
|
|
http://loinc.org
|
100717-8
|
|
|
http://loinc.org
|
100718-6
|
| |
http://loinc.org
|
10071-9
|
| |
http://loinc.org
|
100719-4
|
|
|
http://loinc.org
|
100720-2
|
|
|
http://loinc.org
|
100721-0
|
|
|
http://loinc.org
|
100722-8
|
|
|
http://loinc.org
|
100723-6
|
Sports medicine Discharge summary | |
http://loinc.org
|
100724-4
|
|
|
http://loinc.org
|
100725-1
|
Optometry Discharge summary | |
http://loinc.org
|
100726-9
|
| |
http://loinc.org
|
10072-7
|
S' wave duration in lead AVR | |
http://loinc.org
|
100727-7
|
| |
http://loinc.org
|
100728-5
|
Cardiac surgery Discharge summary | |
http://loinc.org
|
100729-3
|
|
|
http://loinc.org
|
100730-1
|
Transplant surgery Discharge summary | |
http://loinc.org
|
100731-9
|
|
|
http://loinc.org
|
100732-7
|
Cholesterol.in lipoprotein (little a) and Cholesterol.in LDL panel - Serum | |
http://loinc.org
|
100733-5
|
|
|
http://loinc.org
|
100734-3
|
traMADol and Metabolites Panel - Urine by Confirmatory method | |
http://loinc.org
|
10073-5
|
|
|
http://loinc.org
|
100735-0
|
Mannose-6-phosphate isomerase and phosphomannomutase 1 panel - Leukocytes | |
http://loinc.org
|
100736-8
|
|
|
http://loinc.org
|
100737-6
|
Alkaline phosphatase.macromolecular [Presence] in Serum or Plasma | |
http://loinc.org
|
100738-4
|
| |
http://loinc.org
|
100739-2
|
Aspartate aminotransferase.macromolecular [Presence] in Serum or Plasma | |
http://loinc.org
|
1007-4
|
|
|
http://loinc.org
|
100740-0
|
|
|
http://loinc.org
|
100741-8
|
Gamma glutamyl transferase.macromolecular [Presence] in Serum or Plasma | |
http://loinc.org
|
100742-6
|
| |
http://loinc.org
|
10074-3
|
S' wave duration in lead II | |
http://loinc.org
|
100743-4
|
|
|
http://loinc.org
|
100744-2
|
Alpha-1-acid glycoprotein [Mass/volume] in Serum or Plasma by Electrophoresis | |
http://loinc.org
|
100745-9
|
|
|
http://loinc.org
|
100746-7
|
Glucose [Moles/volume] in Mixed venous blood | |
http://loinc.org
|
100747-5
|
|
|
http://loinc.org
|
100748-3
|
Legionella spp [Presence] in Specimen by NAA with probe detection | |
http://loinc.org
|
100749-1
|
|
|
http://loinc.org
|
10075-0
|
S' wave duration in lead III | |
http://loinc.org
|
100750-9
|
|
|
http://loinc.org
|
100751-7
|
Galactose-alpha-1,3-galactose (Alpha-Gal) panel - Serum or Plasma | |
http://loinc.org
|
100752-5
|
|
|
http://loinc.org
|
100753-3
|
Alleviating factors - Reported | |
http://loinc.org
|
100754-1
|
| |
http://loinc.org
|
100755-8
|
Oligoclonal bands [#] in Serum or Plasma by Isoelectric focusing | |
http://loinc.org
|
100756-6
|
|
|
http://loinc.org
|
100757-4
|
Protein fractions.oligoclonal bands panel - Serum and CSF by Isoelectric focusing | |
http://loinc.org
|
100758-2
|
|
|
http://loinc.org
|
100759-0
|
| |
http://loinc.org
|
100760-8
|
XR Radius and Ulna - left Single view | |
http://loinc.org
|
100761-6
|
|
|
http://loinc.org
|
100762-4
|
| |
http://loinc.org
|
100763-2
|
| |
http://loinc.org
|
100764-0
|
|
|
http://loinc.org
|
100765-7
|
|
|
http://loinc.org
|
100766-5
|
Center for Epidemiologic Studies Depression Scale panel [CES-D] | |
http://loinc.org
|
100767-3
|
|
|
http://loinc.org
|
10076-8
|
S' wave duration in lead V1 | |
http://loinc.org
|
100768-1
|
|
|
http://loinc.org
|
100769-9
|
Unhappy even with help from my family or friends | |
http://loinc.org
|
100770-7
|
|
|
http://loinc.org
|
100771-5
|
Trouble focusing | |
http://loinc.org
|
100772-3
|
|
|
http://loinc.org
|
100773-1
|
Feeling everything is too much of an effort | |
http://loinc.org
|
100774-9
|
|
|
http://loinc.org
|
100775-6
|
Feeling life had been a failure | |
http://loinc.org
|
10077-6
|
|
|
http://loinc.org
|
100776-4
|
Feeling fearful | |
http://loinc.org
|
100777-2
|
|
|
http://loinc.org
|
100778-0
|
Feeling happy | |
http://loinc.org
|
100779-8
|
|
|
http://loinc.org
|
100780-6
|
Feeling lonely | |
http://loinc.org
|
100781-4
|
|
|
http://loinc.org
|
100782-2
|
Enjoying life | |
http://loinc.org
|
100783-0
|
|
|
http://loinc.org
|
10078-4
|
S' wave duration in lead V3 | |
http://loinc.org
|
100784-8
|
|
|
http://loinc.org
|
100785-5
|
Feeling people dislike me | |
http://loinc.org
|
100786-3
|
|
|
http://loinc.org
|
100787-1
|
Total Score CES-D | |
http://loinc.org
|
100788-9
|
|
|
http://loinc.org
|
100789-7
|
Rhizopus nigricans IgG4 Ab [Mass/volume] in Serum | |
http://loinc.org
|
100790-5
|
|
|
http://loinc.org
|
100791-3
|
Hamster epithelium IgG Ab [Mass/volume] in Serum | |
http://loinc.org
|
10079-2
|
|
|
http://loinc.org
|
100792-1
|
Forsythia IgE Ab [Units/volume] in Serum | |
http://loinc.org
|
100793-9
|
|
|
http://loinc.org
|
100794-7
|
Follitropin [Units/volume] in Body fluid | |
http://loinc.org
|
100795-4
|
|
|
http://loinc.org
|
100796-2
|
Thyroglobulin [Mass/volume] in Body fluid | |
http://loinc.org
|
100797-0
|
|
|
http://loinc.org
|
100798-8
|
|
|
http://loinc.org
|
100799-6
|
21-Deoxycortisol [Mass/volume] in Serum --1st specimen post XXX challenge | |
http://loinc.org
|
100-8
|
|
|
http://loinc.org
|
10080-0
|
S' wave duration in lead V5 | |
http://loinc.org
|
100800-2
|
|
|
http://loinc.org
|
100801-0
|
21-Deoxycortisol [Mass/volume] in Serum --3rd specimen post XXX challenge | |
http://loinc.org
|
100802-8
|
|
|
http://loinc.org
|
100803-6
|
21-Deoxycortisol [Mass/volume] in Serum --5th specimen post XXX challenge | |
http://loinc.org
|
100804-4
|
|
|
http://loinc.org
|
100805-1
|
Vasopressin [Moles/volume] in Plasma --2nd specimen post XXX challenge | |
http://loinc.org
|
100806-9
|
|
|
http://loinc.org
|
100807-7
|
Vasopressin [Moles/volume] in Plasma --4th specimen post XXX challenge | |
http://loinc.org
|
100808-5
|
|
|
http://loinc.org
|
100809-3
|
Vasopressin [Moles/volume] in Plasma --6th specimen post XXX challenge | |
http://loinc.org
|
100810-1
|
| |
http://loinc.org
|
100811-9
|
Vasopressin [Moles/volume] in Plasma --8th specimen post XXX challenge | |
http://loinc.org
|
100812-7
|
|
|
http://loinc.org
|
100813-5
|
Vasopressin [Moles/volume] in Plasma --10th specimen post XXX challenge | |
http://loinc.org
|
100814-3
|
|
|
http://loinc.org
|
100815-0
|
Vasopressin [Moles/volume] in Plasma --12th specimen post XXX challenge | |
http://loinc.org
|
100816-8
|
|
|
http://loinc.org
|
100817-6
|
|
|
http://loinc.org
|
10081-8
|
S' wave duration in lead V6 | |
http://loinc.org
|
100818-4
|
| |
http://loinc.org
|
100819-2
|
Renin [Mass/volume] in Plasma --2nd specimen post XXX challenge | |
http://loinc.org
|
1008-2
|
|
|
http://loinc.org
|
100820-0
|
| |
http://loinc.org
|
100821-8
|
National POLST form: portable medical order panel | |
http://loinc.org
|
100822-6
|
|
|
http://loinc.org
|
100823-4
|
Initial portable medical treatment orders | |
http://loinc.org
|
100824-2
|
|
|
http://loinc.org
|
100825-9
|
Medically assisted nutrition orders | |
http://loinc.org
|
10082-6
|
|
|
http://loinc.org
|
100826-7
|
Portable medical order AndOr advance directive review | |
http://loinc.org
|
100827-5
|
| |
http://loinc.org
|
100828-3
|
Portable medical order administrative information | |
http://loinc.org
|
100829-1
|
|
|
http://loinc.org
|
100830-9
|
|
|
http://loinc.org
|
100831-7
|
|
|
http://loinc.org
|
100832-5
|
| |
http://loinc.org
|
100833-3
|
|
|
http://loinc.org
|
10083-4
|
ST initial amplitude 6 ms in lead AVL | |
http://loinc.org
|
100834-1
|
|
|
http://loinc.org
|
100835-8
|
|
|
http://loinc.org
|
100836-6
|
Alpha subunit free [Units/volume] in Serum or Plasma --7th specimen post XXX challenge | |
http://loinc.org
|
100837-4
|
|
|
http://loinc.org
|
100838-2
|
|
|
http://loinc.org
|
100839-0
|
|
|
http://loinc.org
|
100840-8
|
IgE [Units/volume] in Body fluid | |
http://loinc.org
|
100841-6
|
|
|
http://loinc.org
|
10084-2
|
ST initial amplitude 6 ms in lead AVR | |
http://loinc.org
|
100842-4
|
|
|
http://loinc.org
|
100843-2
|
|
|
http://loinc.org
|
100844-0
|
|
|
http://loinc.org
|
100845-7
|
|
|
http://loinc.org
|
100846-5
|
| |
http://loinc.org
|
100847-3
|
Gas and ammonia panel - Arterial blood | |
http://loinc.org
|
100848-1
|
|
|
http://loinc.org
|
100849-9
|
|
|
http://loinc.org
|
100850-7
|
Neutrophils [#/volume] in Amniotic fluid by Manual count | |
http://loinc.org
|
100851-5
|
| |
http://loinc.org
|
100852-3
![]() | NM Bones Views for metastasis W Sr-89 IV | |
http://loinc.org
|
100853-1
|
NM Pericardial space Views for effusion | |
http://loinc.org
|
100854-9
|
| TRIAL |
http://loinc.org
|
100855-6
|
| TRIAL |
http://loinc.org
|
100856-4
|
CD3+CD4+ (T4 helper) cells/cells in Blood mononuclear cells | TRIAL |
http://loinc.org
|
100857-2
|
| TRIAL |
http://loinc.org
|
100858-0
|
Cells.CD4+CD154+/CD4 cells in Blood --after stimulation with SARS-CoV-2 Spike peptide | TRIAL |
http://loinc.org
|
10085-9
|
|
|
http://loinc.org
|
100859-8
|
Cells.CD4.Interferon gamma-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Spike peptide | TRIAL |
http://loinc.org
|
100860-6
|
| TRIAL |
http://loinc.org
|
100861-4
|
Cells.CD4+CD154+/CD4 cells in Blood --after stimulation with SARS-CoV-2 Nucleocapsid peptide | TRIAL |
http://loinc.org
|
100862-2
|
| TRIAL |
http://loinc.org
|
100863-0
|
Cells.CD4.Tumor necrosis factor alfa-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Nucleocapsid peptide | TRIAL |
http://loinc.org
|
100864-8
|
|
|
http://loinc.org
|
100865-5
|
|
|
http://loinc.org
|
100866-3
|
|
|
http://loinc.org
|
10086-7
|
ST initial amplitude 6 ms in lead II | |
http://loinc.org
|
100867-1
|
|
|
http://loinc.org
|
100868-9
|
|
|
http://loinc.org
|
100869-7
|
|
|
http://loinc.org
|
100870-5
|
|
|
http://loinc.org
|
100871-3
|
|
|
http://loinc.org
|
100872-1
|
| |
http://loinc.org
|
100873-9
|
|
|
http://loinc.org
|
100874-7
|
|
|
http://loinc.org
|
10087-5
|
|
|
http://loinc.org
|
100875-4
|
Fetal Heart Document limited US | |
http://loinc.org
|
100876-2
|
|
|
http://loinc.org
|
100877-0
|
US Heart Transesophageal during surgery | |
http://loinc.org
|
100878-8
|
|
|
http://loinc.org
|
100879-6
|
US Guidance for cryoablation of Breast - right | |
http://loinc.org
|
100880-4
|
| |
http://loinc.org
|
100881-2
|
MR Guidance for cryoablation of Bone | |
http://loinc.org
|
100882-0
|
MR Peritoneum W contrast percutaneous intraperitoneal | |
http://loinc.org
|
10088-3
|
| |
http://loinc.org
|
100883-8
|
MR Guidance for biopsy of Kidney - left | |
http://loinc.org
|
100884-6
|
MR Guidance for biopsy of Kidney - right | |
http://loinc.org
|
100885-3
|
|
|
http://loinc.org
|
100886-1
|
|
|
http://loinc.org
|
100887-9
|
|
|
http://loinc.org
|
100888-7
|
|
|
http://loinc.org
|
100889-5
|
|
|
http://loinc.org
|
100890-3
|
|
|
http://loinc.org
|
10089-1
|
|
|
http://loinc.org
|
100891-1
|
Orthopoxvirus
IgG
|
|
http://loinc.org
|
100892-9
|
| |
http://loinc.org
|
100893-7
![]() | Orthopoxvirus IgG and IgM Ab panel - Serum or Plasma | |
http://loinc.org
|
100894-5
|
Recommended screening frequency Narrative | |
http://loinc.org
|
100895-2
|
Rickettsia
conorii
IgG
and
IgM
| |
http://loinc.org
|
100896-0
|
Vasopressin [Moles/volume] in Plasma --13th specimen post XXX challenge | |
http://loinc.org
|
100897-8
|
| |
http://loinc.org
|
100898-6
|
Lipid panel - Serum or Plasma | |
http://loinc.org
|
100899-4
|
|
Additional Language Displays
|
Code
|
Arabic (ar) |
| Deutsch (Deutschland) (German (Germany), de) | English (United States) (English (United States), en) | Spanish (Argentina) (es) | Spanish (es) | French (France) (fr) | Nederlands (Nederland) (Dutch (Netherlands), nl) | Portuguese (Brazil) (pt) | Ukrainian (uk) |
| 100000-9 | Health Info Pioneer+Father of LOINC | |||||||||
| 100001-7 |
|
Health Info Pioneer+Cofound LOINC |
|
|||||||
| 100002-5 | Specimen care is maintained | |||||||||
| 100003-3 |
|
Team communication is maintained throughout care |
|
|||||||
| 100004-1 | Demonstrates knowledge of the expected psychosocial responses to the procedure | |||||||||
| 100005-8 |
|
Demonstrates knowledge of nutritional management related to the procedure |
|
|||||||
| 100006-6 | Demonstrates knowledge of medication management | |||||||||
| 100007-4 |
|
Demonstrates knowledge of pain management |
|
|||||||
| 10000-8 | R wave dur L-AVR | duración de la onda R.derivación AVR:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda R. Lead AVR:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | R onda dur L-AVR | ||||||
| 100008-2 |
|
Demonstrates knowledge of wound management |
|
|||||||
| 100009-0 | Demonstrates knowledge of the procedure and expected results | |||||||||
| 100010-8 |
|
No injury related to procedure equipment, medical supplies, or instrumentation |
|
|||||||
| 100011-6 | No injury related to an electrical source | |||||||||
| 100012-4 |
|
Participates in decisions affecting the patient's plan of care |
|
|||||||
| 100013-2 |
Participates
in
| |||||||||
| 100014-0 |
Psychosocial
health
is
maintained
at
or
| |||||||||
| 100015-7 | No injury related to positioning due to care or procedure | |||||||||
| 10001-6 |
|
R wave dur L-I | duración de la onda R.derivación I:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda R.:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG |
| |||||
| 100016-5 | No injury related to a laser source | |||||||||
| 100017-3 |
|
Perioperative nursing data set outcomes panel [PNDS] |
|
|||||||
| 100018-1 | Hospice care Note | Verslag [bevinding] in {instelling} d.m.v. hospicezorg (document) | ||||||||
| 100019-9 |
|
ALK gene targeted mutation analysis, Blood or tissue specimen |
|
ALK-gen
doelgerichte
mutatie-analyse
[identificator]
in
| ||||||
| 100020-7 | GNA11 gene targeted mutation analysis, Blood or tissue specimen | GNA11 gène mutation cible trouvée [Identification] Sang/Tissu ; Résultat nominal ; Biologie moléculaire | GNA11-gen doelgerichte mutatie-analyse [identificator] in bloed of weefsel d.m.v. moleculair genetisch onderzoek | |||||||
| 100021-5 |
|
GNAQ gene targeted mutation analysis, Blood or tissue specimen |
|
GNAQ-gen
doelgerichte
mutatie-analyse
[identificator]
in
| ||||||
| 100022-3 | IDH1 gene targeted mutation analysis, Blood or tissue specimen | IDH1 gène mutation cible trouvée [Identification] Sang/Tissu ; Résultat nominal ; Biologie moléculaire | IDH1-gen doelgerichte mutatie-analyse [identificator] in bloed of weefsel d.m.v. moleculair genetisch onderzoek | |||||||
| 100023-1 |
|
IDH2 gene targeted mutation analysis, Blood or tissue specimen |
|
IDH2-gen
doelgerichte
mutatie-analyse
[identificator]
in
| ||||||
| 10002-4 | R wave dur L-II | duración de la onda R.derivación II:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda R. derivación II:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | R onda dur L-II | ||||||
| 100024-9 |
|
SETBP1 gene targeted mutation analysis, Blood or tissue specimen |
|
SETBP1-gen
doelgerichte
mutatie-analyse
[identificator]
in
| ||||||
| 100025-6 | SRSF2 gene targeted mutation analysis, Blood or tissue specimen | SRSF2 gène mutation cible trouvée [Identification] Sang/Tissu ; Résultat nominal ; Biologie moléculaire | SRSF2-gen doelgerichte mutatie-analyse [identificator] in bloed of weefsel d.m.v. moleculair genetisch onderzoek | |||||||
| 100026-4 |
|
MET gene targeted mutation analysis, Blood or tissue specimen |
|
MET-gen
doelgerichte
mutatie-analyse
[identificator]
in
| ||||||
| 100027-2 | SMAD4 gene targeted mutation analysis, Blood or tissue specimen | SMAD4 gène mutation cible trouvée [Identification] Sang/Tissu ; Résultat nominal ; Biologie moléculaire | SMAD4-gen doelgerichte mutatie-analyse [identificator] in bloed of weefsel d.m.v. moleculair genetisch onderzoek | |||||||
| 100028-0 |
|
FBXW7 gene targeted mutation analysis, Blood or tissue specimen |
|
FBXW7-gen
doelgerichte
mutatie-analyse
[identificator]
in
| ||||||
| 100029-8 | Cancer related multigene analysis (cfDNA) | Analyse multigénique en relation avec le cancer [Recherche] Plasma avec ADN libre circulant ; Document ; Biologie moléculaire | Kankergerelateerde multigen-analyse [bevinding] in plasma.celvrij DNA d.m.v. moleculair genetisch onderzoek (document) | |||||||
| 100030-6 |
|
Axis I: Temporal aspects score [Mainz Pain Staging System] |
|
|||||||
| 100031-4 | Axis II: Spatial aspects score [Mainz Pain Staging System] | |||||||||
| 10003-2 | R wave dur L-III | duración de la onda R.derivación III:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda R. derivación III:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | R onda dur L-III | ||||||
| 100032-2 | Axis III: Drug taking behavior score [Mainz Pain Staging System] | |||||||||
| 100033-0 |
Axis
IV:
Utilization
of
| |||||||||
| 100034-8 | Provider of AED | |||||||||
| 100035-5 |
|
Exam finding location Chest |
|
|||||||
| 100036-3 | Exam finding location Lung | |||||||||
| 100037-1 |
|
Patient contact disposition EMS unit |
|
|||||||
| 100038-9 | Patient eval disposition EMS unit | |||||||||
| 100039-7 |
|
Crew disposition EMS unit |
|
|||||||
| 10004-0 | R wave dur L-V1 | duración de la onda R.derivación V1:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda R. derivación V1:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | R onda dur L-V1 | ||||||
| 100040-5 |
|
Pt transport disposition EMS unit |
|
|||||||
| 100041-3 | Aminoglycosid-Empfindlichkeit | Aminoglycosid [Empfindlichkeit] | Susceptibility to Aminoglycoside | Aminoglycoside [Sensibilité] Isolat ; Alphanumérique | ||||||
| 100042-1 | Atovaquon-Empfindlichkeit | Atovaquon [Empfindlichkeit] | Susceptibility to Atovaquone |
|
Atovaquone [Sensibilité] Isolat ; Alphanumérique | Atovaquone [gevoeligheid] in isolaat | ||||
|
| Azithromycin/Ethambutol-Empfindlichkeit | Azithromycin+Ethambutol [Empfindlichkeit] | Susceptibility to Azithromycin+Ethambutol | Azithromycine+éthambutol [Sensibilité] Isolat ; Alphanumérique |
Azitromycine
+
ethambutol
[gevoeligheid]
in
| |||||
| 100044-7 | Cefcapene-Empfindlichkeit | Cefcapen [Empfindlichkeit] | Susceptibility to Cefcapene | Cefcapene [Sensibilité] Isolat ; Alphanumérique | Cefcapeen [gevoeligheid] in isolaat | |||||
| 100045-4 | Cefozopran-Empfindlichkeit | Cefozopran [Empfindlichkeit] | Susceptibility to Cefozopran |
|
Céfozopran [Sensibilité] Isolat ; Alphanumérique | Cefozopran [gevoeligheid] in isolaat | ||||
|
| Cefquinom-Empfindlichkeit | Cefquinom [Empfindlichkeit] | Susceptibility to Cefquinome | Cefquinome [Sensibilité] Isolat ; Alphanumérique |
Cefquinome
[gevoeligheid]
in
| |||||
| 100047-0 | Cefteram-Empfindlichkeit | Cefteram [Empfindlichkeit] | Susceptibility to Cefteram | Cefteram [Sensibilité] Isolat ; Alphanumérique | Cefteram [gevoeligheid] in isolaat | |||||
| 100048-8 | Clarithromycin/Ethambutol-Empfindlichkeit | Clarithromycin+Ethambutol [Empfindlichkeit] | Susceptibility to Clarithromycin+Ethambutol |
|
Clarithromycine+éthambutol [Sensibilité] Isolat ; Alphanumérique | Clarithromycine + ethambutol [gevoeligheid] in isolaat | ||||
|
| Eravacycline-Empfindlichkeit | Eravacyclin [Empfindlichkeit] | Susceptibility to Eravacycline | Éravacycline [Sensibilité] Isolat ; Alphanumérique |
Eravacycline
[gevoeligheid]
in
| |||||
| 100050-4 | Erythromycin/Ethambutol-Empfindlichkeit | Erythromycin+Ethambutol [Empfindlichkeit] | Susceptibility to Erythromycin+Ethambutol | Érythromycine+éthambutol [Sensibilité] Isolat ; Alphanumérique | Erytromycine + ethambutol [gevoeligheid] in isolaat | |||||
| 100051-2 | Ethambutol/rifAMPin-Empfindlichkeit | Ethambutol+Rifampicin [Empfindlichkeit] | Susceptibility to Ethambutol+rifAMPin |
|
Éthambutol+rifampicine [Sensibilité] Isolat ; Alphanumérique | Ethambutol + rifampicine [gevoeligheid] in isolaat | ||||
|
| Flomoxef-Empfindlichkeit | Flomoxef [Empfindlichkeit] | Susceptibility to Flomoxef | Flomoxef [Sensibilité] Isolat ; Alphanumérique |
Flomoxef
[gevoeligheid]
in
| |||||
| 100053-8 | Fluoroquinolon-Empfindlichkeit | Fluorchinolon [Empfindlichkeit] | Susceptibility to Fluoroquinolone | Fluoroquinolone [Sensibilité] Isolat ; Alphanumérique | Fluorchinolon [gevoeligheid] in isolaat | |||||
| 100054-6 | Gamithromycin-Empfindlichkeit | Gamithromycin [Empfindlichkeit] | Susceptibility to Gamithromycin |
|
Gamithromycine [Sensibilité] Isolat ; Alphanumérique |
|
||||
| 100055-3 | Optochin-Empfindlichkeit | Optochin [Empfindlichkeit] | Susceptibility to Optochin | Optochine [Sensibilité] Isolat ; Alphanumérique |
Optochine
[gevoeligheid]
in
| |||||
| 100056-1 | Panipenem-Empfindlichkeit | Panipenem [Empfindlichkeit] | Susceptibility to Panipenem | Panipénème [Sensibilité] Isolat ; Alphanumérique | Panipenem [gevoeligheid] in isolaat | |||||
| 10005-7 |
|
R wave dur L-V2 | duración de la onda R.derivación V2:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda R. derivación V2:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG |
| |||||
| 100057-9 | Prothionamid-Empfindlichkeit | Prothionamid [Empfindlichkeit] | Susceptibility to Prothionamide | Protionamide [Sensibilité] Isolat ; Alphanumérique |
Prothionamide
[gevoeligheid]
in
| |||||
| 100058-7 | Prulifloxacin-Empfindlichkeit | Prulifloxacin [Empfindlichkeit] | Susceptibility to Prulifloxacin | Prulifloxacine [Sensibilité] Isolat ; Alphanumérique | Prulifloxacine [gevoeligheid] in isolaat | |||||
| 100059-5 | Rifapentin-Empfindlichkeit | Rifapentin [Empfindlichkeit] | Susceptibility to Rifapentine |
|
Rifapentine [Sensibilité] Isolat ; Alphanumérique | Rifapentine [gevoeligheid] in isolaat | ||||
|
| Tildipirosin-Empfindlichkeit | Tildipirosin [Empfindlichkeit] | Susceptibility to Tildipirosin | Tildipirosine [Sensibilité] Isolat ; Alphanumérique | ||||||
| 100061-1 | Tosufloxacin-Empfindlichkeit | Tosufloxacin [Empfindlichkeit] | Susceptibility to Tosufloxacin | Tosufloxacine [Sensibilité] Isolat ; Alphanumérique |
Tosufloxacine
[gevoeligheid]
in
| |||||
| 100062-9 | SDOM panel | |||||||||
| 100063-7 |
|
Primary skin concern |
|
|||||||
| 100064-5 | Itch severity RptPeriod Reported | |||||||||
| 10006-5 |
|
R wave dur L-V3 | duración de la onda R.derivación V3:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda R. derivación V3:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG |
| |||||
| 100065-2 | Satisfied with treatment | |||||||||
| 100066-0 |
|
Specular microscopy panel |
|
Endotheelcelmicroscopie
panel
in
| ||||||
| 100067-8 | Eye Image magnification | |||||||||
| 100068-6 |
|
R eye Fixation point [Angle] |
|
|||||||
| 100069-4 | L eye Fixation point [Angle] | |||||||||
| 100070-2 |
|
R cornea Cell density |
|
|||||||
| 100071-0 | L cornea Cell density | |||||||||
| 100072-8 |
|
R cornea Coefficient of variation |
|
|||||||
| 10007-3 | R wave dur L-V4 | duración de la onda R.derivación V4:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda R. derivación V4:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | R onda dur L-V4 | ||||||
| 100073-6 |
|
L cornea Coefficient of variation |
|
|||||||
| 100074-4 | R cornea Hexagonality | |||||||||
| 100075-1 |
|
L cornea Hexagonality |
|
|||||||
| 100076-9 | R cornea Endothelial cells counted | |||||||||
| 100077-7 |
|
L cornea Endothelial cells counted |
|
|||||||
| 100078-5 | R cornea Endothelial cell area.min | |||||||||
| 100079-3 |
|
L cornea Endothelial cell area.min |
|
|||||||
| 100080-1 | R cornea Endothelial cell area.max | |||||||||
| 10008-1 |
|
R wave dur L-V5 | duración de la onda R.derivación V5:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda R. Plomo V5:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG |
| |||||
| 100081-9 | L cornea Endothelial cell area.max | |||||||||
| 100082-7 |
|
R cornea Endothelial cell area.mean |
|
|||||||
| 100083-5 | L cornea Endothelial cell area.mean | |||||||||
| 100084-3 |
|
R cornea Cell area.sd |
|
|||||||
| 100085-0 | L cornea Cell area.sd | |||||||||
| 100086-8 |
|
R cornea Analysis method |
|
|||||||
| 100087-6 | Toxocara canis 24-35kD IgG antibody, Blood | Toxocara canis 24-35kD Ac IgG [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot |
Toxocara
canis
24-35kD
As.IgG
[aanwezigheid]
in
| |||||||
| 100088-4 | Taenia solium larva Ab bands panel, Blood | Taenia solium cysticerque Ac bandes panel [-] Sérum ; - ; Immunoblot | Taenia solium larve As banden panel in serum d.m.v. immunoblotting | |||||||
| 100089-2 |
|
Taenia solium larva 6-8kD antibody, Blood |
|
Taenia
solium
larve
6-8kD
As
[aanwezigheid]
in
| ||||||
| 1000-9 | DBG antibody, Blood Product Unit | [anticuerpo anti - ] DBG [Ac]:concentración arbitraria:punto en el tiempo:suero/plasma^unidad de hemoderivado:ordinal: | DBG Ab: Suero o plasma Unidad de hemoderivado: Punto temporal: Presencia o umbral: Ordinal: | DBG As [aanwezigheid] in serum of plasma^bloedproducteenheid | DBG Ac SerPl BPU Ql | |||||
| 100090-0 |
|
Taenia solium larva 45kD antibody, Blood |
|
Taenia
solium
larve
45kD
As
[aanwezigheid]
in
| ||||||
| 100091-8 | Trypanosoma cruzi antibody, Blood | Trypanosoma cruzi Ac [Arbitraire/Volume] Sérum ; Numérique ; Immunoanalyse | Trypanosoma cruzi As [eenheid/volume] in serum d.m.v. immunoassay | |||||||
| 100092-6 |
|
Trypanosoma cruzi Ab bands panel, Blood |
|
Trypanosoma
cruzi
As
banden
panel
in
| ||||||
| 100093-4 | Trypanosoma cruzi 15-16kD IgG antibody, Blood | Trypanosoma cruzi 15-16kD Ac IgG [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot | Trypanosoma cruzi 15-16kD As.IgG [aanwezigheid] in serum d.m.v. immunoblotting | |||||||
| 100094-2 |
|
Trypanosoma cruzi 21-22kD IgG antibody, Blood |
|
Trypanosoma
cruzi
21-22kD
As.IgG
[aanwezigheid]
in
| ||||||
| 100095-9 | Trypanosoma cruzi 27-28kD IgG antibody, Blood | Trypanosoma cruzi 27-28kD Ac IgG [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot | Trypanosoma cruzi 27-28kD As.IgG [aanwezigheid] in serum d.m.v. immunoblotting | |||||||
| 100096-7 |
|
Trypanosoma cruzi 42kD IgG antibody, Blood |
|
Trypanosoma
cruzi
42kD
As.IgG
[aanwezigheid]
in
| ||||||
| 100097-5 | Trypanosoma cruzi 45-47kD IgG antibody, Blood | Trypanosoma cruzi 45-47kD Ac IgG [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot | Trypanosoma cruzi 45-47kD As.IgG [aanwezigheid] in serum d.m.v. immunoblotting | |||||||
| 100098-3 |
|
Trypanosoma cruzi 120-200kD IgG antibody, Blood |
|
Trypanosoma
cruzi
120-200kD
As.IgG
[aanwezigheid]
in
| ||||||
| 10009-9 | R wave dur L-V6 | duración de la onda R.derivación V6:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda R. Plomo V6:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | R onda dur L-V6 | ||||||
| 100099-1 |
|
Trypanosoma cruzi 160kD IgG antibody, Blood |
|
Trypanosoma
cruzi
160kD
As.IgG
[aanwezigheid]
in
|
||||||
| 100100-7 |
|
Fasciola sp IgG antibody, Blood |
|
Fasciola
sp.
As.IgG
[aanwezigheid]
in
| ||||||
| 100101-5 | Fasciola sp 8-9kD IgG antibody, Blood | Fasciola 8-9kD Ac IgG [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot | Fasciola sp. 8-9kD As.IgG [aanwezigheid] in serum d.m.v. immunoblotting | |||||||
| 100102-3 |
|
Fasciola sp 27-28kD IgG antibody, Blood |
|
Fasciola
sp.
27-28kD
As.IgG
[aanwezigheid]
in
| ||||||
| 100103-1 | Fasciola sp 60kD IgG antibody, Blood | Fasciola 60kD Ac IgG [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot | Fasciola sp. 60kD As.IgG [aanwezigheid] in serum d.m.v. immunoblotting | |||||||
| 100104-9 |
|
Fasciola sp 42kD IgG antibody, Blood |
|
Fasciola
sp.
42kD
As.IgG
[aanwezigheid]
in
| ||||||
| 100105-6 | Filaria IgG and IgM panel, Blood | Filaria Ac IgG et IgM panel [-] Sérum ; - | Filaria As.IgG & IgM panel in serum | |||||||
| 100106-4 |
|
Filaria IgG antibody, Blood |
|
Filaria
As.IgG
[aanwezigheid]
in
| ||||||
| 10010-7 | R' wave Amp L-AVF | amplitud de la onda R'.derivación AVF:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda R 'plomo AVF:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | R' onda Amp L-AVF | ||||||
| 100107-2 |
|
Leishmania sp IgG antibody, Blood |
|
Leishmania
sp.
As.IgG
[aanwezigheid]
in
| ||||||
| 100108-0 | Leishmania sp IgG antibody, Blood | Leishmania Ac IgG [Arbitraire/Volume] Sérum ; Numérique ; Immunoanalyse | Leishmania sp. As.IgG [eenheid/volume] in serum d.m.v. immunoassay | |||||||
| 100109-8 |
|
Leishmania sp Ab bands panel, Blood |
|
Leishmania
sp.
As
banden
panel
in
| ||||||
| 100110-6 | Leishmania sp 14kD IgG antibody, Blood | Leishmania 14 kD Ac IgG [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot | Leishmania sp. 14kD As.IgG [aanwezigheid] in serum d.m.v. immunoblotting | |||||||
| 100111-4 |
|
Leishmania sp 16kD IgG antibody, Blood |
|
Leishmania
sp.
16kD
As.IgG
[aanwezigheid]
in
| ||||||
| 100112-2 | Fasciola sp Ab bands panel, Blood | Fasciola Ac bandes panel [-] Sérum ; - ; Immunoblot | Fasciola sp. As-banden panel in serum d.m.v. immunoblotting | |||||||
| 100113-0 |
|
Helicobacter pylori Ab panel, Blood |
|
Helicobacter
pylori
As
panel
in
| ||||||
| 100114-8 | Toxoplasma gondii 30kD antibody, Blood | Toxoplasma gondii 30kD Ac [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot | Toxoplasma gondii 30kD As [aanwezigheid] in serum d.m.v. immunoblotting | |||||||
| 10011-5 |
|
R' wave Amp L-AVL | amplitud de la onda R'.derivación AVL:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda R 'plomo AVL:Corazón :Punto temporal:Elpot:Cuantitativo:EKG |
| |||||
| 100115-5 | Toxoplasma gondii 31kD antibody, Blood | Toxoplasma gondii 31kD Ac [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot |
Toxoplasma
gondii
31kD
As
[aanwezigheid]
in
| |||||||
| 100116-3 | Toxoplasma gondii 33kD antibody, Blood | Toxoplasma gondii 33kD Ac [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot | Toxoplasma gondii 33kD As [aanwezigheid] in serum d.m.v. immunoblotting | |||||||
| 100117-1 |
|
Toxoplasma gondii 40kD antibody, Blood |
|
Toxoplasma
gondii
40kD
As
[aanwezigheid]
in
| ||||||
| 100118-9 | Toxoplasma gondii 41kD antibody, Blood | Toxoplasma gondii 41kD Ac [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot | Toxoplasma gondii 41kD As [aanwezigheid] in serum d.m.v. immunoblotting | |||||||
| 100119-7 |
|
Toxoplasma gondii 45kD antibody, Blood |
| Toxoplasma gondii 45kD As [aanwezigheid] in serum d.m.v. immunoblotting | ||||||
| 100120-5 | Chlamydia trachomatis Ab panel, Blood | Chlamydia trachomatis Ac panel [-] Sérum ; - | Chlamydia trachomatis As panel in serum | |||||||
| 100121-3 |
Chlamydia
trachomatis
IgA-Antikörper
[Nachweis]
in
Serum
| Chlamydia trachomatis IgA antibody, Blood | Chlamydia trachomatis Ac IgA [Présence/Seuil] Sérum ; Qualitatif ; Immunoanalyse | Chlamydia trachomatis As.IgA [aanwezigheid] in serum d.m.v. immunoassay | Chlamydia trachomatis Антитіла.IgA ІА (Свтк) [НвнПор] | |||||
| 100122-1 | C. pneumoniae Ab panel, Blood | Chlamydia pneumoniae Ac panel [-] Sérum ; - | Chlamydophila pneumoniae As panel in serum | |||||||
| 10012-3 |
|
R' wave Amp L-AVR | amplitud de la onda R'.derivación AVR:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda R 'plomo AVR:Corazón :Punto temporal:Elpot:Cuantitativo:EKG |
| |||||
| 100123-9 |
Chlamydophila
pneumoniae
IgA
antibody,
Blood
|
Chlamydia pneumoniae Ac IgA [Présence/Seuil] Sérum ; Qualitatif ; Immunoanalyse | Chlamydophila pneumoniae As.IgA [aanwezigheid] in serum d.m.v. immunoassay | |||||||
| 100124-7 |
Chlamydophila
pneumoniae
IgA
antibody,
Blood
|
Chlamydia pneumoniae Ac IgA [Arbitraire/Volume] Sérum ; Numérique ; Immunoanalyse | Chlamydophila pneumoniae As.IgA [eenheid/volume] in serum d.m.v. immunoassay | |||||||
| 100125-4 | C. psittaci Ab panel, Blood | Chlamydia psittaci Ac panel [-] Sérum ; - | Chlamydophila psittaci As panel in serum | |||||||
| 100126-2 |
|
Bordetella pertussis Ab.IgG panel, Blood |
|
Bordetella
pertussis
As.IgG
panel
in
| ||||||
| 100127-0 | Campylobacter sp Ab panel, Blood | Campylobacter Ac panel [-] Sérum ; - | Campylobacter sp. As panel in serum | |||||||
| 100128-8 |
|
Cryptococcus sp Ag panel, Blood |
|
Cryptococcus
sp.
Ag
panel
in
| ||||||
| 100129-6 | Schistosoma sp antibody, Blood | Schistosoma Ac [Titre] Sérum ; Semi-Quantitatif ; Hémagglutination | Schistosoma sp. As [titer] in serum d.m.v. hemagglutinatie | |||||||
| 100130-4 |
|
Schistosoma mansoni antibody, Blood |
|
Schistosoma
mansoni
As
[aanwezigheid]
in
| ||||||
| 10013-1 | R' wave Amp L-I | amplitud de la onda R'.derivación I:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de la onda R '. I:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | R' onda Amp L-I | ||||||
| 100131-2 |
|
Schistosoma sp 8kD antibody, Blood |
|
Schistosoma
sp.
8kD
As
[aanwezigheid]
in
| ||||||
| 100132-0 | Schistosoma sp 9kD antibody, Blood | Schistosoma 9kD Ac [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot | Schistosoma sp. 9kD As [aanwezigheid] in serum d.m.v. immunoblotting | |||||||
| 100133-8 |
|
Schistosoma sp 10kD antibody, Blood |
|
Schistosoma
sp.
10kD
As
[aanwezigheid]
in
| ||||||
| 100134-6 | Schistosoma sp 11kD antibody, Blood | Schistosoma 11kD Ac [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot | Schistosoma sp. 11kD As [aanwezigheid] in serum d.m.v. immunoblotting | |||||||
| 100135-3 |
|
Schistosoma sp 12-13kD antibody, Blood |
|
Schistosoma
sp.
12-13kD
As
[aanwezigheid]
in
| ||||||
| 100136-1 | Schistosoma sp 14-15kD antibody, Blood | Schistosoma 14-15kD Ac [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot | Schistosoma sp. 14-15kD As [aanwezigheid] in serum d.m.v. immunoblotting | |||||||
| 100137-9 |
|
Schistosoma sp 15-16kD antibody, Blood |
|
Schistosoma
sp.
15-16kD
As
[aanwezigheid]
in
| ||||||
| 100138-7 | Schistosoma sp 18-19kD antibody, Blood | Schistosoma 18-19kD Ac [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot | Schistosoma sp. 18-19kD As [aanwezigheid] in serum d.m.v. immunoblotting | |||||||
| 100139-5 |
|
Schistosoma sp 22-24kD antibody, Blood |
|
Schistosoma
sp.
22-24kD
As
[aanwezigheid]
in
| ||||||
| 100140-3 | Schistosoma sp 30-34kD antibody, Blood | Schistosoma 30-34kD Ac [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot | Schistosoma sp. 30-34kD As [aanwezigheid] in serum d.m.v. immunoblotting | |||||||
| 100141-1 |
|
Schistosoma sp 65kD antibody, Blood |
|
Schistosoma
sp.
65kD
As
[aanwezigheid]
in
| ||||||
| 100142-9 | Schistosoma sp 70kD antibody, Blood | Schistosoma 70kD Ac [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot | Schistosoma sp. 70kD As [aanwezigheid] in serum d.m.v. immunoblotting | |||||||
| 100143-7 |
|
Schistosoma sp 80kD antibody, Blood |
|
Schistosoma
sp.
80kD
As
[aanwezigheid]
in
| ||||||
| 100144-5 | Schistosoma sp 95kD antibody, Blood | Schistosoma 95kD Ac [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot | Schistosoma sp. 95kD As [aanwezigheid] in serum d.m.v. immunoblotting | |||||||
| 100145-2 |
|
Schistosoma sp 110kD antibody, Blood |
| Schistosoma sp. 110kD As [aanwezigheid] in serum d.m.v. immunoblotting | ||||||
| 100146-0 |
Schistosoma
sp
120kD
antibody,
Blood
|
Schistosoma 120kD Ac [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot | Schistosoma sp. 120kD As [aanwezigheid] in serum d.m.v. immunoblotting | |||||||
| 100147-8 | Toxoplasma gondii Ab bands panel, Blood | Toxoplasma gondii Ac bandes panel [-] Sérum ; - ; Immunoblot | Toxoplasma gondii As banden panel in serum d.m.v. immunoblotting | |||||||
| 100148-6 |
|
Schistosoma sp Ab bands panel, Blood |
|
Schistosoma
sp.
As
banden
panel
in
| ||||||
| 10014-9 | R' wave Amp L-II | amplitud de la onda R'.derivación II:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda R 'derivación II:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | R' onda Amp L-II | ||||||
| 100149-4 |
|
6-oxo-piperidine-2-carboxylate and 6(R+S)-oxo-propylpiperidine-2-carboxylate panel, Urine+Blood |
|
6-oxo-piperidine-2-carboxylaat
&
6(R+S)-oxo-propylpiperidine-2-carboxylaat
in
|
||||||
| 100150-2 |
|
6(R+S)-oxo-propylpiperidine-2-carboxylate, Blood |
|
6(R+S)-oxo-propylpiperidine-2-carboxylaat
[mol/volume]
in
| ||||||
| 100151-0 | 6-oxo-piperidine-2-carboxylate, Blood | 6-oxo-pipéridine-2-carboxylate [Moles/Volume] Plasma ; Numérique | 6-oxo-piperidine-2-carboxylaat [mol/volume] in plasma | |||||||
| 100152-8 |
|
6-oxo-piperidine-2-carboxylate/Creatinine, Urine |
|
6-oxo-piperidine-2-carboxylaat/creatinine
[molaire
verhouding]
in
| ||||||
| 100153-6 | 6(R+S)-oxo-propylpiperidine-2-carboxylate/Creatinine, Urine | 6(R+S)-oxo-propylpipéridine-2-carboxylate/créatinine [Moles ratio] Urine ; Numérique | 6(R+S)-oxo-propylpiperidine-2-carboxylaat/creatinine [molaire verhouding] in urine | |||||||
| 100154-4 |
|
Collection supervision level, Specimen |
| |||||||
| 100155-1 | L cornea Analysis method | |||||||||
| 10015-6 |
|
R' wave Amp L-III | amplitud de la onda R'.derivación III:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda R 'derivación III:Corazón :Punto temporal:Elpot:Cuantitativo:EKG |
| |||||
| 100156-9 |
SARS-CoV-2
(COVID-19)-Variante
[Typ]
in
| SARS-CoV-2 (COVID-19) variant, Specimen | Coronavirus SARS-CoV-2 variant [Type] Milieux divers ; Résultat nominal ; PCR amplification de cible | SARS-CoV-2-variant [type] d.m.v. probe-detectie | ||||||
| 100157-7 | SARS-CoV-2 (COVID-19)-Abstammungslinie [Typ] in Probenmaterial mittels Sequenzierung | SARS-CoV-2 (COVID-19) lineage, Specimen | Coronavirus SARS-CoV-2 lignée [Type] Milieux divers ; Résultat nominal ; Séquençage | SARS-CoV-2 lineage [type] d.m.v. sequencing | ||||||
| 100158-5 |
|
Albumin, Urine |
|
Albumine
[massa/volume]
in
| ||||||
| 100159-3 | Knee Society Score pre-op panel [Knee Society Score] | |||||||||
| 100160-1 |
|
Knee replacement |
|
|||||||
| 100161-9 | Charnley Functional Classification | |||||||||
| 100162-7 |
|
Alignment W Stand Knee XR |
|
|||||||
| 100163-5 | Knee medial AndOr lateral instability W full extension | |||||||||
| 10016-4 | R' wave Amp L-V1 | amplitud de la onda R'.derivación V1:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda R 'derivación V1:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | R' onda Amp L-V1 | ||||||
| 100164-3 | Knee AP instability W 90 degree flexion | |||||||||
| 100165-0 | Knee Qn | |||||||||
| 100166-8 | Flexion contracture range Knee | |||||||||
| 100167-6 | Extensor lag range Knee | |||||||||
| 100168-4 | Knee pain severity with level walking | |||||||||
| 100169-2 | Knee pain severity with stairs or inclines | |||||||||
| 1001-7 | DBG antibody, Donor Blood | [anticuerpo anti - ] DBG [Ac]:concentración arbitraria:punto en el tiempo:relación suero/plasma^donante:ordinal: | DBG Ab: Suero o plasma Donante: Punto temporal: Presencia o umbral: Ordinal: |
DBG
As
[aanwezigheid]
in
serum
of
| DBG Ac SerPl Donr Ql | |||||
| 100170-0 | Knee feels normal | |||||||||
| 100171-8 |
|
Satisfaction with level of knee pain while sitting |
|
|||||||
| 10017-2 | R' wave Amp L-V2 | amplitud de la onda R'.derivación V2:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda R 'derivación V2:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | R' onda Amp L-V2 | ||||||
| 100172-6 |
Satisfaction
with
level
of
| |||||||||
| 100173-4 | Satisfaction with knee function while getting out of bed | |||||||||
| 100174-2 |
|
Satisfaction with knee function while performing light household duties |
|
|||||||
| 100175-9 | Satisfaction with knee function while performing recreational activities | |||||||||
| 100176-7 |
|
Expect surgery to relieve pain |
|
|||||||
| 100177-5 |
Expect
surgery
will
improve
ability
to
perform
activities
of
| |||||||||
| 100178-3 | Expect surgery will improve ability to perform leisure, recreational, or sports activities | |||||||||
| 100179-1 |
|
Walk without assistive mobility devices |
|
|||||||
| 10018-0 | R' wave Amp L-V3 | amplitud de la onda R'.derivación V3:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda R 'derivación V3:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | R' onda Amp L-V3 | ||||||
| 100180-9 | Assistive mobility devices used | |||||||||
| 100181-7 | Assistive mobility devices used due to health condition | |||||||||
| 100182-5 |
Duration
of
| |||||||||
| 100183-3 | Duration of walking before stopping due to knee discomfort | |||||||||
| 100184-1 |
|
How bothersome is knee when walking on an uneven surface |
|
|||||||
| 100185-8 | How bothersome is knee when turning or pivoting leg | |||||||||
| 100186-6 |
|
How bothersome is knee when climbing up or down a flight of stairs |
|
|||||||
| 100187-4 | How bothersome is knee when getting up from a low seat without armrests | |||||||||
| 100188-2 |
|
How bothersome is knee when getting into or out of a car |
|
|||||||
| 100189-0 | How bothersome is knee when moving laterally | |||||||||
| 100190-8 |
|
How bothersome is knee when climbing a ladder or step stool |
|
|||||||
| 100191-6 | How bothersome is knee when carrying a bag for one block | |||||||||
| 100192-4 |
|
How bothersome is knee when squatting |
|
|||||||
| 100193-2 | How bothersome is knee when kneeling | |||||||||
| 100194-0 |
|
How bothersome is knee when running |
|
|||||||
| 100195-7 | Pain severity--during activity | |||||||||
| 100196-5 |
|
Pre-op total score [Knee Society Score] |
|
|||||||
| 100197-3 | Exercise activity and pain severity panel | |||||||||
| 10019-8 |
|
R' wave Amp L-V4 | amplitud de la onda R'.derivación V4:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda R 'derivación V4:Corazón :Punto temporal:Elpot:Cuantitativo:EKG |
| |||||
| 100198-1 | Pre-op objective knee indicators score [Knee Society Score] | |||||||||
| 100199-9 |
|
Pre-op symptoms score [Knee Society Score] |
|
|||||||
| 100200-5 | Pre-op patient expectations score [Knee Society Score] | |||||||||
| 100201-3 |
|
Pre-op functional activities score [Knee Society Score] |
|
|||||||
| 100202-1 | Pre-op discretionary knee activities score [Knee Society Score] | |||||||||
| 100203-9 |
|
Knee Society Score post-op panel [Knee Society Score] |
|
|||||||
| 100204-7 |
Accuracy
of
| |||||||||
| 100205-4 | Accuracy of pre-surgery expectations to perform activities of daily living | |||||||||
| 10020-6 |
|
R' wave Amp L-V5 | amplitud de la onda R'.derivación V5:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda R 'derivación V5:Corazón :Punto temporal:Elpot:Cuantitativo:EKG |
| |||||
| 100206-2 |
Accuracy
of
| |||||||||
| 100207-0 | Post-op total score [Knee Society Score] | |||||||||
| 100208-8 |
|
Post-op objective knee indicators score [Knee Society Score] |
|
|||||||
| 100209-6 | Post-op symptoms score [Knee Society Score] | |||||||||
| 100210-4 |
|
Post-op patient expectations score [Knee Society Score] |
|
|||||||
| 100211-2 | Post-op functional activities score [Knee Society Score] | |||||||||
| 100212-0 |
|
Post-op discretionary knee activities score [Knee Society Score] |
|
|||||||
| 100213-8 | Prostate cancer multigene analysis, Blood or tissue specimen | Analyse multigénique du cancer de la prostate [Recherche] Sang/Tissu ; Document ; Biologie moléculaire |
Multigen-analyse
op
prostaatkanker
[bevinding]
in
| |||||||
| 10021-4 | R' wave Amp L-V6 | amplitud de la onda R'.derivación V6:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda R 'derivación V6:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | R' onda Amp L-V6 | ||||||
| 100214-6 |
|
Dental model prior auth Doc |
|
|||||||
| 100215-3 |
Episode
of
| Verslag van zorgepisode [bevinding] d.m.v. transplantatiechirurgie (document) | ||||||||
| 100216-1 | Surgical synoptic report | Beknopt rapport [bevinding] d.m.v. chirurgie (document) | ||||||||
| 100217-9 |
|
Synoptic report Doc Surg Onc |
|
|||||||
| 100218-7 | Surg onc colon CA synoptic rep | |||||||||
| 100219-5 |
|
Surg onc melanoma CA synoptic rep |
|
|||||||
| 100220-3 | Surg onc breast CA synoptic rep | |||||||||
| 100221-1 |
|
Surg onc thyroid CA synoptic rep |
|
|||||||
| 10022-2 | R' wave dur L-AVF | duración de la onda R'.derivación AVF:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda R 'plomo AVF:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | R' onda dur L-AVF | ||||||
| 100222-9 |
|
Surg onc pancreas CA synoptic rep |
|
|||||||
| 100223-7 | Retina Phys find | |||||||||
| 100224-5 |
|
Cardiac LV SWM Pnl LV US |
|
|||||||
| 100225-2 | Bone density QUS | |||||||||
| 100226-0 |
|
Sm bowel capsule endo study Doc |
|
|||||||
| 100227-8 | Colon capsule endo study Doc | |||||||||
| 100228-6 |
|
UGI capsule endo study Doc |
|
|||||||
| 100229-4 | Endo US study Doc | |||||||||
| 10023-0 |
|
R' wave dur L-AVL | duración de la onda R'.derivación AVL:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda R 'plomo AVL:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG |
| |||||
| 100230-2 | Routine prenatal pnl | |||||||||
| 100231-0 |
|
EBUS study |
|
|||||||
| 100232-8 | Impacts of Events Scale-Revised panel | |||||||||
| 100233-6 |
|
Reminders brought back feelings about adverse event |
|
|||||||
| 100234-4 | Trouble staying asleep | |||||||||
| 100235-1 |
|
Other things triggered persistent thoughts about adverse event |
|
|||||||
| 100236-9 | Felt irritable AndOr angry | |||||||||
| 100237-7 |
|
Avoided getting upset when unintentionally thought about adverse event |
|
|||||||
| 100238-5 | Thought about adverse event unintentionally | |||||||||
| 100239-3 |
|
Felt as if adverse event did not happen |
|
|||||||
| 100240-1 | Avoided reminders of adverse event | |||||||||
| 100241-9 |
|
Experienced mental images of adverse event |
|
|||||||
| 100242-7 | Easily startled | |||||||||
| 100243-5 |
|
Tried to not think of adverse event |
|
|||||||
| 100244-3 | Aware of feelings about adverse event, but did not address them | |||||||||
| 100245-0 |
|
Feelings about adverse event were numb |
|
|||||||
| 100246-8 |
Acted
or
| |||||||||
| 100247-6 | Trouble falling asleep | |||||||||
| 10024-8 |
|
R' wave dur L-AVR | duración de la onda R'.derivación AVR:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda R 'plomo AVR:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG |
| |||||
| 100248-4 | Waves of strong feelings about adverse event | |||||||||
| 100249-2 |
|
Tried to remove adverse event from memory |
|
|||||||
| 1002-5 | DBG antibody, Blood | [anticuerpo anti - ] DBG [Ac]:concentración arbitraria:punto en el tiempo:suero/plasma:ordinal: | DBG Ab: Suero o Plasma : Punto temporal: Presencia o umbral: Ordinal: |
DBG
As
[aanwezigheid]
in
| DBG Ac SerPl Ql | |||||
| 100250-0 | Trouble concentrating | |||||||||
| 100251-8 |
|
Reminders of adverse event caused physical reactions |
|
|||||||
| 100252-6 | Had dreams about adverse event | |||||||||
| 100253-4 |
|
Felt watchful and on-guard |
|
|||||||
| 100254-2 | Tried not to talk about adverse event | |||||||||
| 10025-5 |
|
R' wave dur L-I | duración de la onda R'.derivación I:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda R '.:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG |
| |||||
| 100255-9 | Total score [Impact of Event Scale-Revised] | |||||||||
| 100256-7 |
Fallen
in
| |||||||||
| 100257-5 | Feel unsteady when standing or walking | |||||||||
| 100258-3 |
|
History of fall related injury |
|
|||||||
| 100259-1 | Aware of tactile sensations | |||||||||
| 100260-9 |
|
Easy to describe thoughts AndOr feelings |
|
|||||||
| 100261-7 | Critical of own thoughts AndOr feelings | |||||||||
| 100262-5 |
|
Able to notice distressing thoughts AndOr feelings without having to react |
|
|||||||
| 10026-3 | R' wave dur L-II | duración de la onda R'.derivación II:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda R 'derivación II:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | R' onda dur L-II | ||||||
| 100263-3 |
|
Easily distracted |
|
|||||||
| 100264-1 | Able to notice thoughts AndOr feelings without being overwhelmed | |||||||||
| 100265-8 |
|
Aware of dietary intake impact on self |
|
|||||||
| 100266-6 | Difficult to describe thoughts AndOr feelings | |||||||||
| 100267-4 |
|
Aware of auditory stimuli |
|
|||||||
| 100268-2 |
Able
to
avoid
immediate
reaction
in
| |||||||||
| 100269-0 | Do things without paying attention | |||||||||
| 100270-8 |
Recover
quickly
from
| |||||||||
| 10027-1 | R' wave dur L-III | duración de la onda R'.derivación III:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda R 'derivación III:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | R' onda dur L-III | ||||||
| 100271-6 |
|
Aware of olfactory stimuli |
|
|||||||
| 100272-4 | Aware of visual stimuli | |||||||||
| 100273-2 |
|
Aware of emotions affect on thoughts AndOr behavior |
|
|||||||
| 100274-0 | Observing score [FFMQ] | |||||||||
| 100275-7 |
|
Describing score [FFMQ] |
|
|||||||
| 100276-5 | Acting with awareness score [FFMQ] | |||||||||
| 100277-3 |
|
Nonjudging score [FFMQ] |
|
|||||||
| 100278-1 | Nonreactivity score [FFMQ] | |||||||||
| 100279-9 |
|
Total score [FFMQ] |
|
|||||||
| 100280-7 | Five Facet Mindfulness Questionnaire panel [FFMQ] | |||||||||
| 100281-5 |
|
D antibody, Blood |
|
D
As
[eenheid/volume]
in
| ||||||
| 100282-3 | Vaccine exemption cert | |||||||||
| 100283-1 |
|
Harris Hip Score panel [Harris Hip Score] |
|
|||||||
| 100284-9 | Walking - functional ability | |||||||||
| 100285-6 |
|
Comfortable seated position |
|
|||||||
| 100286-4 | Able to board public transportation | |||||||||
| 100287-2 |
|
Put on shoes and socks |
|
|||||||
| 100288-0 | Absence of deformity score [Harris Hip Score] | |||||||||
| 10028-9 |
|
R' wave dur L-V1 | duración de la onda R'.derivación V1:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda R 'derivación V1:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG |
| |||||
| 100289-8 | Absence of hip deformity measurements | |||||||||
| 100290-6 |
|
Range of motion score [Harris Hip Score] |
|
|||||||
| 100291-4 | Total score [Harris Hip Score] | |||||||||
| 100292-2 |
|
Pre-op patient satisfaction score [Knee Society Score] |
|
|||||||
| 100293-0 | Hip Flexion range of motion | |||||||||
| 100294-8 |
|
Hip Abduction range of motion |
|
|||||||
| 100295-5 | Hip Adduction range of motion | |||||||||
| 100296-3 |
|
Hip External rotation range of motion |
|
|||||||
| 10029-7 | R' wave dur L-V2 | duración de la onda R'.derivación V2:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda R 'derivación V2:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | R' onda dur L-V2 | ||||||
| 100297-1 |
|
Hip Internal rotation range of motion |
|
|||||||
| 100298-9 | Rep count | |||||||||
| 100299-7 |
|
Post-op patient satisfaction score [Knee Society Score] |
|
|||||||
| 100300-3 | End time | |||||||||
| 100301-1 |
|
Start time |
|
|||||||
| 100302-9 | Time start/end panel Spec | |||||||||
| 100303-7 |
|
Condition certainty of presence |
|
|||||||
| 100304-5 | Flights climbed RptPeriod | |||||||||
| 10030-5 |
|
R' wave dur L-V3 | duración de la onda R'.derivación V3:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda R 'derivación V3:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG |
| |||||
| 100305-2 | IDH1 gene exon 4 targeted mutation analysis, Blood Or Bone marrow | IDH1 gène exon 4 mutation cible trouvée [Présence/Seuil] Sang/Moelle osseuse ; Qualitatif ; Biologie moléculaire | IDH1-gen exon 4 doelgerichte mutatie-analyse [aanwezigheid] in bloed of beenmerg d.m.v. moleculair genetisch onderzoek | |||||||
| 100306-0 |
|
IDH2 gene exon 4 targeted mutation analysis, Blood Or Bone marrow |
|
IDH2-gen
exon
4
doelgerichte
mutatie-analyse
[aanwezigheid]
in
| ||||||
| 100307-8 | Behavioral screening elder mistreatment | |||||||||
| 100308-6 |
|
Need help getting to essential places |
|
|||||||
| 100309-4 | Activity support person | |||||||||
| 100310-2 |
|
Reliability of support person |
|
|||||||
| 100311-0 |
Need
help
to
make
sure
there
is
enough
food,
medicines
or
| |||||||||
| 100312-8 | Person or persons that makes sure there is enough food, medicines or any other things needed in house | |||||||||
| 10031-3 |
|
R' wave dur L-V4 | duración de la onda R'.derivación V4:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda R 'derivación V4:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG |
| |||||
| 100313-6 | Need help with household things such as cook meals, help feed, or provide correct medicines each day | |||||||||
| 100314-4 |
|
Need help with house cleaning or yard work |
|
|||||||
| 100315-1 | Need help getting out of bed, showered, or dressed | |||||||||
| 100316-9 |
|
Need help to make sure bills get paid |
|
|||||||
| 100317-7 | Relationship of usual support person for daily activities | |||||||||
| 100318-5 |
|
Have help with finances AndOr financial decisions |
|
|||||||
| 100319-3 | Relationship of financial support person | |||||||||
| 100320-1 |
|
Financial support person usually asks for permission before making decisions |
|
|||||||
| 10032-1 | R' wave dur L-V5 | duración de la onda R'.derivación V5:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda R 'plomo V5:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | R' onda dur L-V5 | ||||||
| 100321-9 |
|
Financial support person usually makes good decisions about finances |
|
|||||||
| 100322-7 | Have access to paperwork for financial decisions made | |||||||||
| 100323-5 |
|
Financial support person forged signature |
|
|||||||
| 100324-3 |
Coercion
of
financial
support
person
for
signing
a
document
in
| |||||||||
| 100325-0 |
Experienced
theft
by
| |||||||||
| 100326-8 | Money spent or property sold without permission | |||||||||
| 100327-6 |
|
Stranger forged signature for financial gain |
|
|||||||
| 100328-4 | Stranger forced document signature for financial gain | |||||||||
| 100329-2 |
|
Feared for safety due to verbal attack |
|
|||||||
| 1003-3 | اختبار كومبس الغير مباشر | Indirect Antiglobulin Test (IAT; Indirect Coombs), Blood | prueba de antiglobulina indirecta.reactivo específico de complemento:concentración arbitraria:punto en el tiempo:suero/plasma:ordinal: | Prueba de antiglobulina indirecta, reactivo específico del complemento: Suero o Plasma : Punto temporal: Presencia o umbral: Ordinal: | Test indirect à l'antiglobuline (TIA) complément spécifique [Présence/Seuil] Sérum/Plasma ; Qualitatif |
Indirecte
antiglobulinetest.complement-specifiek
reagent
[aanwezigheid]
in
| IAT Comp-Sp Reag SerPl Ql | |||
| 100330-0 | Felt humiliated due to ridicule | |||||||||
| 100331-8 |
|
Coerced to do something |
|
|||||||
| 100332-6 |
Ignored
by
| |||||||||
| 100333-4 | Physically hit or threatened | |||||||||
| 100334-2 | Been physically hurt with some degree of injury | |||||||||
| 100335-9 |
|
Coerced sexual activity |
|
|||||||
| 100336-7 | Coerced touching of private body parts of self or others | |||||||||
| 100337-5 |
|
Coerced to undress or expose private body area |
|
|||||||
| 100338-3 |
Photographed
in
| |||||||||
| 10033-9 | R' wave dur L-V6 | duración de la onda R'.derivación V6:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda R 'plomo V6:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | R' onda dur L-V6 | ||||||
| 100339-1 |
|
Experienced attempted physical restraint |
|
|||||||
| 100340-9 | Range of motion panel Hip | |||||||||
| 100341-7 | Rötelnvirus Antikörper-Index |
Röteln-Virus
IgG-Antikörperindex
[Einheiten/Volumen]
in
| Rubella virus IgG index, Serum+Cerebrospinal fluid | Rubéole virus Ac IgG index [Arbitraire/Volume] Sérum+Liquide céphalorachidien ; Numérique | Rubellavirus As.IgG-index [eenheid/volume] in serum en liquor cerebrospinalis | |||||
| 100342-5 | Flüchtige organische Verbindungen assoziiert mit SARS-CoV-2-Infektion [Nachweis] in Exhalat mittels GC-MS | Volatile Organic Compounds associated with SARS-CoV-2 infection, Exhaled gas | Composés organiques volatiles associés à l'infection SARS-CoV-2 [Présence/Seuil] Gaz expiré ; Qualitatif ; GC-MS | Vluchtige organische componenten bij SARS-CoV-2-infectie [aanwezigheid] in uitgeademde lucht d.m.v. gaschromatografie-massaspectrometrie | ||||||
| 100343-3 |
|
Influenza-Virus B RNA [Nachweis] in Speichel mittels Nukleinsäureamplifikation mit Sondendetektion | Influenza B (Flu B), Saliva | Influenza virus B ARN [Présence/Seuil] Salive ; Qualitatif ; PCR amplification de cible | Influenzavirus B RNA [aanwezigheid] in speeksel d.m.v. probe-detectie |
|
||||
| 100344-1 |
Influenza-Virus
A
RNA
[Nachweis]
in
| Influenza A (Flu A), Saliva | Influenza virus A ARN [Présence/Seuil] Salive ; Qualitatif ; PCR amplification de cible | Influenzavirus A RNA [aanwezigheid] in speeksel d.m.v. probe-detectie | ||||||
| 100345-8 | Influenza-Virus A und Influenza-Virus B und SARS-CoV-2 (COVID-19) RNA (Liste) - Probenmaterial mittels Nukleinsäureamplifikation mit Sondendetektion | Influenza virus A and B and SARS-CoV-2 (COVID-19) RNA panel, Specimen | Influenza virus A et B et Coronavirus SARS-Cov-2 ARN panel [-] Milieux divers ; - ; PCR amplification de cible | Influenzavirus A & influenzavirus B & SARS-CoV-2 RNA panel d.m.v. probe-detectie | ||||||
| 100346-6 | Clotting Time FIBTEM |
|
Clotting time.extrinsic coagulation system activated.platelets inhibited, Blood | Temps de coagulation (activation de la voie extrinsèque) avec inhibition des plaquettes [Temps] Sang ; Numérique ; Thromboélastographie rotationelle |
|
|||||
| 10034-7 | S wave Amp L-AVF | amplitud de la onda S.derivación AVF:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda S. Conducir AVF:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | S onda Amp L-AVF | ||||||
| 100347-4 | Clot Formation Time FIBTEM |
|
Clot formation.extrinsic coagulation system activated.platelets inhibited, Blood | Temps de formation du caillot (activation de la voie extrinsèque) avec inhibition des plaquettes [Temps] Sang ; Numérique ; Thromboélastographie rotationelle |
|
|||||
| 100348-2 | MELDNa score | |||||||||
| 100349-0 |
|
DOP Penis ves W vasodilator IV |
|
|||||||
| 100350-8 | Sesamum indicum 1 allergy test | Sésame (graine) 1 Ac IgE [Arbitraire/Volume] Sérum ; Numérique |
Sesamum
indicum
1
As.IgE
[eenheid/volume]
in
| |||||||
| 100351-6 | Pioglitazone, Blood | Pioglitazone [Présence/Seuil] Sérum/Plasma ; Qualitatif | Pioglitazon [aanwezigheid] in serum of plasma | |||||||
| 100352-4 |
|
Rosiglitazone, Blood |
|
Rosiglitazon
[aanwezigheid]
in
| ||||||
| 100353-2 | Norwalk Community Health Center Screening Tool [NCHC] | |||||||||
| 10035-4 |
|
S wave Amp L-AVL | amplitud de la onda S.derivación AVL:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda S. Conducir AVL:Corazón :Punto temporal:Elpot:Cuantitativo:EKG |
| |||||
| 100354-0 |
Frequency
of
participating
in
| |||||||||
| 100355-7 | Frequency of participating in spoken language expression communication without assistance | |||||||||
| 100356-5 |
|
Chlamydia trachomatis and Neisseria gonorrhoeae and Trichomonas vaginalis, Specimen |
| Chlamydia trachomatis & Neisseria gonorrhoeae & Trichomonas vaginalis DNA [identificator] d.m.v. probe-detectie | ||||||
| 100357-3 | Naloxone, Umbilical cord tissue | Naloxone [Présence/Seuil] Tissu de cordon ; Qualitatif ; Dépistage | Naloxon [aanwezigheid] in weefsel van navelstreng d.m.v. screening | |||||||
| 100358-1 |
|
Phentermine, Umbilical cord tissue |
| Fentermine [aanwezigheid] in weefsel van navelstreng d.m.v. screening | ||||||
| 100359-9 |
Gliadin
33
mer
peptide,
Stool
|
Gliadine 33-mer peptide [Masse/Volume] Selle ; Numérique ; Immunoanalyse | Gliadin 33-mer peptide [massa/volume] in feces d.m.v. immunoassay | |||||||
| 100360-7 | Brief Resilience Scale panel [BRS] | |||||||||
| 100361-5 |
|
Quickly recover from bad events |
|
|||||||
| 10036-2 | S wave Amp L-AVR | amplitud de la onda S.derivación AVR:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda S. Conducir AVR:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | S onda Amp L-AVR | ||||||
| 100362-3 | Difficulty making it through stressful events | |||||||||
| 100363-1 |
Easily
recover
from
| |||||||||
| 100364-9 | Difficulty recovering from bad events | |||||||||
| 100365-6 |
|
Easily recover from difficulties |
|
|||||||
| 100366-4 | Lengthy recovery from setbacks | |||||||||
| 100367-2 |
|
Total Score BRS |
|
|||||||
| 100368-0 | Amino Acids Urea Cycle Panel, Blood | Acides aminés du cycle de l'urée panel [-] Sérum/Plasma ; - ; LC/MS/MS |
Aminozuren
ureumcyclus
panel
in
| |||||||
| 100369-8 | NM Thyroid Views W Tl-201 IV | |||||||||
| 10037-0 |
|
S wave Amp L-I | amplitud de la onda S.derivación I:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de la onda S. Conduzca I:Corazón :Punto temporal:Elpot:Cuantitativo:EKG |
| |||||
| 100370-6 |
Orthopoxvirus
DNA
| Orthopoxvirus, Specimen | Orthopoxvirus ADN [Identification] Milieux divers ; Résultat nominal ; PCR amplification de cible | Orthopoxvirus DNA [identificator] d.m.v. probe-detectie | ||||||
| 100371-4 |
|
Titin antibody, Blood |
| |||||||
| 100372-2 |
|
Abiraterone, Blood |
| Abirateron [massa/volume] in serum of plasma | ||||||
| 100373-0 | Agar- agar IgG antibody | Eucheuma Ac IgG [Arbitraire/Volume] Sérum ; Numérique | Eucheuma As.IgG [eenheid/volume] in serum | |||||||
| 100374-8 |
|
Aloe vera IgG antibody |
|
Aloë
vera
As.IgG
[eenheid/volume]
in
| ||||||
| 100375-5 | Anise IgG antibody | Anis Ac IgG [Arbitraire/Volume] Sérum ; Numérique | Pimpinella anisum As.IgG [eenheid/volume] in serum | |||||||
| 100376-3 |
|
Bamboo sprouts IgG antibody |
|
Bambusa
vulgaris
As.IgG
[eenheid/volume]
in
| ||||||
| 100377-1 | Goat cheese IgG antibody | Fromage de chèvre Ac IgG [Arbitraire/Volume] Sérum ; Numérique | Geitenkaas As.IgG [eenheid/volume] in serum | |||||||
| 100378-9 |
|
Sheep cheese IgG antibody |
|
Schapenkaas
As.IgG
[eenheid/volume]
in
| ||||||
| 100379-7 | Leeks IgG antibody | Poireau vivace Ac IgG [Arbitraire/Volume] Sérum ; Numérique | Allium ampeloprasum As.IgG [eenheid/volume] in serum | |||||||
| 100380-5 |
|
Red cabbage IgG antibody |
|
Brassica
oleracea
var
capitata
f
rubra
As.IgG
[eenheid/volume]
in
| ||||||
| 100381-3 | Mint IgG antibody | Menthe poivrée hybride Ac IgG [Arbitraire/Volume] Sérum ; Numérique | Mentha piperita As.IgG [eenheid/volume] in serum | |||||||
| 100382-1 |
|
FDA insert REMS addressed risk |
|
|||||||
| 100383-9 | Affenpockenvirus-DNA ql. /Sondermaterial PCR |
Affenpocken-Virus
DNA
[Nachweis]
in
| Monkeypox virus, Specimen | Monkeypox virus ADN [Présence/Seuil] Milieux divers ; Qualitatif ; PCR amplification de cible | Mpoxvirus DNA [aanwezigheid] d.m.v. probe-detectie | |||||
| 100384-7 | Turnip IgG antibody | Chou champêtre Ac IgG [Arbitraire/Volume] Sérum ; Numérique | Brassica rapa As.IgG [eenheid/volume] in serum | |||||||
| 100385-4 |
|
Corn salad IgG antibody |
| Valerianella locusta As.IgG [eenheid/volume] in serum | ||||||
| 100386-2 | Rosemary IgG antibody | Romarin Ac IgG [Arbitraire/Volume] Sérum ; Numérique | Rosmarinus officinalis As.IgG [eenheid/volume] in serum | |||||||
| 100387-0 |
|
Poppy seed IgG antibody |
|
Papaver
somniferum
As.IgG
[eenheid/volume]
in
| ||||||
| 10038-8 | S wave Amp L-II | amplitud de la onda S.derivación II:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda S. derivación II:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | S onda Amp L-II | ||||||
| 100388-8 |
|
Cocoa IgG antibody |
|
Theobroma
cacao
As.IgG
[eenheid/volume]
in
|
||||||
| 100389-6 |
|
Pistachio IgG antibody |
|
Pistacia
vera
As.IgG
[eenheid/volume]
in
| ||||||
| 100390-4 | Sunflower seed IgG antibody | Tournesol (graine) Ac IgG [Arbitraire/Volume] Sérum ; Numérique | Helianthus annuus zaad As.IgG [eenheid/volume] in serum | |||||||
| 100391-2 |
|
Dates IgG antibody |
|
Phoenix
dactylifera
As.IgG
[eenheid/volume]
in
| ||||||
| 100392-0 | Duck meat IgG antibody | Canard (viande) Ac IgG [Arbitraire/Volume] Sérum ; Numérique | Eendenvlees As.IgG [eenheid/volume] in serum | |||||||
| 100393-8 |
|
Allergen Mushroom mix 2 (Xerocomus, Boletus) IgG antibody |
|
Paddenstoelallergenen
mix
2
(Xerocomus
+
Boletus)
As.IgG
[eenheid/volume]
in
| ||||||
| 100394-6 | Decapod crustaceans IgG antibody | Astacoidea Ac IgG [Arbitraire/Volume] Sérum ; Numérique | Astacoidea As.IgG [eenheid/volume] in serum | |||||||
| 100395-3 |
|
Carob IgG antibody |
|
Ceratonia
siliqua
As.IgG
[eenheid/volume]
in
| ||||||
| 10039-6 | S wave Amp L-III | amplitud de la onda S.derivación III:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda S. derivación III:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | S onda Amp L-III | ||||||
| 100396-1 |
|
Rapeseed IgG antibody |
|
Brassica
napus
As.IgG
[eenheid/volume]
in
|
||||||
| 100397-9 |
|
Goat Meat IgG antibody |
|
Geitenvlees
As.IgG
[eenheid/volume]
in
| ||||||
| 100398-7 | Goose meat IgG antibody | Oie (viande) Ac IgG [Arbitraire/Volume] Sérum ; Numérique | Ganzenvlees As.IgG [eenheid/volume] in serum | |||||||
| 100399-5 |
|
Ostrich meat IgG antibody |
|
Struisvogelvlees
As.IgG
[eenheid/volume]
in
| ||||||
| 100400-1 | Quail meat IgG antibody | Caille (viande) Ac IgG [Arbitraire/Volume] Sérum ; Numérique | Kwartelvlees As.IgG [eenheid/volume] in serum | |||||||
| 100401-9 |
|
Rabbit meat IgG antibody |
|
Konijnenvlees
As.IgG
[eenheid/volume]
in
| ||||||
| 100402-7 | Venison meat IgG antibody | Venaison (viande) Ac IgG [Arbitraire/Volume] Sérum ; Numérique | Hertenvlees As.IgG [eenheid/volume] in serum | |||||||
| 100403-5 |
|
Guineafowl IgG antibody |
|
Parelhoen
As.IgG
[eenheid/volume]
in
| ||||||
| 10040-4 | S wave Amp L-V1 | amplitud de la onda S.derivación V1:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda S. derivación V1:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | S onda Amp L-V1 | ||||||
| 100404-3 |
|
Horse meat IgG antibody |
|
Paardenvlees
As.IgG
[eenheid/volume]
in
|
||||||
| 100405-0 |
|
Kefir IgG antibody |
|
Kefir
As.IgG
[eenheid/volume]
in
| ||||||
| 100406-8 | Butter IgG antibody | Beurre Ac IgG [Arbitraire/Volume] Sérum ; Numérique | Boter As.IgG [eenheid/volume] in serum | |||||||
| 100407-6 |
|
Camembert cheese IgG antibody |
|
Camembert
As.IgG
[eenheid/volume]
in
| ||||||
| 100408-4 | Emmental cheese IgG antibody | Fromage emmental Ac IgG [Arbitraire/Volume] Sérum ; Numérique | Emmentaler kaas As.IgG [eenheid/volume] in serum | |||||||
| 100409-2 |
|
Processed cheese IgG antibody |
|
Smeltkaas
As.IgG
[eenheid/volume]
in
| ||||||
| 1004-1 | Direct Antiglobulin Test (DAT; Direct Coombs), Red blood cells | prueba de antiglobulina directa.reactivo específico de complemento:concentración arbitraria:punto en el tiempo:eritrocitos:ordinal: | Test de antiglobulina directo, reactivo específico del complemento: Eritrocitos : Punto temporal: Presencia o umbral: Ordinal: | Test direct à l'antiglobuline (EDA) complément spécifique [Présence/Seuil] Érythrocytes ; Qualitatif | Directe antiglobulinetest.complement specifiek reagens [aanwezigheid] in erytrocyten | DAT Comp-Sp Reag RBC Ql | ||||
| 100410-0 |
|
Curd cheese IgG antibody |
|
Kwark
As.IgG
[eenheid/volume]
in
|
||||||
| 100411-8 |
|
Sugar beet IgG antibody |
|
Bèta-vulgaris
As.IgG
[eenheid/volume]
in
| ||||||
| 10041-2 | S wave Amp L-V2 | amplitud de la onda S.derivación V2:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda S. derivación V2:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | S onda Amp L-V2 | ||||||
| 100412-6 |
|
Chinese cabbage IgG antibody |
|
Chinese
kool
As.IgG
[eenheid/volume]
in
|
||||||
| 100413-4 |
|
Fennel fresh IgG antibody |
|
Foeniculum
vulgare
vers
As.IgG
[eenheid/volume]
in
| ||||||
| 100414-2 | Gourd IgG antibody | Cucurbitaceae Ac IgG [Arbitraire/Volume] Sérum ; Numérique | Genera in Cucurbitaceae As.IgG [eenheid/volume] in serum | |||||||
| 100415-9 |
|
Kale IgG antibody |
|
Brassica
oleracea
var.
Borecole
As.IgG
[eenheid/volume]
in
| ||||||
| 100416-7 | Savoy cabbage IgG antibody | Chou de Milan [Arbitraire/Volume] Sérum ; Numérique | Brassica oleracea var. Sabauda As.IgG [eenheid/volume] in serum | |||||||
| 100417-5 |
|
Vitis sp leaf IgG antibody |
|
Blad
van
Vitis
sp.
As.IgG
[eenheid/volume]
in
| ||||||
| 100418-3 | Liquorice IgG antibody | Réglisse Ac IgG [Arbitraire/Volume] Sérum ; Numérique | Glycyrrhiza glabra As.IgG [eenheid/volume] in serum | |||||||
| 100419-1 |
|
Snow pea IgG antibody |
|
Pisum
sativum
var.
saccharatum
As.IgG
[eenheid/volume]
in
| ||||||
| 10042-0 | S wave Amp L-V3 | amplitud de la onda S.derivación V3:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda S. derivación V3:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | S onda Amp L-V3 | ||||||
| 100420-9 |
|
Fava bean IgG antibody |
|
Vicia
faba
As.IgG
[eenheid/volume]
in
| ||||||
| 100421-7 |
|
Chickpea IgG antibody |
|
Cicer
arietinus
As.IgG
[eenheid/volume]
in
| ||||||
| 100422-5 | Common Chicory IgG antibody | Chicorée sauvage Ac IgG [Arbitraire/Volume] Sérum ; Numérique | Cichorium intybus As.IgG [eenheid/volume] in serum | |||||||
| 100423-3 |
|
Button + oyster + Shiitaki + chanterelle mushroom IgG antibody |
|
Paddenstoelallergenen
mix
1
| ||||||
| 100424-1 | 8(9)-Cholestenol, Blood | 8(9)-cholesténol [Masse/Volume] Sérum/Plasma ; Numérique | 8(9)-cholestenol [massa/volume] in serum of plasma | |||||||
| 100425-8 |
|
DiHydro T-Mas, Blood |
|
DiHydro
T-Mas
[massa/volume]
in
| ||||||
| 100426-6 | Squalene, Blood | Squalène [Masse/Volume] Sérum/Plasma ; Numérique | ||||||||
| 100427-4 |
|
Stigmasterol, Blood |
|
Stigmasterol
[massa/volume]
in
| ||||||
| 100428-2 | Carnitine free and total and acylcarnitine panel, Urine | Carnitine libre et totale et acylcarnitine panel [-] Urine ; - | Carnitine.vrij & totaal & acylcarnitine panel in urine | |||||||
| 100429-0 |
|
LRBA deficiency panel, Blood |
|
LRBA-deficiëntie
panel
in
| ||||||
| 100430-8 | Cells.LRBA+/Cells.CD3+CD14-CD45+, Blood | LRBA+/100 cellules CD3+CD14-CD45+ [Fraction de nombres] Sang ; Numérique ; Cytométrie de flux | Cellen.LRBA+/100 cellen.CD3+CD14-CD45+ [getalsfractie] in bloed d.m.v. flowcytometrie | |||||||
| 100431-6 |
|
T-cells LRBA MFI, Blood |
|
Cellen.CD3+CD14-CD45+.LRBA
gemiddelde
fluorescentie-intensiteit
[aanwezigheid]
in
| ||||||
| 100432-4 | Cells.LRBA+/Cells.CD3-CD14-CD19+CD45+, Blood | LRBA+/100 cellules CD3-CD14-CD19+CD45+ [Fraction de nombres] Sang ; Numérique ; Cytométrie de flux | Cellen.LRBA+/100 cellen.CD3-CD14-CD19+CD45+ [getalsfractie] in bloed d.m.v. flowcytometrie | |||||||
| 100433-2 |
|
B-cells LRBA MFI, Blood |
|
Cellen.CD3-CD14-CD19+CD45+.LRBA
gemiddelde
fluorescentie-intensiteit
[aanwezigheid]
in
| ||||||
| 100434-0 | Orthopoxvirus.nicht-variola DNA [Nachweis] in Probenmaterial mittels Nukleinsäureamplifikation mit Sondendetektion | Orthopoxvirus.non-variola, Specimen | Orthopoxvirus non variola ADN [Présence/Seuil] Milieux divers ; Qualitatif ; PCR amplification de cible | Orthopoxvirus anders dan variolavirus DNA [aanwezigheid] d.m.v. probe-detectie | ||||||
| 100435-7 |
|
Glial fibrillary acidic protein, Blood |
|
Gliaal
fibrillair
acidisch
proteïne
[massa/volume]
in
| ||||||
| 100436-5 | Ubiquitin carboxyl-terminal hydrolase-L1, Blood | Ubiquitin carboxyl-terminal hydrolase-L1 [Masse/Volume] Sérum ; Numérique ; Immunoanalyse | ||||||||
| 100437-3 |
|
Norsufentanil, Urine |
|
Norsufentanil
[massa/volume]
in
| ||||||
| 10043-8 | S wave Amp L-V4 | amplitud de la onda S.derivación V4:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda S. derivación V4:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | S onda Amp L-V4 | ||||||
| 100438-1 | Adolescent med OP Prog note | |||||||||
| 100439-9 |
|
Allergy+Immunology OP Prog note |
|
Voortgangsrapport
[bevinding]
in
| ||||||
| 100440-7 | Allergy OP Prog note | |||||||||
| 100441-5 |
|
Attend OP Prog note |
|
Voortgangsrapport
[bevinding]
in
| ||||||
| 100442-3 | Audiology OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. audiologie (document) | ||||||||
| 100443-1 |
|
Bariatric surg OP Prog note |
|
|||||||
| 100444-9 | Bld Bnk+Trans Med OP Prog note | |||||||||
| 100445-6 |
|
BM Transplant OP Prog note |
|
Voortgangsrapport
[bevinding]
in
| ||||||
| 10044-6 | S wave Amp L-V5 | amplitud de la onda S.derivación V5:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda S. derivación V5:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | S onda Amp L-V5 | ||||||
| 100446-4 |
|
Breastfeeding OP Prog note |
| |||||||
| 100447-2 | Burn OP Prog note | |||||||||
| 100448-0 |
|
Cardiac surgery OP Prog note |
|
Voortgangsrapport
[bevinding]
in
| ||||||
| 100449-8 | Cardio+Pulm dis OP Prog note | |||||||||
| 100450-6 |
|
Child+teen psych OP Prog note |
|
|||||||
| 100451-4 | Chiropractic med OP Prog note |
Voortgangsrapport
[bevinding]
in
| ||||||||
| 100452-2 | Electrophysiology OP Prog note | |||||||||
| 10045-3 |
|
S wave Amp L-V6 | amplitud de la onda S.derivación V6:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda S. derivación V6:Corazón :Punto temporal:Elpot:Cuantitativo:EKG |
| |||||
| 100453-0 | Clinical genetics OP Prog note |
Voortgangsrapport
[bevinding]
in
| ||||||||
| 100454-8 | Clinical Neurophys OP Prog note | |||||||||
| 100455-5 |
|
Clin Path OP Prog note |
|
|||||||
| 100456-3 | Col+rec surg OP Prog note | |||||||||
| 100457-1 |
|
Consultant OP Prog note |
|
|||||||
| 100458-9 | OP COVID-19 Intub+Progress | |||||||||
| 100459-7 |
|
OP COVID-19 Progress note |
|
|||||||
| 100460-5 | Dermatology OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. dermatologie (document) | ||||||||
| 10046-1 |
|
S wave dur L-AVF | duración de la onda S.derivación AVF:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda S. plomo AVF:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG |
| |||||
| 100461-3 | Develop-behav peds OP Prog note | |||||||||
| 100462-1 |
|
Dialy+Ther Apher OP Prog note |
|
Voortgangsrapport [bevinding] in poliklinisch d.m.v. dialyse en therapeutische aferese (document) | ||||||
| 100463-9 | Eating disorders OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. eetstoornis (document) | ||||||||
| 100464-7 |
|
Endocrinology OP Prog note |
|
Voortgangsrapport
[bevinding]
in
| ||||||
| 100465-4 | Fam Med OP Prog note | |||||||||
| 100466-2 |
|
Gastroenterology OP Prog note |
|
|||||||
| 100467-0 |
|
Geri med OP Prog note |
|
Voortgangsrapport
[bevinding]
in
| ||||||
| 100468-8 | Gyn Onc OP Prog note | |||||||||
| 100469-6 |
|
Gynecology OP Prog note |
|
Voortgangsrapport
[bevinding]
in
| ||||||
| 100470-4 | Navigator OP Prog note | |||||||||
| 100471-2 |
|
Heart failure OP Prog note |
|
|||||||
| 100472-0 | HF+TC OP Prog note | |||||||||
| 100473-8 |
|
Hematology OP Prog note |
|
Voortgangsrapport
[bevinding]
in
|
||||||
| 100474-6 |
|
HemOnc OP Prog note |
|
Voortgangsrapport
[bevinding]
in
| ||||||
| 100475-3 | Hepatology OP Prog note | |||||||||
| 100476-1 |
|
Immunology OP Prog note |
|
Voortgangsrapport
[bevinding]
in
| ||||||
| 100477-9 | Infectious disease OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. infectioloog (document) | ||||||||
| 100478-7 |
|
Internal Med OP Prog note |
|
Voortgangsrapport
[bevinding]
in
| ||||||
| 10047-9 | S wave dur L-AVL | duración de la onda S.derivación AVL:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda S. Plomo AVL:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | S onda dur L-AVL | ||||||
| 100479-5 |
|
IC OP Prog note |
|
|||||||
| 100480-3 | IR OP Prog note | |||||||||
| 100481-1 |
|
OP MCS+progress note |
|
|||||||
| 100482-9 | MAiD OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. medische zorg bij sterven (document) | ||||||||
| 100483-7 |
|
Mental health OP Prog note |
|
Voortgangsrapport
[bevinding]
in
| ||||||
| 100484-5 | Multi-spec prog OP Prog note | |||||||||
| 100485-2 | Neo peri med OP Prog note | |||||||||
| 100486-0 |
|
Nephrology OP Prog note |
|
Voortgangsrapport
[bevinding]
in
| ||||||
| 10048-7 | S wave dur L-AVR | duración de la onda S.derivación AVR:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda S. Lead AVR:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | S onda dur L-AVR | ||||||
| 100487-8 |
|
Neuro surgery OP Prog note |
|
Voortgangsrapport
[bevinding]
in
| ||||||
| 100488-6 | Neurology OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. neurologie (document) | ||||||||
| 100489-4 |
|
Child neuro OP Prog note |
|
|||||||
| 100490-2 | Nurse pract OP Prog note | |||||||||
| 100491-0 | Nurse OP Prog note |
Voortgangsrapport
[bevinding]
in
| ||||||||
| 100492-8 | Nutr+diet OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. voeding en diëtetiek (document) | ||||||||
| 100493-6 |
|
OBGYN OP Prog note |
|
Voortgangsrapport
[bevinding]
in
| ||||||
| 100494-4 | OB OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. obstetrie (document) | ||||||||
| 10049-5 |
|
S wave dur L-I | duración de la onda S.derivación I:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda S. Conduzca I:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG |
| |||||
| 100495-1 | OT OP Prog note |
Voortgangsrapport
[bevinding]
in
| ||||||||
| 100496-9 | Oncology OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. oncologie (document) | ||||||||
| 100497-7 | Ophthalmol OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. oogheelkunde (document) | ||||||||
| 100498-5 |
|
Optometry OP Prog note |
|
Voortgangsrapport
[bevinding]
in
| ||||||
| 100499-3 | OMS OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. oromaxillofaciale chirurgie (document) | ||||||||
| 100500-8 |
|
Orthopaedic surgery OP Prog note |
|
Voortgangsrapport
[bevinding]
in
| ||||||
| 100501-6 | Orthotics prosthetics OP Prog note | |||||||||
| 100502-4 |
|
Otolaryngology OP Prog note |
|
Voortgangsrapport
[bevinding]
in
| ||||||
| 10050-3 | S wave dur L-II | duración de la onda S.derivación II:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda S. derivación II:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | S onda dur L-II | ||||||
| 100503-2 |
|
Pain medicine OP Prog note |
|
Voortgangsrapport
[bevinding]
in
| ||||||
| 100504-0 | Palliative care OP Prog note | |||||||||
| 100505-7 |
|
Peds cardiology OP Prog note |
|
|||||||
| 100506-5 | Peds dermatology OP Prog note | |||||||||
| 100507-3 |
|
Peds endocrinology OP Prog note |
|
|||||||
| 100508-1 | Peds gastroenterology OP Prog note | |||||||||
| 100509-9 |
|
Peds hem-onc OP Prog note |
|
|||||||
| 100510-7 | Peds infect disease OP Prog note | |||||||||
| 10051-1 |
|
S wave dur L-III | duración de la onda S.derivación III:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda S. Plomo III:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG |
| |||||
| 100511-5 | Peds otolaryngology OP Prog note | |||||||||
| 100512-3 |
|
Peds pulmonology OP Prog note |
|
|||||||
| 100513-1 | Peds rheumatology OP Prog note | |||||||||
| 100514-9 |
|
Peds surgery OP Prog note |
|
|||||||
| 100515-6 | Peds transpl hepato OP Prog note | |||||||||
| 100516-4 | Peds urology OP Prog note | |||||||||
| 100517-2 |
|
Pharmacogenomics OP Prog note |
|
|||||||
| 100518-0 | PM+R OP Prog note | |||||||||
| 100519-8 |
|
PT OP Prog note |
|
Voortgangsrapport
[bevinding]
in
| ||||||
| 100520-6 | Plastic surgery OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. plastische chirurgie (document) | ||||||||
| 100521-4 |
|
Podiatry OP Prog note |
|
Voortgangsrapport
[bevinding]
in
| ||||||
| 100522-2 | Psychiatric Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. psychiatrie (document) | ||||||||
| 100523-0 |
|
Psych OP Prog note |
|
Voortgangsrapport
[bevinding]
in
| ||||||
| 100524-8 | Pulmonary disease OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. longaandoening (document) | ||||||||
| 100525-5 |
|
Radiation Onc OP Prog note |
|
Voortgangsrapport
[bevinding]
in
| ||||||
| 100526-3 | Radiology OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. radiologie (document) | ||||||||
| 100527-1 |
|
Rec therapy OP Prog note |
| |||||||
| 100528-9 | REI OP Prog note | |||||||||
| 10052-9 |
|
S wave dur L-V1 | duración de la onda S.derivación V1:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda S. derivación V1:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG |
| |||||
| 100529-7 | Research OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. wetenschappelijk onderzoek (document) | ||||||||
| 100530-5 |
|
Rheumatology OP Prog note |
|
Voortgangsrapport
[bevinding]
in
| ||||||
| 100531-3 | Sleep med OP Prog note | |||||||||
| 100532-1 |
|
SW OP Prog note |
|
|||||||
| 100533-9 | Solid Org Transplant OP Prog note |
Voortgangsrapport
[bevinding]
in
| ||||||||
| 100534-7 | Speech-lang path OP Prog note | |||||||||
| 100535-4 |
|
Spinal surgery OP Prog note |
|
|||||||
| 100536-2 | Sports medicine OP Prog note | |||||||||
| 10053-7 |
|
S wave dur L-V2 | duración de la onda S.derivación V2:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda S. derivación V2:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG |
| |||||
| 100537-0 | Hand Surgery OP Prog note | |||||||||
| 100538-8 |
|
Telehealth+Outpatient Prog note |
|
|||||||
| 100539-6 | Thromboemb OP Prog note | |||||||||
| 100540-4 |
|
Transpl surg OP Prog note |
|
Voortgangsrapport
[bevinding]
in
| ||||||
| 100541-2 | Trauma OP Prog note | |||||||||
| 100542-0 |
|
Urology OP Prog note |
|
Voortgangsrapport
[bevinding]
in
| ||||||
| 100543-8 | Vasc Neuro OP Prog note | |||||||||
| 100544-6 |
|
Vascular surgery OP Prog note |
|
Voortgangsrapport
[bevinding]
in
| ||||||
| 10054-5 | S wave dur L-V3 | duración de la onda S.derivación V3:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda S. Plomo V3:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | S onda dur L-V3 | ||||||
| 100545-3 |
|
Wound care management OP Prog note |
|
Voortgangsrapport
[bevinding]
in
| ||||||
| 100546-1 | WOC OP Prog note | |||||||||
| 100547-9 |
|
Adolescent med Hosp Prog note |
|
|||||||
| 100548-7 | Allergy+Immunology Hosp Prog note |
Voortgangsrapport
[bevinding]
in
| ||||||||
| 100549-5 | Allergy Hosp Prog note | |||||||||
| 100550-3 |
|
Attend Hosp Prog note |
|
Voortgangsrapport
[bevinding]
in
|
||||||
| 100551-1 |
|
Audiology Hosp Prog note |
|
Voortgangsrapport
[bevinding]
in
| ||||||
| 10055-2 | S wave dur L-V4 | duración de la onda S.derivación V4:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda S. Plomo V4:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | S onda dur L-V4 | ||||||
| 100552-9 |
|
Bariatric surg Hosp Prog note |
|
|||||||
| 100553-7 | Bld Bnk+Trans Med Hosp Prog note | |||||||||
| 100554-5 |
|
BM Transplant Hosp Prog note |
|
Voortgangsrapport
[bevinding]
in
|
||||||
| 100555-2 |
|
Breastfeeding Hosp Prog note |
| |||||||
| 100556-0 | Burn Hosp Prog note | |||||||||
| 100557-8 |
|
Cardiac surgery Hosp Prog note |
|
Voortgangsrapport
[bevinding]
in
| ||||||
| 100558-6 | Cardio+Pulm dis Hosp Prog note | |||||||||
| 100559-4 |
|
Child+teen psych Hosp Prog note |
|
|||||||
| 10056-0 | S wave dur L-V5 | duración de la onda S.derivación V5:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda S. Plomo V5:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | S onda dur L-V5 | ||||||
| 100560-2 |
|
Electrophysiology Hosp Prog note |
|
|||||||
| 100561-0 | Clinical genetics Hosp Prog note |
Voortgangsrapport
[bevinding]
in
| ||||||||
| 100562-8 | Clinical Neurophys Hosp Prog note | |||||||||
| 100563-6 |
|
Clin Path Hosp Prog note |
|
|||||||
| 100564-4 | Col+rec surg Hosp Prog note | |||||||||
| 100565-1 |
|
Consultant Hosp Prog note |
|
|||||||
| 100566-9 | Dentistry Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. tandheelkunde (document) | ||||||||
| 100567-7 |
|
Dermatology Hosp Prog note |
|
Voortgangsrapport
[bevinding]
in
| ||||||
| 100568-5 | Develop-behav peds Hosp Prog note | |||||||||
| 100569-3 |
|
Dialy+Ther Apher Hosp Prog note |
|
Voortgangsrapport
[bevinding]
in
| ||||||
| 100570-1 | Eating disorders Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. eetstoornis (document) | ||||||||
| 100571-9 |
|
Endocrinology Hosp Prog note |
|
Voortgangsrapport
[bevinding]
in
| ||||||
| 100572-7 | Fam Med Hosp Prog note | |||||||||
| 100573-5 |
|
Gastroenterology Hosp Prog note |
|
Voortgangsrapport
[bevinding]
in
| ||||||
| 100574-3 | General medicine Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. algemene geneeskunde (document) | ||||||||
| 100575-0 |
|
Geri med Hosp Prog note |
|
Voortgangsrapport
[bevinding]
in
| ||||||
| 100576-8 | Gyn Onc Hosp Prog note | |||||||||
| 100577-6 |
|
Gynecology Hosp Prog note |
|
Voortgangsrapport
[bevinding]
in
| ||||||
| 10057-8 | S wave dur L-V6 | duración de la onda S.derivación V6:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda S. Plomo V6:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | S onda dur L-V6 | ||||||
| 100578-4 |
|
Navigator Hosp Prog note |
|
|||||||
| 100579-2 | Heart failure Hosp Prog note | |||||||||
| 1005-8 | Indirect Antiglobulin Test (IAT; Indirect Coombs), Blood | prueba de antiglobulina indirecta.reactivo específico de IgG [Inmunoglobulina G]:concentración arbitraria:punto en el tiempo:suero/plasma:ordinal: | Prueba de antiglobulina indirecta Reactivo específico IgG: Suero o Plasma : Punto temporal: Presencia o umbral: Ordinal: | Test indirect à l'antiglobuline (TIA) IgG spécifique [Présence/Seuil] Sérum/Plasma ; Qualitatif |
Indirecte
antiglobulinetest.IgG-specifiek
reagent
[aanwezigheid]
in
| IAT IgG-Sp Reag SerPl Ql | ||||
| 100580-0 | HF+TC Hosp Prog note | |||||||||
| 100581-8 |
|
Hematology Hosp Prog note |
|
Voortgangsrapport
[bevinding]
in
|
||||||
| 100582-6 |
|
HemOnc Hosp Prog note |
|
Voortgangsrapport
[bevinding]
in
| ||||||
| 100583-4 | Hepatology Hosp Prog note | |||||||||
| 100584-2 |
|
Immunology Hosp Prog note |
|
Voortgangsrapport
[bevinding]
in
| ||||||
| 100585-9 | Infectious disease Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. infectioloog (document) | ||||||||
| 10058-6 |
|
S' wave Amp L-AVF | amplitud de la onda S'.derivación AVF:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda S. Conducir AVF:Corazón :Punto temporal:Elpot:Cuantitativo:EKG |
| |||||
| 100586-7 | Internal Med Hosp Prog note |
Voortgangsrapport
[bevinding]
in
| ||||||||
| 100587-5 | IC Hosp Prog note | |||||||||
| 100588-3 |
|
IR Hosp Prog note |
|
|||||||
| 100589-1 | Hosp MCS+progress note | |||||||||
| 100590-9 |
|
MAiD Hosp Prog note |
|
Voortgangsrapport
[bevinding]
in
| ||||||
| 100591-7 | Mental health Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. geestelijke gezondheidszorg (document) | ||||||||
| 100592-5 |
|
Multi-spec prog Hosp Prog note |
|
|||||||
| 100593-3 | Neo peri med Hosp Prog note | |||||||||
| 10059-4 | S' wave Amp L-AVL | amplitud de la onda S'.derivación AVL:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda S. Conduzca AVL:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | S' onda Amp L-AVL | ||||||
| 100594-1 | Nephrology Hosp Prog note |
Voortgangsrapport
[bevinding]
in
| ||||||||
| 100595-8 | Neuro surgery Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. neurochirurgie (document) | ||||||||
| 100596-6 |
|
Neurology Hosp Prog note |
|
Voortgangsrapport
[bevinding]
in
| ||||||
| 100597-4 | Child neuro Hosp Prog note | |||||||||
| 100598-2 |
|
Nurse pract Hosp Prog note |
|
|||||||
| 100599-0 | Nurse Hosp Prog note |
Voortgangsrapport
[bevinding]
in
| ||||||||
| 100600-6 | Nutr+diet Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. voeding en diëtetiek (document) | ||||||||
| 100601-4 |
|
OBGYN Hosp Prog note |
| |||||||
| 10060-2 | S' wave Amp L-AVR | amplitud de la onda S'.derivación AVR:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda S. Conduzca AVR:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | S' onda Amp L-AVR | ||||||
| 100602-2 |
|
OB Hosp Prog note |
|
Voortgangsrapport
[bevinding]
in
| ||||||
| 100603-0 | OT Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. bezigheidstherapie (document) | ||||||||
| 100604-8 |
|
Oncology Hosp Prog note |
|
Voortgangsrapport
[bevinding]
in
| ||||||
| 100605-5 | Ophthalmol Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. oogheelkunde (document) | ||||||||
| 100606-3 |
|
OMS Hosp Prog note |
|
Voortgangsrapport
[bevinding]
in
| ||||||
| 100607-1 | Orthopaedic surgery Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. orthopedische chirurgie (document) | ||||||||
| 100608-9 |
|
Orthotics prosthetics Hosp Prog note |
|
|||||||
| 100609-7 | Otolaryngology Hosp Prog note |
Voortgangsrapport
[bevinding]
in
| ||||||||
| 10061-0 | S' wave Amp L-I | amplitud de la onda S'.derivación I:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda S. Conduzca I:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | S' onda Amp L-I | ||||||
| 100610-5 |
|
Pain medicine Hosp Prog note |
|
Voortgangsrapport
[bevinding]
in
| ||||||
| 100611-3 | Palliative care Hosp Prog note | |||||||||
| 100612-1 |
|
Pastoral Care Hosp Prog note |
|
|||||||
| 100613-9 | Peds cardiology Hosp Prog note | |||||||||
| 100614-7 |
|
Peds dermatology Hosp Prog note |
|
|||||||
| 100615-4 | Peds endocrinology Hosp Prog note | |||||||||
| 100616-2 |
|
Peds gastroenterology Hosp Prog note |
|
|||||||
| 100617-0 | Peds hem-onc Hosp Prog note | |||||||||
| 100618-8 |
|
Peds infect disease Hosp Prog note |
|
|||||||
| 100619-6 | Peds otolaryngology Hosp Prog note | |||||||||
| 100620-4 |
|
Peds pulmonology Hosp Prog note |
|
|||||||
| 100621-2 | Peds rheumatology Hosp Prog note | |||||||||
| 100622-0 |
|
Peds surgery Hosp Prog note |
|
|||||||
| 100623-8 | Peds transpl hepato Hosp Prog note | |||||||||
| 100624-6 |
|
Pharmacogenomics Hosp Prog note |
|
|||||||
| 100625-3 | Pharmacology Hosp Prog note | |||||||||
| 100626-1 | PM+R Hosp Prog note | |||||||||
| 100627-9 | PT Hosp Prog note |
Voortgangsrapport
[bevinding]
in
| ||||||||
| 10062-8 | S' wave Amp L-II | amplitud de la onda S'.derivación II:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda S. derivación II:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | S' onda Amp L-II | ||||||
| 100628-7 |
|
Plastic surgery Hosp Prog note |
|
Voortgangsrapport
[bevinding]
in
| ||||||
| 100629-5 | Podiatry Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. podologie (document) | ||||||||
| 100630-3 |
|
Psych Hosp Prog note |
| |||||||
| 100631-1 | Radiation Onc Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. radiotherapie (document) | ||||||||
| 100632-9 |
|
Radiology Hosp Prog note |
|
Voortgangsrapport
[bevinding]
in
| ||||||
| 100633-7 | Rapid response team Hosp Prog note | |||||||||
| 100634-5 |
|
Rec therapy Hosp Prog note |
|
Voortgangsrapport
[bevinding]
in
| ||||||
| 100635-2 | REI Hosp Prog note | |||||||||
| 10063-6 |
|
S' wave Amp L-III | amplitud de la onda S'.derivación III:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda S. derivación III:Corazón :Punto temporal:Elpot:Cuantitativo:EKG |
| |||||
| 100636-0 | Research Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. wetenschappelijk onderzoek (document) | ||||||||
| 100637-8 |
|
Rheumatology Hosp Prog note |
|
Voortgangsrapport
[bevinding]
in
| ||||||
| 100638-6 | Sleep med Hosp Prog note | |||||||||
| 100639-4 |
|
SW Hosp Prog note |
|
|||||||
| 100640-2 | Solid Org Transplant Hosp Prog note |
Voortgangsrapport
[bevinding]
in
| ||||||||
| 100641-0 | Speech-lang path Hosp Prog note | |||||||||
| 100642-8 |
|
Spinal surgery Hosp Prog note |
|
|||||||
| 100643-6 | Hand Surgery Hosp Prog note | |||||||||
| 10064-4 |
|
S' wave Amp L-V1 | amplitud de la onda S'.derivación V1:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda S. derivación V1:Corazón :Punto temporal:Elpot:Cuantitativo:EKG |
| |||||
| 100644-4 | Thromboemb Hosp Prog note | |||||||||
| 100645-1 |
|
Trauma Hosp Prog note |
|
|||||||
| 100646-9 | Urology Hosp Prog note |
Voortgangsrapport
[bevinding]
in
| ||||||||
| 100647-7 | Vasc Neuro Hosp Prog note | |||||||||
| 100648-5 |
|
Vascular surgery Hosp Prog note |
|
Voortgangsrapport
[bevinding]
in
|
||||||
| 100649-3 |
|
Wound care management Hosp Prog note |
|
Voortgangsrapport
[bevinding]
in
| ||||||
| 100650-1 | WOC Hosp Prog note | |||||||||
| 10065-1 |
|
S' wave Amp L-V2 | amplitud de la onda S'.derivación V2:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda S. derivación V2:Corazón :Punto temporal:Elpot:Cuantitativo:EKG |
| |||||
| 100651-9 | Hosp COVID-19 Intub+Progress | |||||||||
| 100652-7 | Pure tone bone thresh Pnl | |||||||||
| 100653-5 | Pure tone air thresh Pnl | |||||||||
| 100654-3 | M2-PK (Pyruvatkinase) /Stuhl |
Pyruvatkinase
M2
[Nachweis]
in
| Pyruvate kinase M2, Stool | Pyruvate kinase M2 [Présence/Seuil] Selle ; Qualitatif | Pyruvaatkinase M2 [aanwezigheid] in feces | |||||
| 100655-0 | XR ST Lat | |||||||||
| 100656-8 |
|
Mat fetal med OP Prog note |
|
|||||||
| 100657-6 | Mat fetal med Phone+Hosp Prog note | |||||||||
| 100658-4 | Hosp COVID-19 Progress note | |||||||||
| 100659-2 | Mat fetal med Hosp Prog note | |||||||||
| 1006-6 | Direkter Antiglobulintest.IgG-spezifisches Reagenz [Interpretation] auf Erythrozyten | Direct Antiglobulin Test (DAT; Direct Coombs), Red blood cells | prueba de antiglobulina directa.reactivo específico de IgG [Inmunoglobulina G]:impresión/interpretación del estudio:punto en el tiempo:eritrocitos:Nominal: | Prueba de antiglobulina directa Reactivo específico IgG: Eritrocitos : Punto temporal: Impresión / interpretación del estudio: Nominal: | Test direct à l'antiglobuline (EDA) IgG spécifique [Interprétation] Érythrocytes ; Résultat nominal |
Directe
antiglobulinetest.IgG
specifiek
reagens
[interpretatie]
in
| DAT IgG-Sp Reag RBC-Imp | |||
| 100660-0 | Mat fetal med Phone+OP Prog note | |||||||||
| 100661-8 |
|
Psychiatric OP Prog note |
|
Voortgangsrapport
[bevinding]
in
| ||||||
| 100662-6 | Cortisol free and total panel, Blood | Cortisol libre et total panel [-] Sérum/Plasma ; - | Cortisol vrij & totaal panel in serum of plasma | |||||||
| 100663-4 |
|
TPMT gene c.460G>A&c.719A>G, Blood |
|
TPMT-gen
c.460G>A&c.719A>G
[aanwezigheid]
in
| ||||||
| 100664-2 |
NUDT15
gene
c.50_55dup&c.415C>T,
Blood
|
NUDT15 gène c.50_55dup et c.415C>T [Présence/Seuil] Sang ; Qualitatif ; Biologie moléculaire | NUDT15-gen c.50_55dup&c.415C>T [aanwezigheid] in bloed d.m.v. moleculair genetisch onderzoek | |||||||
| 100665-9 | NUDT15 gene c.415C>T, Blood | NUDT15 gène c.415C>T [Présence/Seuil] Sang ; Qualitatif ; Biologie moléculaire | NUDT15-gen c.415C>T [aanwezigheid] in bloed d.m.v. moleculair genetisch onderzoek | |||||||
| 100666-7 |
|
NUDT15 gene c.52G>A, Blood |
|
NUDT15-gen
c.416G>A
[aanwezigheid]
in
| ||||||
| 100667-5 | NUDT15 gene c.52G>A, Blood | NUDT15 gène c.52G>A [Présence/Seuil] Sang ; Qualitatif ; Biologie moléculaire | NUDT15-gen c.52G>A [aanwezigheid] in bloed d.m.v. moleculair genetisch onderzoek | |||||||
| 100668-3 |
|
NUDT15 gene c.50_55dup, Blood |
|
NUDT15-gen
c.50_55dup
[aanwezigheid]
in
| ||||||
| 10066-9 | S' wave Amp L-V3 | amplitud de la onda S'.derivación V3:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda S. derivación V3:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | S' onda Amp L-V3 | ||||||
| 100669-1 |
|
NUDT15 gene c.50_55del, Blood |
|
NUDT15-gen
c.50_55del
[aanwezigheid]
in
| ||||||
| 100670-9 | Fetal RHD gene allele--fetus | RHD gène allèle du fœtus [Identification] Plasma avec ADN libre circulant ; Résultat nominal | RHD-allel^foetus [identificator] in plasma.celvrij DNA | |||||||
| 100671-7 |
|
Aspergillus sp, Blood |
|
Aspergillus
sp.
DNA
[aanwezigheid]
in
| ||||||
| 100672-5 | Aspergillus fumigatus, Blood | Aspergillus fumigatus ADN [Présence/Seuil] Sang ; Qualitatif ; PCR amplification de cible | Aspergillus fumigatus DNA [aanwezigheid] in bloed d.m.v. probe-detectie | |||||||
| 100673-3 |
|
Aspergillus terreus, Blood |
|
Aspergillus
terreus
DNA
[aanwezigheid]
in
| ||||||
| 100674-1 | BK virus, Blood | BK virus ADN [Log Nombre/Volume] Sang ; Numérique ; PCR amplification de cible | BK-virus DNA [logaritmisch aantal/volume] in bloed d.m.v. probe-detectie | |||||||
| 100675-8 |
|
Cytomegalie-Virus DNA [Einheiten/Volumen] (Viruslast) in Blut mittels Nukleinsäureamplifikation mit Sondendetektion | Cytomegalovirus (CMV), Blood | Cytomégalovirus ADN [Arbitraire/Volume] Sang ; Numérique ; PCR amplification de cible | Cytomegalovirus DNA [eenheid/volume] in bloed d.m.v. probe-detectie |
|
||||
| 100676-6 |
Cytomegalie-Virus
DNA
[log
Einheiten/Volumen]
(Viruslast)
in
| Cytomegalovirus (CMV), Blood | Cytomégalovirus ADN [Log arbitraire/Volume] Sang ; Numérique ; PCR amplification de cible | Cytomegalovirus DNA [logaritmische eenheid/volume] in bloed d.m.v. probe-detectie | ||||||
| 10067-7 | S' wave Amp L-V4 | amplitud de la onda S'.derivación V4:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda S. derivación V4:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | S' onda Amp L-V4 | ||||||
| 100677-4 |
|
Epstein Barr virus (EBV), Blood |
|
Epstein-Barr-virus
DNA
[logaritmisch
aantal/volume]
in
| ||||||
| 100678-2 | Epstein Barr virus (EBV), Blood | Epstein barr virus ADN [Log Nombre/Volume] Sang ; Numérique ; PCR amplification de cible | Epstein-Barr-virus DNA [logaritmisch aantal/volume] in bloed d.m.v. probe-detectie | |||||||
| 100679-0 |
|
Herpes virus (HHV) 6, Blood |
|
Humaan
betaherpesvirus
type
6
DNA
[logaritmisch
aantal/volume]
in
| ||||||
| 100680-8 | Herpes virus (HHV) 6, Blood | Herpes virus 6 ADN [Log Nombre/Volume] Sang ; Numérique ; PCR amplification de cible | Humaan betaherpesvirus type 6 DNA [logaritmisch aantal/volume] in bloed d.m.v. probe-detectie | |||||||
| 100681-6 |
|
Herpes virus (HHV) 7, Blood |
|
Humaan
betaherpesvirus
type
7
DNA
[logaritmisch
aantal/volume]
in
| ||||||
| 100682-4 | Herpes virus (HHV) 7, Blood | Herpes virus 7 ADN [Log Nombre/Volume] Sang ; Numérique ; PCR amplification de cible | Humaan betaherpesvirus type 7 DNA [logaritmisch aantal/volume] in bloed d.m.v. probe-detectie | |||||||
| 100683-2 |
|
Herpes virus (HHV) 8, Blood |
|
Humaan
herpesvirus
8
DNA
[logaritmisch
aantal/volume]
in
| ||||||
| 100684-0 | Herpes virus (HHV) 8, Blood | Herpes virus 8 ADN [Log Nombre/Volume] Sang ; Numérique ; PCR amplification de cible | Humaan herpesvirus 8 DNA [logaritmisch aantal/volume] in bloed d.m.v. probe-detectie | |||||||
| 10068-5 |
|
S' wave Amp L-V5 | amplitud de la onda S'.derivación V5:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda S. derivación V5:Corazón :Punto temporal:Elpot:Cuantitativo:EKG |
| |||||
| 100685-7 | JC virus, Blood | JC virus ADN [Log Nombre/Volume] Sérum/Plasma ; Numérique ; PCR amplification de cible | JC-virus DNA [logaritmisch aantal/volume] in serum of plasma d.m.v. probe-detectie | |||||||
| 100686-5 |
|
JC virus, Spinal fluid |
| JC-virus DNA [logaritmisch aantal/volume] in liquor cerebrospinalis d.m.v. probe-detectie | ||||||
| 100687-3 | JC virus, Urine | JC virus ADN [Log Nombre/Volume] Urine ; Numérique ; PCR amplification de cible | JC-virus DNA [logaritmisch aantal/volume] in urine d.m.v. probe-detectie | |||||||
| 100688-1 | Parvovirus B19 DNA [log #/Volumen] (Viruslast) in Blut mittels Nukleinsäureamplifikation mit Sondendetektion | Parvovirus B19, Blood | Parvovirus B19 ADN [Log Nombre/Volume] Sang ; Numérique ; PCR amplification de cible | Parvovirus B19 DNA [logaritmisch aantal/volume] in bloed d.m.v. probe-detectie | ||||||
| 100689-9 |
Toxoplasma
gondii
DNA
[log
#/Volumen]
in
Serum
| Toxoplasma gondii, Blood | Toxoplasma gondii ADN [Log Nombre/Volume] Sérum/Plasma ; Numérique ; PCR amplification de cible | Toxoplasma gondii DNA [logaritmisch aantal/volume] in serum of plasma d.m.v. probe-detectie | ||||||
| 100690-7 | Toxoplasma gondii DNA [log #/Volumen] in Liquor mittels Nukleinsäureamplifikation mit Sondendetektion | Toxoplasma gondii, Spinal fluid | Toxoplasma gondii ADN [Log Nombre/Volume] Liquide céphalorachidien ; Numérique ; PCR amplification de cible | Toxoplasma gondii DNA [logaritmisch aantal/volume] in liquor cerebrospinalis d.m.v. probe-detectie | ||||||
| 100691-5 |
|
Varicella-Zoster-Virus DNA [log #/Volumen] (Viruslast) in Blut mittels Nukleinsäureamplifikation mit Sondendetektion | Varicella zoster virus (VZV; Chickenpox), Blood | Varicelle zona virus ADN [Log Nombre/Volume] Sang ; Numérique ; PCR amplification de cible | Varicella-zostervirus DNA [logaritmisch aantal/volume] in bloed d.m.v. probe-detectie | |||||
|
|
Varicella-Zoster-Virus
DNA
[log
#/Volumen]
(Viruslast)
in
| Varicella zoster virus (VZV; Chickenpox), Spinal fluid | Varicelle zona virus ADN [Log Nombre/Volume] Liquide céphalorachidien ; Numérique ; PCR amplification de cible | Varicella-zostervirus DNA [logaritmisch aantal/volume] in liquor cerebrospinalis d.m.v. probe-detectie | ||||||
| 10069-3 | S' wave Amp L-V6 | amplitud de la onda S'.derivación V6:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda S. derivación V6:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | S' onda Amp L-V6 | ||||||
| 100693-1 |
|
Pneumocystis jirovecii, Respiratory system specimen |
|
Pneumocystis
jiroveci
DNA
[logaritmisch
aantal/volume]
in
|
||||||
| 100694-9 |
|
SMN1 gene silent carrier analysis, Blood or tissue specimen |
|
Stille
drager
van
SMN1-gen
analyse
[aanwezigheid]
in
| ||||||
| 100695-6 | Genetic disease analysis overall carrier interpretation, Blood or tissue specimen | Maladie génétique transmise interprétation globale [Interprétation] Sang/Tissu ; Résultat textuel ; Biologie moléculaire | ||||||||
| 100696-4 |
|
CTNS related multigene analysis, Body Fld+S/P |
|
CTNS-gerelateerde
multigen-analyse
[identificator]
in
| ||||||
| 100697-2 | IR OP Note | |||||||||
| 100698-0 |
|
SDOH screen report Doc |
|
|||||||
| 100699-8 | Rifabutin/Ethambutol-Empfindlichkeit | Rifabutin+Ethambutol [Empfindlichkeit] | Susceptibility to Rifabutin+Ethambutol | Rifabutine+éthambutol [Sensibilité] Isolat ; Alphanumérique | Rifabutine + ethambutol [gevoeligheid] in isolaat | |||||
| 100700-4 |
|
Trichomonas vaginalis, Urethra |
|
Trichomonas
vaginalis
DNA
[aanwezigheid]
in
| ||||||
| 10070-1 | S' wave dur L-AVF | duración de la onda S'.derivación AVF:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda S. Plomo AVF:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | S' onda dur L-AVF | ||||||
| 100701-2 |
|
Trichomonas vaginalis, Urethra |
|
Trichomonas
vaginalis
rRNA
[aanwezigheid]
in
|
||||||
| 100702-0 |
|
Mycoplasma genitalium rRNA [Nachweis] in Harnröhre mittels Nukleinsäureamplifikation mit Sondendetektion | Mycoplasma genitalium, Urethra | Mycoplasma genitalium ARNr [Présence/Seuil] Urètre ; Qualitatif ; PCR amplification de cible | Mycoplasma genitalium rRNA [aanwezigheid] in urethra d.m.v. probe-detectie |
|
||||
| 100703-8 |
Mycoplasma
genitalium
rRNA
[Nachweis]
in
| Mycoplasma genitalium, Urine | Mycoplasma genitalium ARNr [Présence/Seuil] Urine ; Qualitatif ; PCR amplification de cible | Mycoplasma genitalium rRNA [aanwezigheid] in urine d.m.v. probe-detectie | ||||||
| 100704-6 | Mycoplasma genitalium rRNA [Nachweis] in Probenmaterial vom Gebärmutterhals mittels Nukleinsäureamplifikation mit Sondendetektion | Mycoplasma genitalium, Cervix | Mycoplasma genitalium ARNr [Présence/Seuil] Col de l'utérus ; Qualitatif ; PCR amplification de cible | Mycoplasma genitalium rRNA [aanwezigheid] in cervix d.m.v. probe-detectie | ||||||
| 100705-3 |
|
Mycoplasma genitalium rRNA [Nachweis] in anorektalem Probenmaterial mittels Nukleinsäureamplifikation mit Sondendetektion | Mycoplasma genitalium, Anorectal | Mycoplasma genitalium ARNr [Présence/Seuil] Anorectal ; Qualitatif ; PCR amplification de cible | Mycoplasma genitalium rRNA [aanwezigheid] in anorectaal d.m.v. probe-detectie | |||||
|
|
Mycoplasma
genitalium
rRNA
[Nachweis]
in
| Mycoplasma genitalium, Specimen | Mycoplasma genitalium ARNr [Présence/Seuil] Milieux divers ; Qualitatif ; PCR amplification de cible | Mycoplasma genitalium rRNA [aanwezigheid] d.m.v. probe-detectie | ||||||
| 100707-9 | Granulocytes, Peritoneal dialysis fluid | Cellules polymorphonucléaires [Nombre/Volume] Liquide de dialyse péritonéale ; Numérique ; Comptage automate | Granulocyten [aantal/volume] in periteonale dialysevloeistof d.m.v. geautomatiseerde telling | |||||||
| 100708-7 |
|
Plasma cells/White Blood Cells, Synovial fluid |
|
Plasmacellen/leukocyten
[getalsfractie]
in
| ||||||
| 100709-5 | Hepatocellular carcinoma risk | Risque de cancer hépatocellulaire [Score] Patient ; Numérique ; GAAD | Risico op hepatocellulair carcinoom [score] d.m.v. GAAD-score | |||||||
| 100710-3 |
|
Chlamydia trachomatis and Neisseria gonorrhoeae panel, Throat |
| Chlamydia trachomatis & Neisseria gonorrhoeae rRNA panel in keel d.m.v. probe-detectie | ||||||
| 100711-1 |
Borrelia
burgdorferi.VlsE1+pepC10
Antikörper
[Einheiten/Volumen]
in
Serum
| Borrelia burgdorferi.VlsE1+pepC10 antibody, Blood | Borrelia burgdorferi VlsE1+pepC10 Ac [Arbitraire/Volume] Sérum ; Numérique ; Immunoanalyse | Borrelia burgdorferi.VlsE1+pepC10 As [eenheid/volume] in serum d.m.v. immunoassay | ||||||
| 100712-9 | Brexpiprazol | Brexpiprazole, Blood | Brexpiprazole [Masse/Volume] Sérum/Plasma ; Numérique | Brexpiprazol [massa/volume] in serum of plasma | ||||||
| 100713-7 | Cariprazin |
|
Cariprazine, Blood | Cariprazine [Masse/Volume] Sérum/Plasma ; Numérique | Cariprazine [massa/volume] in serum of plasma |
|
||||
| 100714-5 | Guanfacin | Guanfacine, Blood | Guanfacine [Masse/Volume] Sérum/Plasma ; Numérique |
Guanfacine
[massa/volume]
in
| ||||||
| 100715-2 | Prothipendyl | Prothipendyl, Blood | Prothipendyl [Masse/Volume] Sérum/Plasma ; Numérique | Prothipendyl [massa/volume] in serum of plasma | ||||||
| 100716-0 |
|
Prostate specific antigen, Dried blood spot |
|
Prostaatspecifiek
Ag
[massa/volume]
in
|
||||||
| 100717-8 |
|
FCGR3A gene.p.Phe176Val, Blood or tissue specimen |
|
FCGR3A-gen.p.Phe176Val
[aanwezigheid]
in
| ||||||
| 100718-6 | Undersea+hyperbar D/C sum | |||||||||
| 10071-9 |
|
S' wave dur L-AVL | duración de la onda S'.derivación AVL:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda S. Liderar AVL:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG |
| |||||
| 100719-4 | Surg Onc D/C sum | |||||||||
| 100720-2 |
|
REI D/C sum |
|
|||||||
| 100721-0 | Comm hlth care D/C sum | |||||||||
| 100722-8 |
|
Integrative medicine D/C sum |
|
|||||||
| 100723-6 | Sports medicine D/C sum | |||||||||
| 100724-4 |
|
Diabetology D/C sum |
| |||||||
| 100725-1 | Optometry D/C sum | Samenvattende ontslagbrief [bevinding] in {instelling} d.m.v. optometrie (document) | ||||||||
| 100726-9 |
|
Podiatry D/C sum |
|
Samenvattende
ontslagbrief
[bevinding]
in
| ||||||
| 10072-7 | S' wave dur L-AVR | duración de la onda S'.derivación AVR:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda S. adelantar AVR:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | S' onda dur L-AVR | ||||||
| 100727-7 |
|
Chiropractic med D/C sum |
|
Samenvattende
ontslagbrief
[bevinding]
in
| ||||||
| 100728-5 | Cardiac surgery D/C sum | Samenvattende ontslagbrief [bevinding] in {instelling} d.m.v. cardiochirurgie (document) | ||||||||
| 100729-3 |
|
Breastfeeding D/C sum |
|
Samenvattende
ontslagbrief
[bevinding]
in
| ||||||
| 100730-1 | Transpl surg D/C sum | Samenvattende ontslagbrief [bevinding] in {instelling} d.m.v. transplantatiechirurgie (document) | ||||||||
| 100731-9 |
|
Urgent care D/C sum |
|
|||||||
| 100732-7 |
Cholesterol.in
lipoprotein
(little
a)
&
Cholesterol.in
LDL
panel,
Blood
|
Cholesterol Lp(a) et cholesterol LDL panel [-] Sérum ; - | Cholesterol.in lipoproteïne (kleine a) & cholesterol.in LDL panel in serum | |||||||
| 100733-5 | LDL cholesterol corrected for Cholesterol.in lipoprotein (little a), Blood | Cholestérol LDL corrigé par cholestérol Lp(a) [Masse/Volume] Sérum ; Numérique ; Résultat calculé | Cholesterol.in LDL^gecorrigeerd voor cholesterol.in lipoproteïne (kleine a) [massa/volume] in serum d.m.v. berekend | |||||||
| 100734-3 |
|
traMADol and Metabolites Panel, Urine |
|
Tramadol
&
metabolieten
panel
in
| ||||||
| 10073-5 | S' wave dur L-I | duración de la onda S'.derivación I:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda S.:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | S' onda dur L-I | ||||||
| 100735-0 |
|
Mannose-6-phosphate isomerase and phosphomannomutase 1 panel, White blood cells |
|
Mannose-6-fosfaatisomerase
&
fosfomannomutase
1
panel
in
| ||||||
| 100736-8 | Acylcarnitine Analysis Post Mortem, Specimen | Acylcarnitine post-mortem [Recherche] Milieux divers ; Document | Acylcarnitine postmortale analyse [bevinding] (document) | |||||||
| 100737-6 |
|
Alkaline phosphatase.macromolecular, Blood |
|
Alkalinefosfatase.macromoleculair
[aanwezigheid]
in
| ||||||
| 100738-4 | Macromolecular alanine aminotransferase, Blood | Alanine aminotransférase macroenzyme [Présence/Seuil] Sérum/Plasma ; Qualitatif | Alanine-aminotransferase.macromoleculair [aanwezigheid] in serum of plasma | |||||||
| 100739-2 |
|
Macromolecular aspartate aminotransferase, Blood |
|
Aspartaataminotransferase.macromoleculair
[aanwezigheid]
in
| ||||||
| 1007-4 | اختبار كومبس المباشر | Direkter Coombs Test polyspezifisch | Direkter Antiglobulintest.polyspezifisches Reagenz [Nachweis] auf Erythrozyten | Direct Antiglobulin Test (DAT; Direct Coombs), Red blood cells | prueba de antiglobulina directa.reactivo poliespecífico:concentración arbitraria:punto en el tiempo:eritrocitos:ordinal: | Prueba de antiglobulina directa, reactivo específico de poli: Eritrocitos : Punto temporal: Presencia o umbral: Ordinal: | Test direct à l'antiglobuline (EDA) polyvalente [Présence/Seuil] Érythrocytes ; Qualitatif | Directe antiglobulinetest.polyspecifiek reagens [aanwezigheid] in erytrocyten | DAT Poly-Sp Reag RBC Ql | |
| 100740-0 |
|
Amylase.macromolecular, Blood |
|
Amylase.macromoleculair
[aanwezigheid]
in
| ||||||
| 100741-8 | Gamma glutamyl transferase.macromolecular, Blood | Gamma glutamyltransférase macroenzyme [Présence/Seuil] Sérum/Plasma ; Qualitatif | Gamma-glutamyltransferase.macromoleculair [aanwezigheid] in serum of plasma | |||||||
| 100742-6 |
|
Lactate dehydrogenase.macromolecular, Blood |
|
Lactaatdehydrogenase.macromoleculair
[aanwezigheid]
in
| ||||||
| 10074-3 | S' wave dur L-II | duración de la onda S'.derivación II:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda S. Plomo II:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | S' onda dur L-II | ||||||
| 100743-4 |
|
Lipase.macromolecular, Blood |
|
Lipase.macromoleculair
[aanwezigheid]
in
|
||||||
| 100744-2 |
|
Alpha-1-acid glycoprotein, Blood |
|
Alfa-1-zure
glycoproteïne
[massa/volume]
in
| ||||||
| 100745-9 | Chloride, Blood | Chlorure [Moles/Volume] Sang mêlé veineux ; Numérique | Chloride [mol/volume] in gemengd veneus bloed | |||||||
| 100746-7 |
|
Glucose, Blood |
|
Glucose
[mol/volume]
in
| ||||||
| 100747-5 | Legionella serogroup panel, Specimen | Legionella sérogroupe panel [-] Milieux divers ; - | Legionella serogroep panel | |||||||
| 100748-3 |
|
Legionella spp [Nachweis] in Probenmaterial mittels Nukleinsäureamplifikation mit Sondendetektion | Legionella spp, Specimen | Legionella spp [Présence/Seuil] Milieux divers ; Qualitatif ; PCR amplification de cible | Legionella spp. [aanwezigheid] d.m.v. probe-detectie | |||||
|
|
Legionella
pneumophila,
Serogruppe
1
[Nachweis]
in
| Legionella pneumophila serogroup 1, Specimen | Legionella pneumophila sérogroupe 1 [Présence/Seuil] Milieux divers ; Qualitatif ; PCR amplification de cible | Legionella pneumophila serogroep 1 [aanwezigheid] d.m.v. probe-detectie | ||||||
| 10075-0 | S' wave dur L-III | duración de la onda S'.derivación III:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda S. Plomo III:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | S' onda dur L-III | ||||||
| 100750-9 |
|
Legionella pneumophila, nicht Serogruppe 1 [Nachweis] in Probenmaterial mittels Nukleinsäureamplifikation mit Sondendetektion | Legionella pneumophila non-serogroup 1, Specimen | Legionella pneumophila non sérogroupe 1 [Présence/Seuil] Milieux divers ; Qualitatif ; PCR amplification de cible | Legionella pneumophila anders dan serogroep 1 [aanwezigheid] d.m.v. probe-detectie |
|
||||
| 100751-7 |
Galactose-alpha-1,3-galactose
(Alpha-Gal)
panel,
Blood
|
Galactose-alpha-1,3-galactose panel [-] Sérum/Plasma ; - | Galactose-alfa-1,3-galactose panel in serum of plasma | |||||||
| 100752-5 | Exacerbating factors Reported | |||||||||
| 100753-3 |
|
Alleviating factors Reported |
|
|||||||
| 100754-1 | Platelet disorders multigene analysis, Blood or tissue specimen | Analyse multigénique des troubles plaquettaires [Recherche] Sang/Tissu ; Document ; Séquençage | Trombocytopathie multigen-analyse [bevinding] in bloed of weefsel d.m.v. sequencing (document) | |||||||
| 100755-8 |
|
Oligoclonal bands, Blood |
| Eiwitfracties.oligoklonale banden [aantal] in serum of plasma d.m.v. iso-elektrisch focusseren | ||||||
| 100756-6 | Oligoclonal bands, Spinal fluid | Protéines fractions oligoclonales [Interprétation] Liquide céphalorachidien ; Résultat nominal ; Isoélectrofocalisation | Eiwitfracties.oligoklonale banden [interpretatie] in liquor cerebrospinalis d.m.v. iso-elektrisch focusseren | |||||||
| 100757-4 |
|
Protein fractions.oligoclonal bands panel, Serum+Cerebrospinal fluid |
|
Eiwitfracties.oligoklonale
banden
panel
in
| ||||||
| 100758-2 | Estimated lung age from clin data | |||||||||
| 100759-0 |
|
Inspiratory reserve vol spirometry |
|
|||||||
| 100760-8 | XR Radius+Ulna-L 1V | |||||||||
| 100761-6 |
|
PALB2 gene targeted mutation analysis, Blood or tissue specimen |
|
PALB2-gen
doelgerichte
mutatie-analyse
[bevinding]
in
| ||||||
| 100762-4 | HBA2 gene.c.377T>C, Blood | HBA2 gène c.377T>C [Présence/Seuil] Sang ; Qualitatif ; Biologie moléculaire | HBA2-gen.c.377T>C [aanwezigheid] in bloed d.m.v. moleculair genetisch onderzoek | |||||||
| 100763-2 |
|
Mycobacterium sp comparative reaction interpretation, Skin |
|
Comparatieve
reactie
op
Mycobacterium
sp.
Interpretatie
[interpretatie]
in
| ||||||
| 100764-0 | Mycobacterium bovis reaction wheal 3 days after Mammalian Tuberculin Intradermal, Skin | Mycobacterium bovis huidreactie^3 dagen na dosis zoogdiertuberculine ID [diameter] in huid | ||||||||
| 100765-7 |
|
Homocysteine and Methylmalonate and Methylcitrate panel, Dried blood spot |
|
Homocysteïne
&
methylmalonaat
&
2-methylcitraat
panel
in
| ||||||
| 100766-5 | Center for Epidemiologic Studies Depression Scale panel [CES-D] | |||||||||
| 100767-3 |
|
Bothered by things that are not usually bothersome |
|
|||||||
| 10076-8 | S' wave dur L-V1 | duración de la onda S'.derivación V1:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda S. Plomo V1:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | S' onda dur L-V1 | ||||||
| 100768-1 |
|
Poor appetite |
|
|||||||
| 100769-9 |
Unhappy
even
with
help
from
my
family
or
| |||||||||
| 100770-7 | Feeling just as good as others | |||||||||
| 100771-5 |
|
Trouble focusing |
|
|||||||
| 100772-3 | Feeling depressed | |||||||||
| 100773-1 |
|
Feeling everything is too much of an effort |
|
|||||||
| 100774-9 | Feeling hopeful about the future | |||||||||
| 100775-6 |
|
Feeling life had been a failure |
|
|||||||
| 10077-6 | S' wave dur L-V2 | duración de la onda S'.derivación V2:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda S. Plomo V2:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | S' onda dur L-V2 | ||||||
| 100776-4 |
|
Feeling fearful |
|
|||||||
| 100777-2 | Restless sleep | |||||||||
| 100778-0 |
|
Feeling happy |
|
|||||||
| 100779-8 | Quieter than usual | |||||||||
| 100780-6 |
|
Feeling lonely |
|
|||||||
| 100781-4 | People were unfriendly | |||||||||
| 100782-2 |
|
Enjoying life |
|
|||||||
| 100783-0 | Crying spells | |||||||||
| 10078-4 |
|
S' wave dur L-V3 | duración de la onda S'.derivación V3:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda S. Plomo V3:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG |
| |||||
| 100784-8 | Feeling sad | |||||||||
| 100785-5 |
|
Feeling people dislike me |
|
|||||||
| 100786-3 | Lack of energy | |||||||||
| 100787-1 | Total Score CES-D | |||||||||
| 100788-9 |
|
Stemphylium botryosum IgG4 antibody |
|
Stemphylium
botryosum
As.IgG4
[massa/volume]
in
| ||||||
| 100789-7 | Rhizopus nigricans IgG4 antibody | Rhizopus nigricans Ac IgG4 [Masse/Volume] Sérum ; Numérique | Rhizopus nigricans As.IgG4 [massa/volume] in serum | |||||||
| 100790-5 |
|
Lepidoglyphus destructor IgG antibody |
|
Lepidoglyphus
destructor
As.IgG
[massa/volume]
in
|
||||||
| 100791-3 |
|
Hamster epithelium IgG antibody |
|
Hamsterepitheel
As.IgG
[massa/volume]
in
| ||||||
| 10079-2 | S' wave dur L-V4 | duración de la onda S'.derivación V4:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda S. Plomo V4:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | S' onda dur L-V4 | ||||||
| 100792-1 |
|
Forsythia allergy test |
|
Forsythia
As.IgE
[eenheid/volume]
in
|
||||||
| 100793-9 |
|
Testosterone, Body fluid |
|
Testosteron
[massa/volume]
in
|
||||||
| 100794-7 |
|
Follitropin (FSH; Follicle Stimulating Hormone), Body fluid |
|
Follikelstimulerend
hormoon
[eenheid/volume]
in
|
||||||
| 100795-4 |
|
S100 Calcium Binding Protein B, Body fluid |
|
S100
calciumbindend
eiwit
B
[massa/volume]
in
|
||||||
| 100796-2 |
|
Thyroglobulin, Body fluid |
|
Thyreoglobuline
[massa/volume]
in
| ||||||
| 100797-0 | Free testosterone 1st specimen after challenge, Blood | Testostérone libre T01 après épreuve [Masse/Volume] Sérum ; Numérique | Testosteron.vrij^1ste monster na XXX belasting [massa/volume] in serum | |||||||
| 100798-8 |
|
Free testosterone 2nd specimen after challenge, Blood |
| Testosteron.vrij^2de monster na XXX belasting [massa/volume] in serum | ||||||
| 100799-6 |
21-Deoxycortisol
1st
specimen
after
challenge,
Blood
|
21-déoxycortisol T01 après épreuve [Masse/Volume] Sérum ; Numérique | 21-deoxycortisol^1ste monster na XXX belasting [massa/volume] in serum | |||||||
| 100-8 | Cefoperazon [Empfindlichkeit] mittels Bestimmung der minimalen Hemmkonzentration (MHK) | Susceptibility to Cefoperazone | cefoperazona:susceptibilidad:punto en el tiempo:cepa clínica:ordinal o cuantitativo:concentración inhibitoria mínima | Cefoperazona: Aislado : Punto temporal: Susceptibilidad (microorganismos): Ordinal Cuantitativo: Concentración mínima inhibitoria (MIC) | Céfopérazone [Sensibilité] Isolat ; Alphanumérique ; CMI | Cefoperazon [gevoeligheid] in isolaat d.m.v. minimaal inhiberende concentratie | Cefoperazone Islt MIC | |||
| 10080-0 |
|
S' wave dur L-V5 | duración de la onda S'.derivación V5:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda S. Plomo V5:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG |
| |||||
| 100800-2 | 21-Deoxycortisol 2nd specimen after challenge, Blood | 21-déoxycortisol T02 après épreuve [Masse/Volume] Sérum ; Numérique | 21-deoxycortisol^2de monster na XXX belasting [massa/volume] in serum | |||||||
| 100801-0 |
|
21-Deoxycortisol 3rd specimen after challenge, Blood |
|
21-deoxycortisol^3de
monster
na
XXX
belasting
[massa/volume]
in
| ||||||
| 100802-8 | 21-Deoxycortisol 4th specimen after challenge, Blood | 21-déoxycortisol T04 après épreuve [Masse/Volume] Sérum ; Numérique | 21-deoxycortisol^4de monster na XXX belasting [massa/volume] in serum | |||||||
| 100803-6 |
|
21-Deoxycortisol 5th specimen after challenge, Blood |
|
21-deoxycortisol^5de
monster
na
XXX
belasting
[massa/volume]
in
| ||||||
| 100804-4 |
Vasopressin
1st
specimen
| Vasopressine T01 après épreuve [Moles/Volume] Plasma ; Numérique | Vasopressine^1ste monster na XXX belasting [mol/volume] in plasma | |||||||
| 100805-1 | Vasopressin 2nd specimen after challenge, Blood | Vasopressine T02 après épreuve [Moles/Volume] Plasma ; Numérique | Vasopressine^2de monster na XXX belasting [mol/volume] in plasma | |||||||
| 100806-9 |
|
Vasopressin 3rd specimen after challenge, Blood |
|
Vasopressine^3de
monster
na
XXX
belasting
[mol/volume]
in
| ||||||
| 100807-7 | Vasopressin 4th specimen after challenge, Blood | Vasopressine T04 après épreuve [Moles/Volume] Plasma ; Numérique | Vasopressine^4de monster na XXX belasting [mol/volume] in plasma | |||||||
| 100808-5 |
|
Vasopressin 5th specimen after challenge, Blood |
| Vasopressine^5de monster na XXX belasting [mol/volume] in plasma | ||||||
| 100809-3 |
Vasopressin
6th
specimen
after
challenge,
Blood
|
Vasopressine T06 après épreuve [Moles/Volume] Plasma ; Numérique | Vasopressine^6de monster na XXX belasting [mol/volume] in plasma | |||||||
| 100810-1 | Vasopressin 7th specimen after challenge, Blood | Vasopressine T07 après épreuve [Moles/Volume] Plasma ; Numérique | Vasopressine^7de monster na XXX belasting [mol/volume] in plasma | |||||||
| 100811-9 |
|
Vasopressin 8th specimen after challenge, Blood |
|
Vasopressine^8ste
monster
na
XXX
belasting
[mol/volume]
in
| ||||||
| 100812-7 | Vasopressin 9th specimen after challenge, Blood |
Vasopressine
T09
après
épreuve
[Moles/Volume]
Plasma
| Vasopressine^9de monster na XXX belasting [mol/volume] in plasma | |||||||
| 100813-5 | Vasopressin 10th specimen after challenge, Blood | Vasopressine T10 après épreuve [Moles/Volume] Plasma ; Numérique | Vasopressine^10de monster na XXX belasting [mol/volume] in plasma | |||||||
| 100814-3 |
|
Vasopressin 11th specimen after challenge, Blood |
|
Vasopressine^11de
monster
na
XXX
belasting
[mol/volume]
in
| ||||||
| 100815-0 |
Vasopressin
12th
specimen
| Vasopressine T12 après épreuve [Moles/Volume] Plasma ; Numérique | Vasopressine^12de monster na XXX belasting [mol/volume] in plasma | |||||||
| 100816-8 | Glucagon 6th specimen after challenge, Blood | Glucagon T06 après épreuve [Masse/Volume] Sérum/Plasma ; Numérique | Glucagon^6de monster na XXX belasting [massa/volume] in serum of plasma | |||||||
| 100817-6 |
|
Glucagon 7th specimen after challenge, Blood |
|
Glucagon^7de
monster
na
XXX
belasting
[massa/volume]
in
| ||||||
| 10081-8 | S' wave dur L-V6 | duración de la onda S'.derivación V6:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda S. Plomo V6:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | S' onda dur L-V6 | ||||||
| 100818-4 |
|
Renin 1st specimen after challenge, Blood |
|
Renine^1ste
monster
na
XXX
belasting
[massa/volume]
in
|
||||||
| 100819-2 |
|
Renin 2nd specimen after challenge, Blood |
|
Renine^2de
monster
na
XXX
belasting
[massa/volume]
in
| ||||||
| 1008-2 | Indirekter Coombs Test polyspezifisch | Indirect Antiglobulin Test (IAT; Indirect Coombs), Blood | prueba de antiglobulina indirecta.reactivo multiespecífico:concentración arbitraria:punto en el tiempo:suero/plasma:ordinal: | Prueba de antiglobulina indirecta, reactivo específico de poli: Suero o Plasma : Punto temporal: Presencia o umbral: Ordinal: | Test indirect à l'antiglobuline (TIA) polyvalente [Présence/Seuil] Sérum/Plasma ; Qualitatif | Indirecte antiglobulinetest.polyspecifiek reagent [aanwezigheid] in serum of plasma | IAT Poly-Sp Reag SerPl Ql | |||
| 100820-0 |
|
Renin 3rd specimen after challenge, Blood |
| Renine^3de monster na XXX belasting [massa/volume] in plasma | ||||||
| 100821-8 | POLST panel | |||||||||
| 100822-6 |
|
Cardiopulmonary resuscitation orders |
|
|||||||
| 100823-4 | Initial portable medical treatment orders | |||||||||
| 100824-2 |
|
Additional portable medical orders or instructions |
|
|||||||
| 100825-9 | Medically assisted nutrition orders | |||||||||
| 10082-6 |
|
ST I-Amp 6ms L-AVF | amplitud inicial del segmento ST, 6 mseg.derivación AVF:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | ST amplitud inicial 6 ms plomo AVF:Corazón :Punto temporal:Elpot:Cuantitativo:EKG |
| |||||
| 100826-7 | Portable medical order &or advance directive review | |||||||||
| 100827-5 |
|
Portable medical order discussion participants |
|
|||||||
| 100828-3 | Portable medical order administrative information | |||||||||
| 100829-1 |
|
Renin 4th specimen after challenge, Blood |
|
Renine^4de
monster
na
XXX
belasting
[massa/volume]
in
|
||||||
| 100830-9 |
|
Free alpha subunit 1st specimen after challenge, Blood |
|
Alfa-subeenheid.vrij^1ste
monster
na
XXX
belasting
[eenheid/volume]
in
| ||||||
| 100831-7 | Free alpha subunit 2nd specimen after challenge, Blood | Sous unité alpha libre T02 après épreuve [Arbitraire/Volume] Sérum/Plasma ; Numérique | Alfa-subeenheid.vrij^2de monster na XXX belasting [eenheid/volume] in serum of plasma | |||||||
| 100832-5 |
|
Free alpha subunit 3rd specimen after challenge, Blood |
| Alfa-subeenheid.vrij^3de monster na XXX belasting [eenheid/volume] in serum of plasma | ||||||
| 100833-3 |
Free
alpha
subunit
4th
specimen
after
challenge,
Blood
|
Sous unité alpha libre T04 après épreuve [Arbitraire/Volume] Sérum/Plasma ; Numérique | Alfa-subeenheid.vrij^4de monster na XXX belasting [eenheid/volume] in serum of plasma | |||||||
| 10083-4 | ST I-Amp 6ms L-AVL | amplitud inicial del segmento ST, 6 mseg.derivación AVL:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | ST amplitud inicial 6 ms plomo AVL:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | ST I-Amp 6ms L-AVL | ||||||
| 100834-1 |
|
Free alpha subunit 5th specimen after challenge, Blood |
|
Alfa-subeenheid.vrij^5de
monster
na
XXX
belasting
[eenheid/volume]
in
| ||||||
| 100835-8 | Free alpha subunit 6th specimen after challenge, Blood | Sous unité alpha libre T06 après épreuve [Arbitraire/Volume] Sérum/Plasma ; Numérique | Alfa-subeenheid.vrij^6de monster na XXX belasting [eenheid/volume] in serum of plasma | |||||||
| 100836-6 |
|
Free alpha subunit 7th specimen after challenge, Blood |
| Alfa-subeenheid.vrij^7de monster na XXX belasting [eenheid/volume] in serum of plasma | ||||||
| 100837-4 |
Insulin-like
growth
factor-I
9th
specimen
after
challenge,
Blood
|
Insulin-like growth factor 1 T09 après épreuve [Masse/Volume] Sérum/Plasma ; Numérique | Insulin-like growth factor-I^9de monster na XXX belasting [massa/volume] in serum of plasma | |||||||
| 100838-2 | Testosterone 9th specimen after challenge, Blood | Testostérone T09 après épreuve [Masse/Volume] Sérum/Plasma ; Numérique | Testosteron^9de monster na XXX belasting [massa/volume] in serum of plasma | |||||||
| 100839-0 |
|
Vitamin A/Retinol binding protein, Blood |
|
Retinol/retinolbindend
eiwit
[verhouding]
in
| ||||||
| 100840-8 | IgE, Body fluid | Immunoglobuline E [Arbitraire/Volume] Liquide biologique ; Numérique | IgE [eenheid/volume] in lichaamsvocht | |||||||
| 100841-6 |
|
Zinc finger protein of the cerebellum 4 antibody, Spinal fluid |
|
Zinc
finger
proteïne
of
the
cerebellum
4
As
[aanwezigheid]
in
| ||||||
| 10084-2 | ST I-Amp 6ms L-AVR | amplitud inicial del segmento ST, 6 mseg.derivación AVR:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | ST amplitud inicial 6 ms avance AVR:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | ST I-Amp 6ms L-AVR | ||||||
| 100842-4 |
|
Nonalcoholic steatohepatitis score, Blood |
| |||||||
| 100843-2 | Liver fibrosis score, Blood | Score de fibrose hépatique [Score] Sérum/Plasma ; Numérique ; Calculé par Agile3+ | ||||||||
| 100844-0 | Liver fibrosis score, Blood | Score de fibrose hépatique [Score] Sérum/Plasma ; Numérique ; Calculé par Agile4 | ||||||||
| 100845-7 |
|
Neurofascin155 IgG4 antibody, Blood |
| Neurofascine155 As.IgG4 [aanwezigheid] in serum d.m.v. flowcytometrie | ||||||
| 100846-5 |
Dengue-Virus
1+2+3+4
nsP1
IgG
IgG-Antikörper
[Nachweis]
in
Serum
|
Dengue virus 1+2+3+4 nsP1 IgG antibody, Blood | Dengue virus 1+2+3+4 protéine non structurelle 1 (nsP1) [Présence/Seuil] Sérum/Plasma ; Qualitatif ; Immunoanalyse | Denguevirus 1+2+3+4 niet-structureel proteïne 1 (nsP1) As.IgG [aanwezigheid] in serum of plasma d.m.v. immunoassay | ||||||
| 100847-3 |
|
Gas and ammonia panel, Blood |
|
Gas
en
ammoniak
panel
in
| ||||||
| 100848-1 | Cell count and Differential panel, Amniotic fluid | NFS - Hémogramme panel [-] Liquide amniotique ; - ; Comptage manuel | Celtelling & differentieel panel in vruchtwater d.m.v. manuele telling | |||||||
| 100849-9 |
|
White blood cell (WBC) count, Amniotic fluid |
|
Leukocyten
[aantal/volume]
in
| ||||||
| 100850-7 | Neutrophils, Amniotic fluid | Polynucléaires neutrophiles [Nombre/Volume] Liquide amniotique ; Numérique ; Comptage manuel | Neutrofielen [aantal/volume] in vruchtwater d.m.v. manuele telling | |||||||
| 100851-5 |
|
Other cells, Amniotic fluid |
|
Overige
cellen
[aantal/volume]
in
| ||||||
| 100852-3 | NM Bones Views for mets W Sr-89 IV | |||||||||
| 100853-1 |
|
NM Pericard space Views effusion |
|
|||||||
| 100854-9 |
Lymphocytes/cells,
Blood
|
Lymphocytes/100 cellules [Fraction de nombres] Cellules mononucléées de sang périphérique ; Numérique ; Immunoanalyse | Lymfocyten/cellen [getalsfractie] in mononucleaire cellen in bloed d.m.v. immunoassay | |||||||
| 100855-6 |
CD3
cells/cells,
Blood
|
CD3/100 cellules [Fraction de nombres] Cellules mononucléées de sang périphérique ; Numérique | Cellen.CD3/cellen [getalsfractie] in mononucleaire cellen in bloed | |||||||
| 100856-4 | CD3+CD4+ (T4 Helper) Cells/cells, Blood | CD3+CD4+/100 cellules [Fraction de nombres] Cellules mononucléées de sang périphérique ; Numérique | Cellen.CD3+CD4+/cellen [getalsfractie] in mononucleaire cellen in bloed | |||||||
| 100857-2 |
|
CD3+CD8+ (T8 Suppressor) Cells/cells, Blood |
|
Cellen.CD3+CD8+/cellen
[getalsfractie]
in
| ||||||
| 100858-0 | Zellen.CD4+CD154+/CD4-Zellen in Blut --nach Stimulierung mit SARS-CoV-2-Spike-Peptid | Cells.CD4+CD154+ /CD4 Cells - after stimulation with SARS-CoV-2 Spike peptide, Blood | CD4+CD154+/CD4 après stimulation par le peptide Spike de coronavirus SARS-CoV-2 [Fraction de nombres] Sang ; Numérique | Cellen.CD4+CD154+/cellen.CD4^na stimulatie met SARS-CoV-2 spike-peptide [getalsfractie] in bloed | ||||||
| 10085-9 |
|
ST I-Amp 6ms L-I | amplitud inicial del segmento ST, 6 mseg.derivación I:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | ST amplitud inicial 6 ms plomo I:Corazón :Punto temporal:Elpot:Cuantitativo:EKG |
| |||||
| 100859-8 |
Zellen.CD4.Interferon-gamma-exprimierend/CD4-Zellen
in
| Cells.CD4.Interferon gamma-expressing/CD4 Cells - after stimulation with SARS-CoV-2 Spike peptide, Blood | CD4 exprimant l'interféron gamma/CD4 après stimulation par le peptide Spike de coronavirus SARS-CoV-2 [Fraction de nombres] Sang ; Numérique | Cellen.CD4.interferon-gamma-positief/cellen.CD4^na stimulatie met SARS-CoV-2 spike-peptide [getalsfractie] in bloed | ||||||
| 100860-6 | Zellen.CD4.Tumor-Nekrose-Faktor-alfa-exprimierend/CD4-Zellen in Blut --nach Stimulierung mit SARS-CoV-2-Spike-Peptid | Cells.CD4.Tumor necrosis factor alfa-expressing/CD4 Cells - after stimulation with SARS-CoV-2 Spike peptide, Blood | CD4 exprimant le TNF alpha/CD4 après stimulation par le peptide Spike de coronavirus SARS-CoV-2 [Fraction de nombres] Sang ; Numérique | Cellen.CD4.tumornecrosefactor alfa-positief/cellen.CD4^na stimulatie met SARS-CoV-2 spike-peptide [getalsfractie] in bloed | ||||||
| 100861-4 | Zellen.CD4+CD154+/CD4-Zellen in Blut --nach Stimulierung mit SARS-CoV-2-Nukleokapsid-Peptid | Cells.CD4+CD154+ /CD4 Cells - after stimulation with SARS-CoV-2 Nucleocapsid peptide, Blood | CD4+CD154+/CD4 après stimulation par la nucléocapside de coronavirus SARS-CoV-2 [Fraction de nombres] Sang ; Numérique | Cellen.CD4+CD154+/cellen.CD4^na stimulatie met SARS-CoV-2 nucleocapsidepeptide [getalsfractie] in bloed | ||||||
| 100862-2 |
|
Zellen.CD4.Interferon-gamma-exprimierend/CD4-Zellen in Blut --nach Stimulierung mit SARS-CoV-2-Nukleokapsid-Peptid | Cells.CD4.Interferon gamma-expressing/CD4 Cells - after stimulation with SARS-CoV-2 Nucleocapsid peptide, Blood | CD4 exprimant l'interféron gamma/CD4 après stimulation par la nucléocapside de coronavirus SARS-CoV-2 [Fraction de nombres] Sang ; Numérique | Cellen.CD4.interferon-gamma-positief/cellen.CD4^na stimulatie met SARS-CoV-2 nucleocapsidepeptide [getalsfractie] in bloed |
|
||||
| 100863-0 |
Zellen.CD4.Tumor-Nekrose-Faktor-alfa-exprimierend/CD4-Zellen
in
| Cells.CD4.Tumor necrosis factor alfa-expressing/CD4 Cells - after stimulation with SARS-CoV-2 Nucleocapsid peptide, Blood | CD4 exprimant le TNF alpha/CD4 après stimulation par la nucléocapside de coronavirus SARS-CoV-2 [Fraction de nombres] Sang ; Numérique | Cellen.CD4.tumornecrosefactor alfa-positief/cellen.CD4^na stimulatie met SARS-CoV-2 nucleocapsidepeptide [getalsfractie] in bloed | ||||||
| 100864-8 | Giardia lamblia bg-Gen [Genotyp] in Probenmaterial mittels Molekulargenetik | Giardia lamblia bg gene genotype, Specimen | Giardia lamblia gène bg [Génotype] Milieux divers ; Résultat nominal ; Biologie moléculaire | Giardia lamblia bg-gen [genotype] d.m.v. moleculair genetisch onderzoek | ||||||
| 100865-5 |
|
Avian schistosomes, Specimen |
|
Aviaire Schistosoma DNA [aanwezigheid] d.m.v. probe-detectie | ||||||
| 100866-3 | Febrile antibody profile, Blood | Profil d'anticorps fébriles [-] Sérum ; - | ||||||||
| 10086-7 |
|
ST I-Amp 6ms L-II | amplitud inicial del segmento ST, 6 mseg.derivación II:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | ST amplitud inicial 6 ms plomo II:Corazón :Punto temporal:Elpot:Cuantitativo:EKG |
| |||||
| 100867-1 | Campylobacter jejuni+coli+lari+upsaliensis Antigen [Nachweis] in Stuhl mittels Immunoassay-Schnelltest | Campylobacter jejuni+coli+lari+upsaliensis antigen, Stool | Campylobacter jejuni+coli+lari+upsaliensis Ag [Présence/Seuil] Selle ; Qualitatif ; Immunoanalyse rapide | Campylobacter jejuni + coli + lari + upsaliensis Ag [aanwezigheid] in feces d.m.v. immunoassay.sneltest | ||||||
| 100868-9 | Cryptosporidium sp 18S-LC2 rRNA [Genotyp] in Probenmaterial mittels Molekulargenetik | Cryptosporidium sp 18S-LC2 genotype, Specimen | Cryptosporidium ARNr 18S-LC2 [Génotype] Milieux divers ; Résultat nominal ; Biologie moléculaire | Cryptosporidium sp. 18S-LC2 rRNA [genotype] d.m.v. moleculair genetisch onderzoek | ||||||
| 100869-7 |
|
Cryptosporidium gp60-Gen [Typ] in Probenmaterial mittels Molekulargenetik | Cryptosporidium gp60 gene, Specimen | Cryptosporidium gène gp60 [Type] Milieux divers ; Résultat nominal ; Biologie moléculaire | Cryptosporidium gp60-gen [type] d.m.v. moleculair genetisch onderzoek | |||||
|
|
Cryptosporidium
18S
rRNA
[Genotyp]
in
| Cryptosporidium 18S genotype, Specimen | Cryptosporidium ARNr 18S [Génotype] Milieux divers ; Résultat nominal ; Biologie moléculaire | Cryptosporidium 18S rRNA [genotype] d.m.v. moleculair genetisch onderzoek | ||||||
| 100871-3 | Giardia lamblia gdh-Gen [Genotyp] in Probenmaterial mittels Molekulargenetik | Giardia lamblia gdh gene genotype, Specimen | Giardia lamblia gène gdh [Génotype] Milieux divers ; Résultat nominal ; Biologie moléculaire | Giardia lamblia gdh-gen [genotype] d.m.v. moleculair genetisch onderzoek | ||||||
| 100872-1 |
|
Bacteria producing polysaccharide from sucrose |
|
Uit
sucrose
polysacharideproducerende
bacterie
[aanwezigheid]
in
| ||||||
| 100873-9 | Giardia lamblia tpi-Gen [Genotyp] in Probenmaterial mittels Molekulargenetik | Giardia lamblia tpi gene genotype, Specimen | Giardia lamblia gène tpi [Génotype] Milieux divers ; Résultat nominal ; Biologie moléculaire | Giardia lamblia tpi-gen [genotype] d.m.v. moleculair genetisch onderzoek | ||||||
| 100874-7 |
|
Basidiobolus sp, Specimen |
| Basidiobolus sp. [aanwezigheid] | ||||||
| 10087-5 | ST I-Amp 6ms L-III | amplitud inicial del segmento ST, 6 mseg.derivación III:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | ST amplitud inicial 6 ms plomo III:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | ST I-Amp 6ms L-III | ||||||
| 100875-4 |
|
Fet Hrt Doc Ltd US |
|
|||||||
| 100876-2 | Fet Hrt Doc US | |||||||||
| 100877-0 |
|
US Heart Transesophageal during surgery |
|
|||||||
| 100878-8 | Endo US study Upr GI Tract Doc | |||||||||
| 100879-6 |
|
US Guided Brst-R Cryoablation |
|
|||||||
| 100880-4 | US Guided Brst-L Cryoablation | |||||||||
| 100881-2 |
|
MR Guided Bone Cryoablation | ||||||||
| 100882-0 | MR Peritoneum W contr percu | |||||||||
| 10088-3 | ST I-Amp 6ms L-V1 | amplitud inicial del segmento ST, 6 mseg.derivación V1:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | ST amplitud inicial 6 ms cable V1:Corazón :Punto temporal:Elpot:Cuantitativo:EKG |
Deprecated
| ||||||
| 100883-8 | MR Guided Kidney-L Bx | |||||||||
| 100884-6 |
|
MR Guided Kidney-R Bx |
|
|||||||
| 100885-3 | Parapoxvirus , Specimen | Parapoxvirus ADN [Présence/Seuil] Milieux divers ; Qualitatif ; PCR amplification de cible | Parapoxvirus DNA [aanwezigheid] d.m.v. probe-detectie | |||||||
| 100886-1 |
|
Orf virus, Specimen |
| Orfvirus DNA [aanwezigheid] d.m.v. probe-detectie | ||||||
| 100887-9 | Pseudocowpox virus, Specimen | Pseudocowpox virus ADN [Présence/Seuil] Milieux divers ; Qualitatif ; PCR amplification de cible | Pseudokoepokvirus DNA [aanwezigheid] d.m.v. probe-detectie | |||||||
| 100888-7 |
|
Affenpocken-Virus Klade II DNA [Nachweis] in Probenmaterial mittels Nukleinsäureamplifikation mit Sondendetektion | Monkeypox virus clade II, Specimen | Monkeypox virus clade II ADN [Présence/Seuil] Milieux divers ; Qualitatif ; PCR amplification de cible | 'Mpox'-virus clade II DNA [aanwezigheid] d.m.v. probe-detectie |
|
||||
| 100889-5 |
Affenpocken-Virus
Klade
I
DNA
[Nachweis]
in
| Monkeypox virus clade I, Specimen | Monkeypox virus clade I ADN [Présence/Seuil] Milieux divers ; Qualitatif ; PCR amplification de cible | 'Mpox'-virus clade I DNA [aanwezigheid] d.m.v. probe-detectie | ||||||
| 100890-3 | Poxvirus DNA panel | Poxvirus ADN panel [-] Patient ; - | Pokkenvirus DNA panel | |||||||
| 10089-1 |
|
ST I-Amp 6ms L-V2 | amplitud inicial del segmento ST, 6 mseg.derivación V2:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | ST amplitud inicial 6 ms. Derivación V2:Corazón :Punto temporal:Elpot:Cuantitativo:EKG |
| |||||
| 100891-1 |
Orthopoxvirus
IgG-Antikörper
[Nachweis]
in
Serum
| Orthopoxvirus IgG antibody, Blood | Orthopoxvirus Ac IgG [Présence/Seuil] Sérum/Plasma ; Qualitatif ; Immunoanalyse | Orthopoxvirus As.IgG [aanwezigheid] in serum of plasma d.m.v. immunoassay | ||||||
| 100892-9 | Orthopoxvirus IgM-Antikörper [Nachweis] in Serum oder Plasma mittels Immunoassay | Orthopoxvirus IgM antibody, Blood | Orthopoxvirus Ac IgM [Présence/Seuil] Sérum/Plasma ; Qualitatif ; Immunoanalyse | Orthopoxvirus As.IgM [aanwezigheid] in serum of plasma d.m.v. immunoassay | ||||||
| 100893-7 |
|
Orthopoxvirus IgG & IgM Ab panel, Blood |
|
Orthopoxvirus
IgG
&
IgM
As
panel
in
| ||||||
| 100894-5 | Recommended screen freq | |||||||||
| 100895-2 |
|
Rickettsia conorii IgG and IgM antibodies, Blood |
|
Rickettsia
conorii
As.IgG
&
IgM
[interpretatie]
in
|
||||||
| 100896-0 |
|
Vasopressin 13th specimen after challenge, Blood |
|
Vasopressine^13de
monster
na
XXX
belasting
[mol/volume]
in
| ||||||
| 100897-8 | Staphylococcus aureus culture, Specimen | Staphylococcus aureus [Présence/Seuil] Milieux divers ; Qualitatif ; Culture spécifique | Staphylococcus aureus [aanwezigheid] d.m.v. organisme-specifieke kweek | |||||||
| 100898-6 |
|
Lipid panel, Blood |
|
Lipiden
panel
in
| ||||||
| 100899-4 | Enterobacteriaceae.extended spectrum beta lactamase resistance phenotype culture, Specimen | Enterobacteriaceae phénotype de résistance aux bêta lactamases à spectre élargi [Identification] Milieux divers ; Résultat nominal ; Culture spécifique | Enterobacteriaceae.ESBL-resistentie fenotype [identificator] d.m.v. organisme-specifieke kweek |
See the full registry of value sets defined as part of FHIR.
Explanation of the columns that may appear on this page:
| Lvl | A few code lists that FHIR defines are hierarchical - each code is assigned a level. For value sets, levels are mostly used to organize codes for user convenience, but may follow code system hierarchy - see Code System for further information |
| Source | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
| Code | The code (used as the code in the resource instance). If the code is in italics, this indicates that the code is not selectable ('Abstract') |
| Display | The display (used in the display element of a Coding ). If there is no display, implementers should not simply display the code, but map the concept into their application |
| Definition | An explanation of the meaning of the concept |
| Comments | Additional notes about how to use the code |